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Allostasis is the process through which the human body aims to achieve
homeostasis - long-term physiological stability in each of its systems
- through short-term changes. If someone experiences chronic stress
or repeated bouts of stress, their allostatic systems can experience wear
and tear and enter a state of allostatic load.
The thesis first considered how allostatic load is operationalised.
It outlined problems with modelling allostatic load as a latent
factor, including concerns based on psychometric and substantive
studies. This chapter also posited desirable qualities of allostatic load
operationalisations.
The subsequent substantive chapters were empirical studies that
explored the role of allostatic load in successful ageing. In the first
three of four studies, we fitted latent growth curve models to data
from Waves 1-4 of the Lothian Birth Cohort 1936 (n [M age] at Waves
1-4 = 1,091 [69.5 years], 866 [72.5 years], 697 [76.3 years], 550 [79.3
years]). Additional models tested the role of non-random dropout.
The first of these studies investigated how allostatic load relates to
four other measures of physiological weathering: [Klemera-Doubal]
biological age; extrinsic epigenetic age; intrinsic epigenetic age; and
telomere length. Allostatic load was most strongly related to biological
age, which is an age-linked measure calculated using some of the same
biomarkers as allostatic load. At Wave 1, higher allostatic load was
related to older biological age, with a moderate effect size (r [SE] =
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.28 [.05], p < .001). Greater increase over time in allostatic load was
strongly related to accelerated biological ageing (r [SE] = .53 [.15], p
< .001). However, most correlations between physiological weathering
measures were small, which suggested that they index different aspects
of physiological weathering.
The next study found that at Wave 1, higher allostatic load was related
to lower general cognitive ability, with a small effect size (r [SE] = -.13
[.04], p = .004). However, after controlling for the variance related to
participant dropout, the relationship was attenuated by around a third
(r [SE] = -.08 [.04], p = .08). The third Lothian Birth Cohort 1936 study
found that at Wave 1, higher allostatic load was related to having more
depressive symptoms, with a small-to-moderate effect size (r [SE] =
.19 [.05], p < .001). These studies also went beyond previous research
by testing relationships of associated changes over time. These tests
suggested changes in allostatic load are not strongly related to changes
in cognitive ability and depressive symptoms.
The last empirical study in this thesis used data from the Scotland-based
36-Day-Sample (n range for models = 280-332; M age at cognitive
testing = 78.2 years). In this study, producing more cortisol during the
first 45 minutes after waking was related to higher general cognitive
ability (β [SE] = 0.14 [0.07], Bayes factor10 [BF10] = 5.23), but the total
cortisol produced during the waking day was not related to general
cognitive ability (BF10 < 1/3). We also found that in carriers of the
e4 allele of the apolipoprotein E gene, some measures of cortisol
dynamics were more negatively associated with residualised immediate
recall scores and some measures of total cortisol production were
more negatively associated with residualised Raven’s matrices scores.
Additionally, this study found that depressive symptoms were related
to lower general cognitive ability (β [SE] = -0.15 [0.08], BF10 = 3.47),
but the relationship was not more negative in e4 allele carriers (β [SE]
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= 0.08 [0.07], BF10 = 0.21).
The final chapter considered the results in a wider context, as well as
possible future directions. We discussed the limitations of our allostatic
loadmeasure, which did not include any hypothalamic–pituitary–adrenal
axis biomarkers. We also considered the constraints on generalisability
of all allostatic load findings given the heterogeneity of the
operationalisations used. We questioned the clinical utility of allostatic
load measurement for cognitive decline and depressive illness, given
the small effect sizes we obtained for the relevant relationships.
Finally, we concluded that future research will benefit from using larger
samples and teasing apart how these relationships vary based on the




If you experience too much stress, your body’s stress systems will work
too hard and become damaged. This includes psychological stress,
for example, work stress or anxieties about a family member’s health,
and physiological stress, such as running a marathon without proper
training. Lack of activity, for example, lying stationary in bed for
a month, can also negatively affect the body. Negative impacts on
your stress systems then have knock-on effects on your other bodily
systems. This includes your cardiovascular system, which works to keep
your heart healthy and your body fit, your metabolic system, which
processes the food and drink you consume, and your immune system,
which fights viruses and works to heal damaged muscles and tissue.
The resulting stress-induced state, in which various bodily systems
are not working well, is called allostatic load. It can be measured by
measuring and statistically combining markers from different bodily
systems, such as blood pressure for the cardiovascular system, body
mass index for the metabolic system, and C-reactive protein levels in
blood for the immune system. This thesis looked at allostatic load, how
it relates to cognitive ability, depressive symptoms and other measures
of poor bodily functioning.
We found that in the Lothian Birth Cohort 1936, a sample of 1,091
older adults, changes over time in allostatic load were closely related to
changes over time in biological age, which is a chronological age-linked
measure that is calculated using some of the same biomarkers as
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allostatic load. In the same sample, we found allostatic load was
related to general cognitive ability and depressive symptoms at around
age 70. We did not find that changes in allostatic load were strongly
related to changes in general cognitive ability or depressive symptoms.
Finally, in the 36-Day-Sample, a sample of over 300 older adults, we
tested how cognitive ability is associated with depressive symptoms,
neuroticism, and the levels and within-day changes of cortisol, a
stress-related allostatic load biomarker. We also tested whether
these relationships were more harmful in participants who had a
particular genetic variant, the e4 allele of the apolipoprotein E gene.
We found that participants who produced more cortisol in the first 45
minutes after waking tended to have higher general cognitive ability.
Participants with more depressive symptoms tended to have lower
general cognitive ability, and there was evidence that this association
was not stronger in those with the e4 allele. Furthermore, our results
suggested that there was not an association between the total cortisol
produced while awake and general cognitive ability.
It must be emphasised that while we found associations between
the functioning of the body and the mind, these associations were
small-to-moderate in size. Knowing an older individual’s allostatic
load score would help you to guess their cognitive ability or how many
depressive symptoms they experience (or vice versa), but only slightly.
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1.1 The allostatic load model
The healthy human body is capable of dealing with a wide range of
mental and physical challenges. It is like a machine in that regular use
helps to keep its components in good condition. For example, if a person
takes part in regular physical exercise, they will generally become more
fit and more able to meet certain physical challenges. However, like
with many machines, very rare use, very frequent use, or extreme use
can cause damage. For example, in the case of post-traumatic stress
disorder, extreme psychological stress can lead to adverse mental
(Koenen et al., 2003) and physiological (Pacella, Hruska, & Delahanty,
2013) health outcomes. The allostatic load (AL) model provides a
framework for understanding and studying the wide-ranging effects of
stress on physiological and psychological health. This model, and key
relationships with other physiological and psychological measures to
be studied in this thesis, will now be described.
Homeostatic systems (e.g., body temperature) have to be kept within
small ranges, with severe health consequences if they are not (McEwen,
1998). Allostatic systems (e.g., the hypothalamic-pituitary-adrenal
1
[HPA] axis), on the other hand, can function within wider ranges, with
dysregulation typically leading to damage being incrementally inflicted
on the body (McEwen, 1998).
Allostasis is the ability of the body’s physiological systems to maintain
long-term stability by successfully adapting in the short term to
situations and events (McEwen & Wingfield, 2007). Repeated,
prolonged or insufficient exposure to stress can lead to allostatic
systems becoming dysregulated (McEwen &Wingfield, 2007). Allostatic
load, or allostatic overload, is the the accumulation of damage to the
body’s physiological systems that is caused by allostatic states, that
is, the long-term overactivity or underactivity of allostatic systems
(McEwen & Wingfield, 2007).
McEwen (1998) outlined four origins of allostatic load:
• repeated stress responses, where the healthy stress response
occurs too often;
• a lack of adaptation to stress, where the body does not habituate
to a particular stressor and so it repeats the initial heightened
response to stress during subsequent exposures;
• prolonged response to stress, where the heightened stress
response continues for an extended period;
• and an inadequate response to stress, where a fully heightened
stress response is not achieved by one allostatic system, so another
allostatic system overresponds to compensate.
McEwen & Seeman (1999) added to the allostatic load model by
presenting the following stages of allostasis and allostatic load, each
of which plays a different role in the cascade of reactions and effects
involved in allostasis:
• primary mediators (e.g., cortisol), chemical messengers, such as
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catecholamines, cytokines, and hormones, that are released as part
of allostasis (McEwen, 2005);
• primary effects (e.g., enzymes), cellular events that primary
mediators affect as part of allostasis;
• secondary outcomes (e.g., triglycerides), organ- or tissue-specific
outcomes of the long-term levels of (and fluctuations in levels of)
the primary effects, which were themselves brought about by the
primary mediators;
• and tertiary outcomes (e.g., cardiovascular disease), diseases or
disorders caused by allostatic load, which itself was brought about
by high and/or low values of the primary mediators and secondary
outcomes.
An example cascade starts with psychological stress leading to increased
secretion of the primary mediator cortisol (Chida & Steptoe, 2009).
The higher level of cortisol could relate to the primary effect of DNA
methylation (Lam et al., 2012). This increased cortisol would then lead
to increased levels of the secondary outcome glucose, directly and/or
through effects on diet (Epel, Lapidus, McEwen, & Brownell, 2001;
McEwen & Seeman, 1999). This cascade would be part of a broader
move towards a state of allostatic load, which could ultimately lead
towards the tertiary outcome of Type 2 diabetes (Rosmond, 2003).
Allostatic load, like in the example cascade, involves dysregulation in
multiple physiological systems. Primary mediators are mainly markers
from the neuroendocrine system (e.g., glucocorticoids released by the
HPA axis) and the immune/inflammatory system (e.g., interleukin-6).
The most commonly measured secondary outcomes are markers from
the metabolic (e.g., total cholesterol) and cardiovascular systems (e.g.,
blood pressure). Summary measures of allostatic load generally include
markers of different types from different physiological systems.
Studies using such summary measures have shown the importance
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of studying allostatic load, as they have linked allostatic load scores
to important health outcomes, including mortality. For example,
in the MacArthur Study of Successful Aging, higher allostatic load
was linked to greater all-cause mortality risk (odds ratio = 1.23;
Seeman, McEwen, Rowe, & Singer, 2001). This association was not
only due to commonly administered metabolic system markers; in
fact, neuroendocrine summary scores seemed to be more strongly
predictive of mortality than metabolic syndrome summary scores (odds
ratios = 1.36 and 1.18; Seeman et al., 2001). A similar effect size was
observed in the Taiwan-based Social Environment and Biomarkers of
Aging study (sample aged 54 and over at baseline; n = 1,023), where
an additional allostatic biomarker in the top or bottom sample decile
was associated with a 20% increase in 10-year all-cause mortality risk
(hazard ratio = 1.20; Hwang et al., 2014). The effect size was smaller
in the Scottish Health Survey (at baseline mean [standard devation] age
= 51.0 [18.0]; n = 4,488), where an additional biomarker indicating
risk increased 10-year all-cause mortality risk by 8% (Robertson,
Beveridge, & Bromley, 2017). This study used a younger sample, did
not have neuroendocrine markers and scored allostatic load with the
number of biomarkers in the highest risk sample quartile, rather than
the top and bottom sample deciles (Robertson et al., 2017). Finally,
allostatic load was also related to mortality in the large sample of
the National Health and Nutrition Examination Survey III (sample
aged 30 and over; n = 9,942). For the most predictive allostatic load
measure, those in the highest quintile of allostatic load had almost
seven times the mortality risk of those in the lowest quintile (hazard
ratio for continuous allostatic load = 6.97; Levine & Crimmins, 2014).
Notably, though, the strength of the association differed based on
the allostatic load operationalisation used (Levine & Crimmins, 2014).
Furthermore, another mortality study used data from the same cohort
but operationalised allostatic load using a different biomarker set
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with no neuroendocrine markers (Howard & Sparks, 2016). This study
found that an additional biomarker beyond a clinical cutoff increased
all-cause mortality risk by 7%, with a follow-up period of up to 18
years (hazard ratio = 1.07; sample aged 25 and over; n = 11,733; Howard
& Sparks, 2016).
1.2 Allostatic load operationalisation
When conducting allostatic load research, it is important to carefully
consider the operationalisation used as this can affect the strength and
patterns of results. There is notable heterogeneity in the biomarkers
and the statistical methods used to calculate allostatic load scores.
The biomarker sets used generally contain markers from multiple
physiological systems, such as the neuroendocrine, metabolic, immune
and cardiovascular systems, but operationalisations vary in the systems
represented and the specific biomarkers used (Juster, McEwen, &
Lupien, 2010, Figure 4).
Scores are also affected by the calculation method used. There are
many methods in use. A recent study comparing allostatic load
operationalisations in the same dataset found that in 21 studies, scores
were calculated in 18 ways (Duong, Bingham, Aldana, Chung, & Sumner,
2017). Methods used to calculate allostatic load scores include: sums
of markers dichotomised into 0s (not indicating risk) and 1s (indicating
risk) based on sample quantiles (Seeman, Singer, Rowe, Horwitz, &
McEwen, 1997) or clinical thresholds (Seeman et al., 2008); sums of
z score-transformed markers (Seeman et al., 1997; Seplaki, Goldman,
Glei, & Weinstein, 2005); and correlation-based measures, such as
factor analysis (Seeman et al., 2010), principal component analysis
(Wallace et al., 2013), and latent class analysis (Fried et al., 2009).
Recently, some researchers have argued for the use of a bifactor
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confirmatory factor analysis model in which allostatic load biomarker
levels are causally influenced by a general latent factor of allostatic load
and system-specific latent factors (Wiley, Gruenewald, Karlamangla, &
Seeman, 2016). However, there are practical and theoretical problems
with this allostatic load operationalisation. In Chapter 2, we will
consider this operationalisation and what properties are desirable for
allostatic load operationalisations. Then, we will outline the allostatic
load operationalisation we chose to use in Chapters 4, 5 and 6,
with reference to its measurement properties and previous method
comparisons.
1.3 Allostatic load and other physiological
weathering measures
Allostatic load theory posits particular mechanisms underlying observed
allostatic load. However, summary measures of allostatic load are
sometimes used more as general measures of overall physiological
dysregulation or physiological weathering (e.g., Goldman et al.,
2006). There are other broad measures of physiological weathering
with different theoretical and methodological foundations, although
these have not frequently been studied together with allostatic load.
Three such measures are closely linked to the study of biological
ageing: biomarker panel-based measures of biological age; DNA
methylation-based measures of epigenetic age; and leukocyte telomere
length.
Attempts to measure biological age have been made for decades (see
Jia, Zhang, & Chen, 2017 for a review). The Klemera-Doubal method
(Klemera & Doubal, 2006) has performed well in studies comparing
calculation methods (Cho, Park, & Lim, 2010; Jee & Park, 2017). This
method uses chronological age along with ageing biomarkers, some of
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which have also been used in allostatic load measurement, to estimate
biological age (Klemera & Doubal, 2006). Estimates have been linked
to a variety of mental and physical health outcomes, including mortality
(Belsky et al., 2015; Levine, 2013).
Estimates of epigenetic age use DNA methylation rather than any of
the biomarkers used to operationalise allostatic load. DNA methylation
occurs when a methyl group is added to cytosine nucleotides on the
genome at cytosine-phosphate-guanine (CpG) sites (Beck & Rakyan,
2008). The proportion of methylation at CpG sites can be measured
(Beck & Rakyan, 2008). Recently, through working with models that
predict chronological age from methylation at particular CpG sites,
researchers have developed methods to estimate epigenetic age from
DNA methylation in blood and/or other tissues at a selection of CpG
sites (Hannum et al., 2013; Horvath, 2013). Epigenetic age estimates
from these methods are strongly related to chronological age and,
when combined with chronological age, can be used to generate
estimates of epigenetic age acceleration/deceleration, the pace of the
epigenetic clock (Hannum et al., 2013; Horvath, 2013). Like biological
age, epigenetic age has been linked to mortality (Marioni et al., 2016).
Lastly, telomere length has been put forward as a biomarker for ageing
(Mather, Jorm, Parslow, & Christensen, 2011). Telomeres are repetitive
DNA sequences that sit at the end of each chromosome, protecting
them from damage (Riethman, 2008). Telomeres are shortened each
time a cell replicates DNA and by oxidative stress, until they are shorter
than a critical length, at which point DNA replication stops and the cell
enters a state of senescence (Simons, 2015). Telomeres shorten with
age and telomere length has sometimes been linked to age-related
measures, so it is a contested marker of biological age (Mather et al.,
2011). It has been incorporated in biological age estimation (Zhang
et al., 2014), although it may rather be “a biomarker of somatic
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redundancy, the body’s capacity to absorb damage” (Boonekamp,
Simons, Hemerik, & Verhulst, 2013, p. 330). Telomere length has also
been linked to mortality (Boonekamp et al., 2013) and its relationship
with mortality is independent of that of epigenetic age (Marioni et al.,
2016).
Researchers have begun to explore the relationships between these
different measures. Allostatic load was not related to telomere length
in a sample of reproductive-aged women (Ahrens, Rossen, & Simon,
2016), but three allostatic load measures were strongly correlated
with biological age in the National Health and Nutrition Examination
Survey III, a large representative sample in the United States (n =
9,942; r range = .49 to .65; Levine & Crimmins, 2014). At age 38
in the New Zealand-representative Dunedin Study cohort, biological
age was correlated weakly with epigenetic age (r range = .07 to .15),
but telomere length was not statistically significantly correlated with
biological age or epigenetic age (r range = -.02 to -.05; Belsky et al.,
2018). Chapter 4 will attempt to clarify the relationships between these
measures, including hitherto unexplored longitudinal relationships.
1.4 Allostatic load and cognitive ability
It is important to research the contemporaneous and longitudinal
relationships between allostatic load and cognitive ability, particularly
in older age. Cognitive ageing is a major public health issue, especially in
countries with ageing populations (Deary et al., 2009) and researchers
have suggested that allostatic load could improve the assessment of
risk for age-associated cognitive decline (Seeman et al., 1997).
The brain is central to both cognitive functioning and the stress
response involved in allostasis, so effects on the brain can alter both
the stress response and cognitive ability (McEwen & Gianaros, 2011).
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There are also potential causal pathways in both directions between
the two measures. For example, the allostatic load marker cortisol
may decrease brain area volumes, which in turn can affect cognitive
functioning (Echouffo-Tcheugui et al., 2018). Cognitive ability is
related to unhealthy behaviours (Gottfredson & Deary, 2004), which
have been associated with allostatic load (Forrester, Leoutsakos, Gallo,
Thorpe, & Seeman, 2019). Cohort studies, such as those discussed here
and conducted in this thesis, may inform future mechanistic research
but their focus is on estimating associations.
Allostatic load has previously been related to contemporaneously
measured cognitive ability (Booth et al., 2015; Crook et al., 2018;
Karlamangla et al., 2014; Seplaki et al., 2005). Plus, in the MacArthur
Studies of Successful Aging (based in the United States of America)
and the Lothian Birth Cohort 1936 (based in Scotland), but not the
Social Environment and Biomarkers of Aging Study (based in Taiwan),
allostatic load has been linked to subsequent cognitive decline (Crook
et al., 2018; Karlamangla, Singer, McEwen, Rowe, & Seeman, 2002;
Seeman et al., 2001, 1997; cf. Goldman et al., 2006). A longitudinal
link in the other direction has also been reported: in the West of
Scotland Twenty-07 Study, slower processing speed at age 16 was
related to higher allostatic load at age 36 (Gale et al., 2015).
Aspects of the relationship between allostatic load and cognitive ability
remain unclear, including whether each variable predicts subsequent
change in the other when longitudinal measures of both are modelled
together, whether longitudinal change in both variables is correlated,
and how allostatic load relates over time to general and specific domains
of cognitive ability. Chapter 5 will attempt to clarify the longitudinal
relationship between allostatic load and cognitive ability.
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1.5 Allostatic load and depressive symptoms
Understanding how allostatic load relates to depression is important,
as it could aid in the diagnosis and treatment of depression (Lopresti,
Maker, Hood, & Drummond, 2014) and physiological dysregulation,
enabling more personalised and effective treatment. It is well
established that certain allostatic load biomarkers tend to be
dysregulated in people with depression. This includes endocrine
(Murri et al., 2014), inflammatory (Valkanova, Ebmeier, & Allan, 2013),
and metabolic (Marazziti, Rutigliano, Baroni, Landi, & Dell’Osso, 2014)
biomarkers. Physiological dysregulation in people with depression is
not uniform, as profiles of dysregulation differ between subtypes of
depression (Lamers et al., 2013).
As mentioned previously, the brain is the central mediator of the stress
response (McEwen & Gianaros, 2011). It is also central to depressive
symptoms. Hence, the brain can be a key mediator of the relationship
between allostatic load and depressive symptoms. For example, the
hippocampus is involved in downregulation of the stress response and is
reduced in size in depression as well as in states of chronic stress, chronic
inflammation, and after prolonged glucocorticoid exposure (McEwen &
Rasgon, 2018). Observational cohort studies sometimes help to suggest
future mechanistic studies of allostatic load and depressive symptoms,
but their focus is on estimating the contemporaneous and longitudinal
associations between the measures.
To date, few studies have explored the relationship between allostatic
load summary measures and depressive symptoms. Allostatic
load summary measures have been related to contemporaneously
measured depressive symptoms (Juster et al., 2011; Kobrosly, Seplaki,
Cory-Slechta, Moynihan, & van Wijngaarden, 2013; Kobrosly, van
Wijngaarden, Seplaki, Cory-Slechta, & Moynihan, 2014) and depressive
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symptoms measured years later (Gale et al., 2015; Goldman et al.,
2006; Juster et al., 2011). Research has not yet fully explored how
allostatic load and depressive symptoms relate over time. Notably, the
relationship between change in allostatic load and change in depressive
symptoms has not been tested. This change-change relationship can
be tested by correlating the slopes in a latent growth curve model.
Chapter 6 will fit latent growth curve models to investigate the
contemporaneous and longitudinal relationships between allostatic
load and depressive symptoms.
1.6 Genetic modification of allostatic load
biomarker influences
As mentioned previously, relationships between allostatic load and
cognitive ability have been reported. What is less clear is whether
the relationship between any allostatic load marker and cognitive
ability is modified by the possession of a particular genetic variant.
Understanding whether these relationships are moderated by genes
is important because it could improve our understanding of the
mechanisms of allostatic load and potentially have implications for
genetically informed clinical practice.
One previously reported but unclear gene-by-allostatic load biomarker
interaction effect involves the interaction between two variables
independently linked to cognitive ability: the e4 allele of the
apolipoprotein E (APOE) gene and cortisol levels. APOE e4 has
been related to lower cognitive ability and greater cognitive decline
(Davies et al., 2015, 2014). Also, various measures of cortisol levels
and dynamics have been related to cognitive ability (Beluche, Carrière,
Ritchie, & Ancelin, 2010; Franz et al., 2011; Lee et al., 2007) and
cognitive decline (Franz et al., 2011; Li et al., 2006). Some measures
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of cortisol tend to be positively associated with cognitive outcomes
(e.g., the cortisol awakening response; Stawski et al., 2011) while
others are negatively associated with cognitive outcomes (e.g., evening
cortisol levels; Stawski et al., 2011). Some studies have suggested that
APOE e4 status may moderate the relationship between cortisol and
cognitive ability such that it is more negative in e4 carriers than e4
non-carriers, however, not all studies on this topic have formally tested
the interaction, and the results have varied across measures of cortisol
and cognitive ability (Gerritsen, Comijs, Deeg, Penninx, & Geerlings,
2011; Lee et al., 2008; Singh-Manoux et al., 2014).
Chapter 7 will use a range of cortisol measures and cognitive tests to
attempt to find out whether the level and dynamics of the secretion
of cortisol, a key primary mediator of allostatic load, are related to
different measures of cognitive ability and whether these relationships
are moderated by the possession of the APOE e4 allele.
1.7 Summary
In summary, much has been learned about allostatic load over the last
20 years, but questions remain regarding the relationships between
allostatic load biomarkers, the best way to operationalise allostatic
load, and how allostatic load relates to other broad physiological
dysregulation measures. Questions also remain about how allostatic
load relates to cognitive ability and depressive symptoms over time,
and how genetic variants may modify relationships between allostatic
load biomarkers and cognitive ability. This thesis will attempt to make
a unique contribution to the allostatic load literature by answering
some of these questions.
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Chapter 2
Considering the factor analytic
operationalisation of allostatic
load
This chapter is based around a letter that I (Z.C.) and my primary
supervisor (T.B.) wrote to the editor of Psychosomatic Medicine in
response to a study by Wiley et al. (2016). Their study argued
for a bifactor confirmatory factor analysis operationalisation of
allostatic load. In this letter, we raised concerns with factor analytic
operationalisations of allostatic load. The primary positive contribution
of this letter is that we put forward desirable properties of allostatic
load scores. These properties will help both researchers choosing an
allostatic load operationalisation and researchers conducting future
allostatic load measurement studies. Thanks to funding from the
Economic and Social Research Council, the letter was published open
access with a Creative Commons Attribution 4.0 International (CC BY
4.0) licence (Crook & Booth, 2017b). Here, the letter is presented with
the only edits made to match the letter to the format of this thesis.
After the edited reproduction of the letter, the chapter concludes with
a coda that presents this thesis’s allostatic load operationalisation and
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explains why it was chosen.
2.1 Letter to the editor introduction
In a recent issue of Psychosomatic Medicine, Wiley et al. (2016) made a
valuable contribution to the discussion of the optimal measurement of
allostatic load. In the most comprehensive factor analytic investigation
of allostatic load to date, they found that a bifactor model with a
general AL factor and seven physiological system factors fits better
than a higher-order model in which the seven system factors loaded on
the general AL factor. Similar models have been applied by the author
(T.B.) and others to operationalise allostatic load (Booth et al., 2013;
Howard & Sparks, 2016; Seeman et al., 2010). Here, we consider the
primary theoretical assumptions underlying latent variable modelling,
argue that the construct of allostatic load is inconsistent with these
assumptions, and propose alternate operationalisations of allostatic
load.
2.2 Underlying construct (common cause)
A latent variable model is estimated based on the patterns of covariance
in a set of variables. By including an allostatic load general factor in
a latent variable model, researchers are positing that an underlying
construct is the common cause of the observed covariation in all of
the modelled biological measures. Although the theoretical relation
of the common cause or construct to the original variables differs in
bifactor versus higher-order models, in either case, we must ask: What
could this common factor be? Wiley et al. stated that the AL factor
“[captures] the notion that there is an underlying process influencing
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multiple physiological systems” (Wiley et al., 2016, p. 4). However,
the observation of a general factor estimated from interindividual
summary statistics (i.e., covariances) says little about what this process
may actually be.
2.3 Independence conditional on the latent
trait
In a typical latent variable model, the latent variable is modelled as
causing the values on the indicator variables. A set of indicator variables
are correlated, but this correlation is solely a result of the shared causal
relation with the latent variable. As a result, once the latent variable has
been modelled based on the correlations between indicator variables,
the indicator variables should be uncorrelated, or independent. For
example, a personality psychologist might model the latent variable
of extraversion as causing people to report both feeling “comfortable
around people” and being “the life of the party”, and the two items
would be assumed to be independent after conditioning on extraversion.
If, instead, feeling comfortable around people caused people to be the
life of the party, and this dependence remained after conditioning on
the latent variable, the assumption of conditional independence would
be violated.
The assumption of conditional independence is unlikely to hold in an AL
latent variable model. Levels of different biomarkers are linked causally
to each other, rather than only through the common cause latent
variable(s). For example, body mass index (BMI) has previously been
used as a metabolic system allostatic load biological measure (e.g.,
Booth et al., 2013; Crimmins, Johnston, Hayward, & Seeman, 2003).
However, Mendelian randomisation studies have found that increased
BMI has a causal effect on levels of other metabolic biological measures
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as well as levels of allostatic load biomarkers used to represent other
physiological systems, such as blood pressure and inflammation (e.g.,
Millard et al., 2015). Thus, it is most likely that the biomarkers are
not conditionally independent but are instead dynamically related in
complex networks. Such networks can produce observed correlations
between variables that have no common cause (van der Maas et al.,
2006).
2.4 Interchangeability of indicators
A further assumption of the latent variable model is that the definition
of the latent variable does not change when different sets of indicators
are used (Bollen & Bauldry, 2011). This holds because the indicators are
affected by, but do not affect, the latent variable. Another key finding
of Wiley et al. was that fitting models in which the biological measures
from each of the 7 physiological systems were excluded caused no
large changes in allostatic load factor loadings (Wiley et al., 2016).
This method provides only a weak test of interchangeability. The
stability of general intelligence factor loadings has long been a research
focus for intelligence researchers, so allostatic load researchers may
benefit from applying their approaches to this issue (e.g., Johnson,
Bouchard, Krueger, McGue, & Gottesman, 2004; Thorndike, 1987). For
example, researchers could compute and correlate allostatic load scores
from different nonoverlapping multisystem sets of biological measures
(Bollen & Bauldry, 2011). The existence of diverse causal links between
allostatic load biological measures from different physiological systems
suggests to us that the nature of what relates the biomarkers may
change depending on which measures are included in the model. We
predict that more thorough, more powerful tests of the stability of AL
factor loadings will find that it does not hold.
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2.5 Formative versus reflective indicators
In the common factor model, the biological measures are reflective
indicators, that is, they are manifested by a common cause latent
variable. However, to the extent that the model assumptions are
violated (previously discussed), the factor model is not appropriate.
Thus, it may instead be profitable to consider the biological measures
as formative indicators, that is, as variables that define the construct
(Bollen & Bauldry, 2011). This way of thinking about how the biological
measures relate to allostatic load is consistent with any number of
weighted or sum scores. It is also consistent with allostatic load theory,
in that more severe, more widespread physiological dysregulation will
relate to higher AL scores.
Alternatively, the associations between AL biological measures could
be modelled using each measure individually, without the need for
any single latent or observed summary. This could be done with
network analysis, which has been used beneficially by researchers
studying symptom networks in mental disorders (Borsboom & Cramer,
2013). It should be noted that for any given network model, there is a
statistically equivalent factor analysis model (Kruis & Maris, 2016). This
does not mean, though, that both models are reasonable, nor that they
are theoretically equivalent (Borsboom, 2017; Epskamp & Fried, 2018).
Network models can be more insightful for some research problems
because they switch the focus away from the common variance and
onto the individual indicators and their interrelationships (Epskamp &
Fried, 2018). This approach could be fruitful for allostatic load research.
However, large-sample longitudinal measurements of allostatic
load biomarkers are typically collected years apart, so longitudinal
network analyses using currently available data may not reveal much
about the causal connections between allostatic load biomarkers
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(Fried et al., 2017). To investigate the strength and directions of
the links between biomarkers, future research should aim to collect
longitudinal data on allostatic load biomarkers with shorter intervals
between measurements, such as hours, days or weeks rather than
years (Eatough, Shockley, & Yu, 2016; van Ockenburg, Booij, Riese,
Rosmalen, & Janssens, 2015). This can be combined with data collection
on activities, perceived stress, and psychological symptoms (Beal, 2015;
Treadway & Leonard, 2016).
Allostatic load indicators can also be modelled separately without
consideration of their associations. Consistent with this approach,
Psychosomatic Medicine typically provides data of separate biological
measures when articles report about complex phenomena such as AL
and metabolic syndrome.
Aside from any issues regarding model assumptions, two further points
warrant comment about the models presented by Wiley et al.
2.6 Improved model fit for bifactor approach
Mediators of the stress response from different physiological systems
are causally linked in nonlinear networks that include reciprocal
associations (McEwen, 2006). The complex structure of the
associations between allostatic load markers helps to explain why
the bifactor allostatic load model fits better than the hierarchical
allostatic load model. The hierarchical model imposes “proportionality
constraints” (Yung, Thissen, & McLeod, 1999, p. 115) the ratio of the
allostatic load general factor loadings to the system factor loadings
is constrained to equality within the biological measures of each
physiological system. Considering the diverse causal links between
different allostatic load biomarkers, both within and across systems,
these proportionality constraints are likely to be violated. Furthermore,
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it has been shown that when the true model contains “unmodelled
complexity” (Murray & Johnson, 2013, p. 407) in the form of small
correlated residuals and cross-loadings, or even modelled complexity
in the form of correlated residuals across factors, fit indices and criteria
may be biased in favour of the bifactor model. Consequently, the
better fit of the bifactor model follows from allostatic load theory and
research, as well as from methodological findings, for reasons other
than those Wiley et al. (2016) focused on.
2.7 Variance explained by physiological
dysregulation factors
Statistically, a desirable property of a general factor is that it accounts
for most variance in the constituent indicator variables. In the study
by Wiley et al., the allostatic load factor explained only approximately
11% of the variance in the AL biological measures. Some of the
physiological system-specific factors were also weak. For example,
the hypothalamic-pituitary-adrenal axis and inflammation factors
explained only approximately 9% and 16% of the variance in their
respective biological measures. Note that weak factor saturation of
physiological dysregulation factors has also been an issue in other
samples (Booth et al., 2013; Seeman et al., 2010).
2.8 Properties of optimal scores for
allostatic load
Ideally, allostatic load scores should be: 1) calculated using biological
measures from various physiological systems; 2) consistently calculated
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across samples; and (3) closely related to criterion variables. Those who
desire scores that are rooted in allostatic load theory would prefer the
allostatic load scoring method that produces the scores most closely
related to chronic/repeated perceived stress. For a pragmatist, the focus
may not be on investigating how different physiological dysregulation
scores relate to prior perceived stress but rather on finding the
scores that most strongly predict important health outcomes such
as cardiovascular disease and death. It may also be advantageous to
have scores that explicitly represent the accumulation of the effects of
repeated environmental challenges.
Our theoretical and methodological concerns with the factor analytic
operationalisation of allostatic load suggest to us that factor scores
will not prove to be the optimal allostatic load scoring method. We
therefore believe that further research is required to determine the
optimal operationalisation(s) of allostatic load.
2.9 Coda
It is worth emphasising that the critiques in this letter do not only apply
to allostatic load research. Similar issues exist in other subject areas,
including psychology. For example, depression is frequently modelled
as a latent variable, but network models have recently suggested
that depressive symptoms (depression items) are not independent
conditional on the latent trait because there are causal links between
some symptoms (McNally, 2016). Furthermore, personality factors may
violate the assumption interchangeability of indicators (Konstabel et
al., 2017) and intelligence factor models have been shown to be biased
towards showing better model fit for the bifactor versus higher-order
factor models (Gignac, 2016; Morgan, Hodge, Wells, & Watkins, 2015;
Murray & Johnson, 2013).
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Outside of psychology, socioeconomic status has been modelled as a
latent variable (e.g., Scharoun-Lee, Adair, Kaufman, & Gordon-Larsen,
2009), but the factor indicators used do not have a clearly defined
common cause. Like allostatic load, it may be more appropriately
modelled as a formative rather than a reflective latent variable, or not
as a latent variable at all.
In this thesis, we chose to use to calculate allostatic load scores using
the mean absolute z score method. Teasing apart how scores are
calculated using this method elucidates its favourable properties. Like
with the vast majority of allostatic load operationalisations, scores
are calculated from a panel of biomarkers from different physiological
systems. Firstly, the distribution of each marker is checked and if
a marker’s distribution is not approximately Gaussian, then it will
be transformed to be so. Then, the values of each biomarker are
transformed into z scores where 0 is the mean and 1 the standard
deviation. Next, for all biomarkers where risk can be indicated at both
ends of the distributions - that is, high or low values - the z scores are
changed into absolute values. This means that, for example, whether
an individual has systolic blood pressure 2 standard deviations above
or below the mean, the contribution to the allostatic load score is the
same. Finally, the intraindividual mean of all available absolute z scores
is calculated to give their allostatic load score.
The z score approach has been supported by studies that have compared
how scores from different allostatic load operationalisations relate to
criterion variables. Using data from the Social Environment and
Biomarkers of Aging Study, Seplaki et al. (2005) compared nine
allostatic load operationalisations by calculating scores and comparing
their associations with five criterion variables: self-rated health;
mobility limitations; the presence of any limitations in activities of
daily living; depressive symptoms; and mistakes in identifying the
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current day, date, month and year. The only two operationalisations
associated with all five criterion variables were a z score measure and
a method summing all markers in the top or bottom sample deciles
(Seplaki et al., 2005). The authors concluded that their results support
the use of allostatic operationalisations that preserve the continuous
nature of the constituent biomarker data and incorporate risk at both
tails of biomarker distributions where appropriate (Seplaki et al., 2005).
Although the top and bottom decile sum performed well, it is unlikely
to be the optimal operationalisation as it requires dichotimising each
allostatic load biomarker, which can introduce bias (MacCallum, Zhang,
Preacher, & Rucker, 2002).
A recent study provided another real data example of criterion variable
effect sizes being greater for z score allostatic load scores compared to
allostatic load scores computed with dichotimisation. The study used
data from the National Health and Nutrition Examination Survey III to
compare the predictive power of allostatic load scores for all-cause
mortality, cardiovascular disease mortality, and cancer mortality (n =
9,942; Levine & Crimmins, 2014). As noted in Chapter 1, the effect
sizes varied based on the operationalisation of allostatic load. For all
three criterion variables, allostatic load scores based on absolute z scores
outpredicted allostatic load scores based on clinical or other previously
defined thresholds (Levine & Crimmins, 2014).
We chose not to test operationalisations other than the z-score method
because other widely-tested operationalisations involve dichotomising
indicator variables, which can bias estimates. Dichotimising variables
removes meaningful information, typically reduces effect sizes and
statistical power, and can produce potentially spurious effects, including
interaction effects (MacCallum et al., 2002; Maxwell & Delaney, 1993;
Thoresen, 2019).
In our allostatic load studies, we used secondary data from the Lothian
22
Birth Cohort 1936. The following chapter will outline the methods
common to all studies in thesis using an allostatic load summary




Lothian Birth Cohort 1936
methods
This chapter contains the methods shared by the first three of four
empirical studies in this thesis. These studies used the same sample,
the same allostatic load operationalisation, and the same statistical
modelling approach to testing hypotheses.
The three studies will test how allostatic load relates to: 1) other
measures of physiological weathering; 2) cognitive ability; and (3)
depressive symptoms. We were interested not only in contemporaneous
relationships, but also in associated change relationships, that is,
whether change over time in allostatic load is related to change
over time in the other variable(s). Where previous research on
these relationships exists, it has tended to test contemporaneous
relationships and has rarely, if ever, investigated associated change
relationships, in part due to the lack of suitable data. The Lothian
Birth Cohort 1936 (LBC1936) study offered the rare opportunity to test
these associated change relationships. In these three studies, we tested
contemporaneous and associated change relationships by fitting latent
growth curve models to data from Waves 1-4 of the LBC1936.
To avoid unnecessary repetition and ensure the unique methodological
25
aspects of each study are highlighted, this chapter contains details of
the shared methods and the respective study chapters contain details
of the measures and other methods specific to each study.
3.1 Participants
The LBC1936 study is a healthy ageing study that has followed up
Scottish Mental Survey 1947 participants in older age. On 4th June
1947, the Scottish Mental Survey 1947 tested the intelligence of almost
1936-born children attending school in Scotland. In all, 70,805 children
participated. The LBC1936 study followed up participants based in the
Lothian area, in and around the city of Edinburgh. The study aimed
to conduct in-depth cognitive testing to study cognitive ageing since
childhood and in older age. It also aimed to collect data on a diverse
range of variables related to cognitive ageing, including demographic,
social, genetic, medical, and physiological variables.
Lothian-based 1936-born residents were identified using the Lothian
Community Health Index, a record of patients registered at GP practices
in the area. Recruitment letters were sent to 3,686 of these residents
between June 2004 and November 2006. Initially, there were 1,703
responses, 1,351 of whom were interested in hearing more about
the study. A second letter was sent to 1,741 residents, from which
there were 615 responses, 216 of which were from people interested
in participating. Participants were also recruited via newspaper
advertising, although not many participants were recruited from this
due to the comprehensive nature of the Community Health Index
records. In all, 1,226 people were interested and eligible. Of these
people, 85 withdrew before the start of the study and a further 50 were
not able to be contacted or were not able to attend an appointment
before the end of Wave 1 testing in May 2007. This left a total of 1,091
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participants at Wave 1. At each wave, around a fifth of participants
have dropped out, with the reasons for dropout including withdrawal
with no further reason, death, ill health, and loss of contact (Taylor,
Pattie, & Deary, 2018). Data was collected for Wave 1 in 2004-2007
(n = 1,091 [50.2% male]; M age = 69.6), for Wave 2 in 2007-2010 (n
= 866 [51.7% male]; M age = 72.5), Wave 3 in 2011-2013 (n = 697
[51.6% male]; M age = 76.3), and for Wave 4 in 2014-2017 (n = 550
[50.0% male]; M age = 79.3).
Each wave comprises a participant interview and a study questionnaire.
The participant interview includes questions on social and medical
variables, cognitive tests, physical tests, and the taking of blood
samples. The study questionnaire was completed after the participant
interview and included social, demographic, and activity questions,
personality questionnaires, a quality of life survey, and a food
questionnaire.
The LBC1936 study provides a rich dataset that is well-suited to
answering the studies’ research questions. A data search conducted
prior to this thesis found that the LBC1936 possessed various
advantages over other studies with allostatic load biomarkers,
particularly for longitudinal and psychological studies. The LBC1936
study has four waves of data on the same allostatic load biomarkers,
which enables the relationships between longitudinal change in
allostatic load and longitudinal change in other variables to be
investigated. The range of biological variables, including DNA
methylation and telomere length, enables longitudinal relationships
between allostatic load and other physiological weathering measures
to be tested. A further strength is that cognitive ability has been
tested using a full battery of gold standard intelligence tests. In cohort
studies without a focus on cognitive ageing, it is more common to
test cognitive ability using only a few cognitive tests, or even only a
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cognitive impairment screener.
The sample also has some notable limitations. No primary mediators
of the stress response have been measured in the full sample, which
means the allostatic load measure was computed using data from
secondary outcomes of the stress response only. This also means
that no neuroendocrine biomarkers were included in allostatic load
calculation. Further, the generalisability of findings in the sample
is limited because the sample has a limited age range, is ethnically
white, and has higher premorbid intelligence than the population it
was sampled from (Čukić, Brett, Calvin, Batty, & Deary, 2017; Gow et
al., 2011). Dropout may also have reduced the representativeness of
the sample. Compared to returners, participants who subsequently
dropped out tend to have had lower socioeconomic position, lower
older age cognitive ability, and lower physical fitness (Taylor et al.,
2018).
For further information on participant recruitment and the procedures
of the study, see the LBC1936 cohort profiles (Deary, Gow, Pattie, &
Starr, 2012; Deary et al., 2007; Taylor et al., 2018).
3.2 Allostatic load
3.2.1 Allostatic load biomarkers
Values from nine allostatic load biomarkers were used to calculate
individuals’ allostatic load scores. Body mass index (BMI) was
computed by dividing participants’ weight (in kilograms) by their
squared height (in metres). Systolic blood pressure (SBP) and diastolic
blood pressure (DBP) input variables were the mean of three seated
readings. The following biomarkers were measured using blood
samples: albumin; C-reactive protein (CRP); fibrinogen; glycated
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haemoglobin (HbA1c); total cholesterol to high-density lipoprotein
ratio (HDLR); and triglycerides. Blood samples were taken by a
research nurse at the Wellcome Trust Clinical Research Facility,
Western General Hospital, Edinburgh. Albumin was measured using
Vitros ALB slides, with colourimetric tests conducted using the Vitros
Fusion 5.1 FS and Vitros 4600 Chemistry Systems. C-reactive protein
(CRP) was measured with the OrthoFusion 5.1 F.S. analyser using dry
immuno-rate slides (Vitros Chemistry Products CRP slides, Ortho
Clinical Diagnostics, Buckinghamshire, UK). Fibrinogen was measured
with an automated Clauss assay (TOPS coagulator, Instrumentation
Laboratory, Warrington, UK). Non-fasting glycated haemoglobin
(HbA1c) was measured with an Adams HA-8160 HbA1c analyser, which
uses a high performance liquid chromatography method. High-density
lipoprotein and total cholesterol were measured using the Abbott
Architect c16000 and the high-density lipoprotein ratio was calculated
by dividing total cholesterol by high-density lipoprotein. Triglycerides
were also measured using the Abbott Architect c16000.
The allostatic load indicators were chosen based on their availability
in the sample. Regarding the physiological systems represented
by the allostatic load indicators, there were two markers from the
cardiovascular system (SBP and DBP), three markers from the the
immune system (albumin, CRP, and fibrinogen), and four markers
from the metabolic system (body mass index, HbA1c, HDLR, and
triglycerides). A limitation of the panel of allostatic load biomarkers is
that it does include any neuroendocrine system markers.
Our allostatic load measure has some overlap with the markers used
for other physiological summary measures. The Framingham Risk
Score also uses SBP and uses HDL and TC as separate markers, rather
than the ratio between them (D’Agostino et al., 2008). The metabolic
syndrome is diagnosed using three of the markers we used (SBP, DBP,
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and triglycerides), one marker we used in creating a variable (HDL),
a different obesity marker (waist circumference rather than BMI),
and one other marker (fasting glucose; Alberti et al., 2009). Hence,
our measure has a focus on metabolic and related markers, with the
addition of immune system markers.
Regarding distributions of the markers, we preregistered that we
would not remove any outlier values (see section 3.5; Crook et al.,
2017a, 2017b, 2017c). We did transform biomarker values with skewed
distributions (see section 3.2.2).
3.2.2 Allostatic load calculation
An individual’s allostatic load score was the mean of the absolute z
scores for their allostatic load biomarkers. For one of these biomarkers,
the total cholesterol to high-density lipoprotein ratio, risk is indicated
by only high values, so z scores below zero on this biomarker were
changed to zero before overall allostatic load scores are calculated.
For each of the nine allostatic load indicator variables, skewness was
calculated at Wave 1. We planned that if a variable had Wave 1 skewness
> |1.5|, then the optimal univariate Box-Cox transformation for the
Wave 1 data would be found and applied to all waves of data of that
variable. This was the case for three allostatic load indicator variables
at Wave 1. The skew of triglycerides was 5.38, the skew of CRP was 4.86,
and the skew of HbA1c was 2.99. Hence, all waves of these variables
were transformed. The z scores of the resulting nine variables were
summed to create allostatic load scores for each participant at each
wave.
We also planned that if the Wave 1 allostatic load score had skewness >
|1.5|, then the same Box-Cox transformation process would be repeated
for all waves of this variable, but the skewness was below this threshold
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and so the allostatic load variables were not transformed.
3.3 Covariates
Age in days at each day of assessment was recorded.
Sex, as observed at birth, was recorded at the time of the ScottishMental
Survey 1947.
3.4 Statistical analysis
3.4.1 Latent growth curve models
Latent growth curve models (also known as latent growth models or
latent curve models) are fitted to repeated measures data, typically to
answer research questions about change over time. In a latent growth
curve model, there is an intercept (typically level at time zero) and a
slope (change over time) for every individual in the sample. This means
that individual differences in trajectories are included in the model,
so the relationships between trajectories and other variables can be
tested. For example, researchers can test the relationships between
the trajectory of a variable and trajectories of other variables, and/or
time-invariant covariates (e.g., sex), and/or time-varying covariates
(e.g., marital status).
Latent growth curve models are typically fitted within either a structural
equation modelling framework or a multilevel modelling framework.
Often, but not always, numerically identical models can be fitted within
either framework (Curran, Obeidat, & Losardo, 2010). In this thesis,
the structural equation modelling framework will be used, because
it facilitates the inclusion of latent variables (e.g., general cognitive
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ability) and the assessment of absolute model fit (Curran et al., 2010).
In the structural equation modelling framework, the level and change
in the growth curve variable is represented by intercept and slope latent
variables. The observed variable values load on the intercept and slope
latent variables (Bollen & Curran, 2006).
The studies in the following three chapters attempt to answer novel
research questions about the relationships between trajectories in
allostatic load and trajectories in other variables. In some cases, we are
also interested in the average levels and trajectories and the variation
around them, and in how the levels and trajectories relate to covariates.
Hence, latent growth curve modelling is an ideal method for these
studies.
The studies fitted parallel process latent growth curve models, in
which the levels and trajectories of multiple variables are modelled
together and can be related to each other. Figure 3.1 shows the general
specification of the key parameters in the parallel process latent growth
curve models. Note that some parameters are omitted from the figure
for ease of presentation.
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Figure 3.1: General parallel process latent growth curve model
specification. i = intercept. s = slope. V = variable. W = wave.
Here, V1 and V2 are two variables being modelled longitudinally based
on data from Waves 1-4. In this kind of path diagram, latent variables
are drawn as circles, observed variables inside rectangles, and constants
inside triangles. Each intercept growth factor (V1 i and V2 i) is estimated
by fixing the loadings of the growth indicator variables (V1 W1-4 and
V2 W1-4) on the intercept growth factor to 1. The arrows from the
“1” constants to the growth factors show that means are estimated for
each of the growth factors. Growth factor variances have been omitted
from the diagram for clarity but will also be estimated in our models.
The mean of an intercept factor (i µ) represents the average level of the
construct at baseline and the variance of the intercept factor represents
the individual variation around this average. An intercept-intercept
or i-i correlation between two measures represents their association
at baseline. The slope factors (V1 s and V2 s) are estimated by fixing
the loadings of Wave 1 indicators to 0, and the loadings for Waves
2-4 at the mean number of years since Wave 1 data collection (in
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our studies: 2.98, 6.74, and 9.81). With this scaling, the mean of a
slope factor (s µ) provides an estimate of the average linear change
per year and the variance of a slope factor provides an estimate of
the individual variation around this average. An intercept-slope or i-s
correlation represents the association between the baseline level in
one measure and the subsequent change in another. The slope-slope
or s-s correlation between two variables represents their dual change
association, that is, the association between longitudinal changes in
the measures.
3.4.1.1 Covariates
Age differences within wave were controlled for by including age at
each wave as a predictor of all growth trajectory indicators at its
respective wave (e.g., Wave 3 age was included as a predictor of Wave
3 allostatic load). In our models, age was what is typically referred
to in the methodological literature as a time-varying covariate, as
within-wave differences varied across waves. Age was rescaled so it
was in years. This was done to avoid model-fitting issues that can arise
due to differences in the sizes of variances. To aid the interpretability
of intercepts, the age of the youngest participant at Wave 1 cognitive
testing in whole years was be subtracted from all age values (e.g., if the
youngest participant was 60.2 years, 60 would be subtracted from all
ages). To statistically control for sex, it was included as a predictor of
all growth factors. In our models, sex was a time-invariant covariate as
it did not change over the course of the study. It was a numeric binary
variable with females coded as 0 and males coded as 11.
1We preregistered a plan to code females as -0.5 and males as 0.5. We used a
different coding system to the one in our preregistrations because we decided that
using a more commonly used coding system would facilitate model interpretation.
Note that while the change in coding affected the covariates’ parameter estimates, it
did not affect the hypothesis test results.
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3.4.1.2 Longitudinal dropout
All models were fitted using full information maximum likelihood
estimation, which means that participants with some data missing
were included in the models. At Waves 2-4, the sample size was
20-21% lower than at the previous wave. To investigate the potential
influence of study dropout on the substantive conclusions of the study,
we fitted our parallel process latent growth curve models using two
approaches, each of which makes different assumptions about the
missing data.
The first set of models assumed missing data were missing at random
(MAR), that is, the models assumed the missingness of the data
was random once the observed data in the model was taken into
consideration (Enders, 2010). The second set of models assumed
missing data were not missing at random (NMAR; such data can also be
referred to as missing not at random [MNAR]), that is, the missingness
of the data may be related to the unobserved missing values even
after taking into consideration the observed data in the model (Enders,
2010). For example, high allostatic load values may be more likely to be
missing: a participant who experiences a particularly large increase in
allostatic load after Wave 1 may not survive long enough or be healthy
enough to participate at Wave 2 (see Hwang et al., 2014 on allostatic
load and mortality).
The NMAR models we fitted were pattern-mixture models (Muthén,
Asparouhov, Hunter, & Leuchter, 2011). In these models, three dummy
variables representing dropout time were added (d2-d4) as predictors
of all the growth factors. These dummy variables were coded 1 if a
participant dropped out at the corresponding wave and 0 otherwise.
For example, for a participant who provided data at Waves 1 and 2 but
not Waves 3 and 4, the dummy variables would be coded as follows:
d2 = 0, because the participant provided data at Wave 2; d3 = 1,
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because the participant dropped out at Wave 3; and d4 = 0, because
the participant had previously dropped out. The parameter estimate
for the regression of a growth factor on a dummy variable represented
the difference in the growth factor mean for those who dropped out
at the corresponding wave (Muthén et al., 2011). For example, if the
regression of the allostatic load slope on d4 produced a strong positive
estimate, this would indicate that those who dropped out at Wave 4
had a more positive allostatic load slope than those who did not drop
out at Wave 4. This would mean that Wave 4 dropouts were modelled
as having a steeper increase in allostatic load between Waves 1 and
4. The regressions of each slope growth factor on d2 and d3 were
constrained to equality to identify the model.
We used pattern-mixture modelling because it associates dropout with
the level and change of the variables being modelled, rather than the
values of specific measurements (as in some NMAR selection models,
e.g., Diggle & Kenward, 1994), which makes more sense given our
variables, and because it enabled us to estimate and easily interpret the
parameters testing our hypotheses, unlike latent class NMAR models
(Dantan, Proust-Lima, Letenneur, & Jacqmin-Gadda, 2008).
For all models discussed above, we compared the results of the MAR
and NMAR models. We focused our interpretation on the MAR models
and noted where there were differences between the MAR and NMAR
models.
3.4.1.3 One process models
The focus of our hypotheses was generally on the parallel process latent
growth curve models, but in each study we also fitted and report results
from one process models, where only one set of growth factors was
included (e.g., the allostatic load intercept and slope). Unconditional
models, which had no covariates included, helped us to assess whether
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the linear latent growth curve model fit the data well. Conditional MAR
models, which added sex and age as covariates, were used to interpret
sex differences where they were of interest. Finally, we also interpreted
the regressions in conditional NMAR models, which added the dummy
variables for dropout as predictors of the growth factors. Note that for
convenience, some allostatic load one process models are reported in
multiple chapters.
3.4.2 Model testing
We used the R programming language (version 3.5.1; R Core Team,
2018b) within the RStudio integrated development environment
(version 1.1.456; RStudio Team, 2016) for data wrangling and statistical
analyses. R packages helped to facilitate this. We used devtools (version
1.13.6; Wickham, Hester, & Chang, 2018) for package acquisition,
foreign (version 0.8.71; R Core Team, 2018a) for data importing, psych
(version 1.8.4; Revelle, 2018), taRifx (version 1.0.6; Friedman, 2014),
and mice (version 3.3.0; van Buuren & Groothuis-Oudshoorn, 2011)
for data description and data wrangling, and ggplot2 (version 2.2.1;
Wickham, 2009) with ggthemr (version 1.1.0; Tobin, 2018) for plotting.
Presentation of the results was facilitated by rmarkdown (version 1.9;
Allaire et al., 2018), knitr (version 1.20; Xie, 2018b), kableExtra (version
0.9.0; Zhu, 2018) and bookdown (version 0.7; Xie, 2018a).
The lavaan package (version 0.5.23.1097; Rosseel, 2012) was used
for model fitting. To correct for possible multivariate non-normality,




Each of these studies was preregistered on the Open Science Framework
(Crook et al., 2017a, 2017b, 2017c). The preregistrations are early
versions of the Open Science Framework projects, frozen after the
study was planned but before data analysis was conducted. Each
contains a background document about the rationale for the study and
a structured preregistration document with the design of the study.
Note that the introduction andmethod sections of the LBC1936 chapters
in this thesis were based on the documents from the preregistrations.
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Chapter 4
Allostatic load, biological age,
epigenetic age and telomere
length: how do they relate over
time in the Lothian Birth Cohort
1936?
4.1 Introduction
Stress and ageing are globally recognised public health concerns (World
Health Organization, 1998, 2015). It is crucially important that we seek
to understand the mechanisms underlying the adverse health effects of
stress and ageing so we can improve the prevention and treatment of
stress- and ageing-related morbidity.
Both stress and ageing can cumulatively damage the body, causing
physiological weathering that can be measured in various ways. Stress is
a core aspect of the theory underlying biomarker panel-based summary
measures of allostatic load. Ageing, meanwhile, has motivated research
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into leukocyte telomere length as well as the development of biomarker
panel-based measures of biological age and DNA methylation-based
measures of epigenetic age. Allostatic load, biological age, epigenetic
age, and telomere length have each been related to important health
outcomes, including mortality (Hwang et al., 2014; Levine, 2013;
Marioni et al., 2015; Rode, Nordestgaard, & Bojesen, 2015).
Although the foundations of these physiological weathering measures
overlap, few studies to date have investigated the relationships
between them, and no studies to date have related all four measures.
In particular, more research is needed into how these physiological
weathering measures relate in older age, including the longitudinal
associations between changes in these measures.
The first part of this chapter will introduce biological age, epigenetic
age and telomere length (for an introduction to allostatic load, see
Section 1.1). Next, we will discuss overlap in the underpinnings of these
physiological weathering measures and review previous studies relating
them. We will then introduce the present study, which will investigate
the contemporaneous and longitudinal relationships between these
physiological weathering measures in older age.
4.1.1 Biological age
For over 50 years, researchers have been estimating biological age
by using chronological age together with ageing-related variables
(Hollingsworth, Hashizume, & Jablon, 1965). The Klemera-Doubal
method (Klemera & Doubal, 2006), which uses parameter estimates
from regressions of chronological age on biological age biomarkers,
has been preferred by studies comparing biological age methods (Cho
et al., 2010; Jee & Park, 2017; for a review of methods, see Jia et al.,
2017). Biological age estimation has incorporated markers from the
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immune, metabolic and cardiovascular systems, as well as markers
of kidney, liver and lung function (Levine, 2013). A recent study of
38-year-olds found Klemera-Doubal biological age estimates were
normally distributed, with a mean of 38 years and a standard deviation
of 3.2 years (Belsky et al., 2015). The mean biological and chronological
ages matching shows that the two are close aligned, but the notable
deviation around the mean shows there is substantial individual
variation in humans’ biological ages estimated using this method.
4.1.2 Epigenetic age
Epigenetic age (sometimes referred to as biological age) is estimated
using DNA methylation data. DNA methylation occurs when a
methyl group is added to cytosine nucleotides on the genome at
cytosine-phosphate-guanine (CpG) sites (Beck & Rakyan, 2008).
The proportion of methylation at CpG sites can be measured (Beck
& Rakyan, 2008). Recently, through working with models that
predict chronological age from methylation at particular CpG sites,
researchers have developed methods to estimate epigenetic age
from DNA methylation in blood and/or other tissues (Hannum et al.,
2013; Horvath, 2013). Epigenetic age estimates from these methods
are strongly related to chronological age and, when combined with
chronological age, can be used to generate estimates of epigenetic age
acceleration/deceleration, the pace of the epigenetic clock (Hannum
et al., 2013; Horvath, 2013). Extrinsic epigenetic age acceleration
estimates can also be calculated. These estimates adjust epigenetic
age acceleration estimates for blood cell composition using the
Klemera-Doubal method, the same method often used to calculate the
previously mentioned estimates of biological age (Chen et al., 2016).
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4.1.3 Telomere length
Lastly, telomere length has been used a measure of physiological
weathering. Telomeres are repetitive DNA sequences that sit at the
end of each chromosome, protecting them from damage (Riethman,
2008). Telomeres are shortened each time a cell replicates DNA and by
oxidative stress, until they are shorter than a critical length, at which
point DNA replication stops and the cell enters a state of senescence
(Simons, 2015).
Telomeres shorten with age (Müezzinler, Zaineddin, & Brenner,
2013). Thus, many researchers have investigated telomere length as
a physiological age measure, and some have previously incorporated
telomere length in biomarker-panel based estimates of biological
age (Zhang et al., 2014). However, the status of telomere length
as a biomarker of ageing is contested. Some believe the evidence is
inconclusive (Mather et al., 2011; Sanders & Newman, 2013), while
others have considered it one of the most promising ageing biomarkers
(Blackburn, Epel, & Lin, 2015; Jylhävä, Pedersen, & Hägg, 2017;
López-Otín, Blasco, Partridge, Serrano, & Kroemer, 2013).
4.1.4 Overlap in the underpinnings of physiological
weathering measures
Because allostatic load theory focuses on stress, and the other measures
discussed here aim to track physiological ageing, it may seem that these
measures relate only to distinct causes of physiological weathering.
However, to some unknown extent, all these measures may index
aspects of physiological weathering that can be caused by stress and/or
ageing.
Although stress, rather than age, is key to the foundation of allostatic
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load theory, allostatic load summary measures have been linked to age
(Crimmins et al., 2003). And while epigenetic age and telomere length
are considered biomarkers of physiological age, they have both been
linked to stress (Shalev et al., 2013; Zannas et al., 2015). Plus, recent
research has suggested that physiological stress responses and ageing
may interact to affect epigenetic ageing (see Gassen, Chrousos, Binder,
& Zannas, 2017 for a review).
Another reason that these measures should be related is that there
is overlap in the mechanisms underlying them. The mitochondrial
allostatic load theory may help to explain part of the relationships
between the measures (Picard et al., 2014). Mitochondria are organelles
– cell parts with a particular purpose – but unlike other organelles, they
have their own DNA. Mitochondria’s main role is to generate energy and
they generate most of the energy that cells require. Mitochondria are
both involved in and affected by the hormones released when the body
responds to stress, which means their function is linked to allostasis and
levels of allostatic load (Picard et al., 2014). Chronic exposure to stress
hormones can lead to mitochondrial allostatic load, where mitochondria
and their function are negatively affected (Picard & McEwen, 2018). In
a state of mitochondrial allostatic load, mitochondrial function can be
impaired, mitochondrial DNA can be damaged, and mitochondria size
and number can be increased or decreased (Picard & McEwen, 2018).
The mitochondrial allostatic load theory links allostatic load, telomere
length and epigenetic age, because mitochondrial allostatic load can
reduce telomere length and affect epigenetic functioning (Picard et
al., 2014). Specifically, mitochondrial DNA damage that affects energy
production can shorten telomeres, possibly through reactive oxygen
species and/or oxidative stress (Passos, Saretzki, & von Zglinicki, 2007).
There can also be causal effects in the reverse direction, as telomere
dysfunction can cause mitochondrial dysfunction (Sahin et al., 2011).
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Mitochondria can also be related to epigenetic age because they affect
the methylation of genes (Picard & McEwen, 2018). In an in vitro study,
the expression of most human genes was regulated by mitochondria
(Picard, Zhang, et al., 2014).
Regarding a different overlap, C-reactive protein, a primary mediator
of allostatic load that is also used in biological age estimation, was
found to cause a reduction in telomere length in a recent Mendelian
randomisation study (Rode, Nordestgaard, Weischer, & Bojesen, 2014).
In addition, although allostatic load and biological age use distinct
algorithms, they typically incorporate several of the same markers in
estimation. This means that the relationship between allostatic load
summary measures and biological age estimates will be influenced not
only by any overlap in the underlying mechanisms involved, but also by
overlap in the indicators used. This may mean that only a study with
very many allostatic load and biological age markers could successfully
disentangle the part of the allostatic load-biological age association
that relates to underlying mechanisms and the part that relates to
overlap in the indicators used. This will be outside the scope of the
present study.
4.1.5 Mechanisms of ageing
A 2013 review paper posited nine hallmarks of ageing (López-Otín
et al., 2013). These were separated into: primary hallmarks, which
cause cellular damage; antagonistic hallmarks, which work to reduce
the damage but can become harmful themselves; and integrative
hallmarks, which result from the other hallmarks and relate closely
to ageing-related functional decline (López-Otín et al., 2013). The
hallmarks are briefly introduced below with notes based on the review
paper (López-Otín et al., 2013).
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Primary hallmarks:
• Genomic instability: DNA (including mitochondrial DNA) can be
damaged by exogenous (e.g., UV radiation) and endogenous (e.g.,
reactive oxygen species) variables. Examples of the resulting
genomic instabilities are new mutations and chromosomes being
moved or deleted.
• Telomere attrition: as mentioned above, telomeres shorten as
cells replicate DNA. Mouse studies have established causal links
from telomere shortening to cellular senescence and accelerated
ageing, and have found that telomerase activation can decelerate
ageing.
• Epigenetic alterations: these include DNA methylation, histone
modification, and chromatin remodelling, which lead to epigenetic
changes that accelerate ageing (e.g., worsened DNA repair,
chromosomal instability).
• Loss of proteostasis (protein homeostasis): this loss occurs
when there are nonnative protein aggregates in tissues. It is
caused by stress (e.g., heat shock or oxidative stress) and in turn
it has deleterious effects on stress responses.
Antagonistic hallmarks:
• Deregulated nutrient sensing: increased nutrient signalling
affects ageing through various paths, including through
insulin-like growth factor 1 (IGF-1). It can be controlled through
dietary restriction.
• Mitochondrial dysfunction: this dysfunction is caused by various
defects, including mitochondrial DNA mutations, and it leads to
further mitochondrial and cellular damage. It is related to ageing
through higher reactive oxygen species production and higher
inflammation, as well as through other pathways.
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• Cellular senescence: in ageing, cells experience more damage
and are repaired more slowly, which leads to cellular senescence,
where cells no longer divide. It is commonly caused by telomere
shortening. Possible consequences include increased inflammation
and stem cell exhaustion. Cellular senescence is an adaptive
response that only becomes harmful when tissues can no longer
regenerate cells, so it may not meet all the criteria to be a hallmark
of ageing.
Integrative hallmarks:
• Stem cell exhaustion: reduced stem cell activity can lead to
muscle loss, reduced bone density, and increased inflammation.
Stem cells are an important target for treating age-related disease
and loss of function.
• Altered intercellular communication: inflammation negatively
affects intercellular communication, which itself can affect
inflammatory processes as well as neuroendocrine processes and
communication between different tissue types.
Not all of these have been evidenced by clinical studies in humans
(Shiels, Stenvinkel, Kooman, & McGuinness, 2017). Telomere attrition
and epigenetic alterations are closely related to telomere length and
epigenetic age respectively. Allostatic load and biological age estimates
are not as directly related to the hallmarks, but may well be affected to
some extent by all of them.
4.1.6 Relationships between measures of
physiological weathering
Researchers have begun to explore the relationships between these
physiological weathering measures.
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4.1.6.1 Allostatic load, telomere length and biological age
In the National Health and Nutrition Examination Survey (NHANES)
III, a representative sample in the United States, three allostatic load
measures were strongly positively correlated with biological age in a
sample of participants aged 30 or over (data collected 1988-1994; n =
9,942; r range = .49 to .65; Levine & Crimmins, 2014).
In a study analysing later NHANES data fromwomen aged 20-44, scores
from most allostatic load operationalisations were related to shorter
telomere length in unadjusted analyses (data collected 1999-2002; n
= 1,503; Ahrens et al., 2016). For the allostatic load operationalisation
most strongly related to telomere length, 1 additional biomarker beyond
the clinical cutoff was associated with a reduction in telomere length
of 1.3% (Ahrens et al., 2016). However, the association was no longer
statistically significant after adjustment for age and other covariates
(Ahrens et al., 2016).
Papers studying allostatic load markers without calculating allostatic
load summary scores have suggested allostatic load and telomere length
may be correlated. In an early small-sample study, telomere length was
strongly correlated with 12-hour urinary cortisol and two of four salivary
cortisol measures (r range = -.64 to -.40), and these associations were
also statistically significant in adjusted regression models (N = 23; age
range = 51-79 y; Tomiyama et al., 2012).
In the Netherlands Study of Depression and Anxiety (N = 2,981 [1,737
with current depressive and/or anxiety disorder; 592 with remitted
depressive and/or anxiety disorder; 652 with no current or remitted
psychiatric disorder]; age range = 18-65 y), shorter telomere length
was related to “inflammation, high awakening cortisol response, and
increased heart rate […], especially when they [were] dysregulated
cumulatively” (Révész et al., 2014, p. 1422) in participants without any
psychiatric disorder history as well as those with current or remitted
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depressive and/or anxiety disorders. In an adjusted model, it was found
that compared to having 0 out of 4 biomarkers (the following specific
biomarkers were chosen due to being independently related to telomere
length: C-reactive protein, interleukin-6, cortisol awakening response
area under the curve with respect to the increase, and heart rate) in the
highest risk tertile, having 3 or 4 biomarkers in the highest risk tertile
was associated with a reduction in telomere length of 157 base pairs,
a reduction roughly equivalent to 8-11 years of ageing (Révész et al.,
2014).
Also, in the Heart Scan Study, a subsample of the United Kingdom-based
Whitehall II cohort, adjusted models found that men with short
telomeres and high telomerase activity had allostatic responses to
psychological stress tasks (n = 333; age range = 54-76 y; Zalli et al.,
2014). For example, 40-45 minutes after a mental stress task, a man
having above-median telomere length predicted a reduction in systolic
blood pressure of ~25mmHg, while a man having below-median
telomere length and above-median telomerase activity predicted a
reduction of only ~17mmHg (Zalli et al., 2014). This result suggested
that men with short telomeres and high telomerase activity “exhibited
impaired poststress recovery” (Zalli et al., 2014, p. 4520).
To summarise, some research has suggested that allostatic load and
telomere length may be related, but the study designs and samples used
to explore this relationship have been too diverse for clear conclusions
to be drawn. In particular, it is unclear how allostatic load summary
measures and telomere length relate in older adults, as no study to
date has used a sample comprised entirely of older adults to test this
relationship.
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4.1.6.2 Biological age, epigenetic age and telomere length
At age 38 in the New Zealand-representative Dunedin Study cohort,
biological age was correlated weakly with epigenetic age (r range = .07
to .15), and telomere length was not statistically significantly correlated
with biological age or epigenetic age (r range = -.02 to -.05; N = 1,037;
Belsky et al., 2018).
In subsamples of the Germany-based ESTHER cohort study, epigenetic
age was related to relative telomere length in sex-adjusted regression
models (effect sizes not reported), but epigenetic age acceleration
did not predict relative telomere length in any regression models
(subsample ns = 969 and 851; subsample mean ages = 62 y and 63 y;
Breitling et al., 2016).
4.1.7 The present study
It is important that we clarify how strongly these physiological
weathering measures relate in older age so that we can determine
to what extent they index the same aspects of stress and ageing
processes. However, the strength of these relationships in older age
is currently unclear. This is because previous physiological weathering
studies have typically used data from only one time point, have tended
to used mixed-age, younger and/or relatively small samples, and have
never (to our knowledge) incorporated all four of the physiological
weathering measures discussed here.
The present study will use data from Waves 1-4 of the Lothian Birth
Cohort 1936 (LBC1936), at which participants were aged approximately
70, 73, 76 and 79. A previous LBC1936 study found small and
non-statistically significant cross-sectional correlations between
telomere length and epigenetic age at ages 70, 73 and 76 (Marioni et
al., 2016). The present study will go beyond that and all other previous
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studies by modelling all four of the physiological weathering measures
discussed here using four waves of data. This will enable novel tests
of the associations between longitudinal changes in physiological
weathering measures.
This study will attempt to answer the following research questions
in relation to the four physiological weathering measures of interest
(allostatic load, biological age, epigenetic age, and telomere length):
1. How strongly related are contemporaneous measures of
physiological weathering at age 70?
2. What is the rate of longitudinal change in measures of
physiological weathering between ages 70 and 79?
3. How strongly related are allostatic load, biological age, epigenetic
age and telomere length at age 70 to changes in each of those
measures between ages 70 and 79?
4. How strongly related are longitudinal changes in different
measures of physiological weathering between ages 70 and 79?
Based on previous research (Belsky et al., 2018; Levine & Crimmins,
2014), it is plausible that the correlation between allostatic load and
biological age will be large, because these two measures are calculated
using some of the same biomarkers. The other correlation estimates





Values of the following seven biomarkers were used: HbA1c; the forced
expiratory volume in one second (FEV1); SBP; total cholesterol; CRP;
creatinine; and albumin. The measurement of five of these biomarkers
was described in relation to allostatic load measurement. Creatinine, an
indicator of kidney function, was measured using blood samples. The
FEV1, a measure of lung function, was tested three times per participant
using a Micro Medical Spirometer. The highest value of the three was
used in biological age calculation.
4.2.1.1.1 Biological age estimation. Following Belsky et al. (2018),
we calculated biological age using the Klemera-Doubal method
(Klemera & Doubal, 2006) and previously established weights (Levine,
2013). An R script for calculating biological age estimates using these
weights was graciously provided by Morgan Levine.
4.2.1.2 Epigenetic age
4.2.1.2.1 DNA methylation. DNA extraction from whole blood
samples and methylation typing was conducted at the Wellcome Trust
Clinical Research Facility, Western General Hospital, Edinburgh.
The methylation typing was of 485,512 probes. DNA samples
were bisulphite converted and then hybridised to the Infinium
HumanMethylation450 array using the Infinium HD Methylation
protocol with Tecan robotics (Illumina). Internal controls were used
to background-correct and normalise the raw intensity data. The R
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package minfi (Aryee et al., 2014) was used to generate methylation
beta values. The array control probe signals were manually inspected
for quality. Low quality samples were removed, including those with
staining signal and/or inadequate hybridisation, bisulphite conversion,
or nucleotide extension. Following the low call threshold recommended
by Illumina, samples were removed if under 450,000 probes were
detected at p < .01. Data from participants whose self-reported sex did
not match the sex predicted by XY probes were removed. Then, X and
Y and chromosome probes were removed. After quality control, there
were 450,726 probes.
4.2.1.2.2 Epigenetic age estimation. We considered two measures
of epigenetic age, as defined in Chen et al. (2016): intrinsic epigenetic
age and extrinsic epigenetic age. Each of these epigenetic age
measures are estimated by applying an established formula to data
on DNA methylation from age-linked CpG markers. The resulting
epigenetic age estimates are, like biological age estimates, strongly but
not perfectly correlated with chronological age. The two epigenetic age
measures used differ in the formula applied, the CpGs used, and the
adjustments made based on blood cell data (for full descriptions, see
Chen et al., 2016).
Intrinsic epigenetic age is based on Horvath’s estimate of epigenetic age
(calculated using 353 CpGs; Horvath, 2013). Horvath (2013) obtained
epigenetic age calculation weights by fitting elastic net regression
models with CpG data as independent variables and a function of age
as the dependent variable. Note that because all participants in our
sample were aged over 20, the function of age reduced to (age – 20) /
21 (Horvath, 2013, additional file 2). To calculate epigenetic age in new
samples, regression prediction is used. Horvath’s intercept and beta
values are applied to participants’ CpG data and the resulting values are
multiplied by the inverse of the age function (Horvath, 2013, additional
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file 2). The intrinsic epigenetic age measure has additional adjustments
for blood immune cell counts (plasmablasts, naive and exhausted CD8+
T Cells, CD4+ T cells, natural killer cells, monocytes, and granulocytes).
This means it is cell-intrinsic and independent of much of the variation
in blood cell composition. Intrinsic epigenetic age was calculated by
adding the residuals from the regression of Horvath epigenetic age on
the immune cell counts to the mean of Horvath epigenetic age.
Extrinsic epigenetic age takes a weighted average of Hannum’s
epigenetic age (calculated using 71 CpGs; Hannum et al., 2013), and
three immune blood cell types. Note that the weighted average is
computed using the Klemera-Doubal method (Klemera & Doubal,
2006), which we will use to calculate biomarker panel-based estimates
of biological age. Similar to Horvath (2013), Hannum et al. (2013)
used elastic net regression to find beta weights for CpGs related to
chronological age. However, there are several differences between
their approaches. Notably, Hannum et al. (2013) used covariates in the
selection regressions, had a different CpG selection procedure, and did
not use the function of age above as the dependent variable. Notably,
Hannum et al. (2013) used covariates in the selection regressions,
had a different CpG selection procedure, and did not use the function
of age above as the dependent variable. Extrinsic epigenetic age was
calculated using the Horvath online calculator (Horvath, n.d.).
4.2.1.3 Telomere length
Telomere length was measured with quantitative real-time polymerase
chain reaction (Martin-Ruiz et al., 2004). Polymerase chain reactions
were conducted using an Applied Biosystems (Pleasonton, CA, USA)
7900HT Fast Real Time PCR System. To correct for variation between




Firstly, we computed a correlation matrix of the estimates for all
physiological weathering measures at all waves. This enabled us
to assess the lagged correlations, or the autocorrelations, between
repeated measures of the same physiological weathering variable. The
lag 1 correlation refers to the correlation between measurements one
wave apart, the lag 2 correlation to measurements two waves apart, and
the lag 3 correlation to measurements three waves apart. For example,
because we used data from four waves, the lag 2 correlations for a
physiological weathering measure are the Wave 1-Wave 3 correlation
and the Wave 2-Wave 4 correlation. The correlation matrix also
enabled us to assess the average correlation strength between different
physiological weathering measures measured at the same wave.
4.2.2.2 Latent growth curve models
In this study, we modelled intercept and slope growth factors for
allostatic load, biological age, epigenetic age, and telomere length. We
fitted our MAR and NMAR parallel process latent growth curve models
twice, once with extrinsic epigenetic age as the epigenetic age measure
and once with intrinsic epigenetic age in its place.
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Figure 4.1: Physiological weathering latent growth curve model. A-D
indicate labelled paths described in the text. AL = allostatic load. BA =
biological age. i = intercept. s = slope. W = wave.
Figure 4.1 shows the core structure of the dual change latent growth
curve models for two of the physiological weathering variables:
allostatic load and biological age. Only two variables are displayed
for ease of presentation, but our parallel process latent growth curve
models in this study all included four pairs of physiological weathering
growth factors. This diagram has a similar layout to the general
specification in 3.1.
Research question 1, on the contemporaneous relationships at age
70, was tested by the correlations between the intercept growth
factors; for example, path A in Figure 4.1 tests the age 70 relationship
between allostatic load and biological age. Research question 2, on the
longitudinal change in measures of physiological weathering between
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ages 70 and 79, was tested by the means and variances of the slope
growth factors (see the paths labelled B for the slope means). Research
question 3, on the relationships between age 70 levels and age 70-79
changes, was tested by the intercept-slope correlations (see the paths
labelled C). Research question 4, on the relationships between age
70-79 changes in different measures, was tested by the slope-slope
correlations (see path D).
We preregistered that if the correlations not involving epigenetic
age were similar across these model structures, we would focus our
interpretation on the results from the models with extrinsic epigenetic
age. However, there were model fitting problems with extrinsic
epigenetic age and the models with intrinsic epigenetic age showed
markedly better fit. Hence, we focused our interpretation on the
models with intrinsic epigenetic age as the epigenetic age measure.
4.2.2.2.1 Additional covariates. DNA methylation assessment for
Waves 2 and 3 was conducted in two batches, with approximately half
of the samples from each wave assessed in the first batch and the
remaining samples assessed in the second batch. Hence, to statistically
control for DNA methylation testing batch variation, Wave 2 and Wave
3 batch dummy variables were included in our latent growth curve
models as predictors of Wave 2 and Wave 3 epigenetic age respectively,
for both extrinsic and intrinsic epigenetic age. The batch dummy
variables were coded as -0.5 for participants whose samples were
assessed in the first batch and 0.5 for participants whose samples were
assessed in the second batch. We chose to use the -0.5/0.5 coding
rather than our preregistered 0/1 coding so that the 0 point was in
between the two batch codes, meaning that the intercepts in the model
were not biased by batch effects.
56
4.2.2.2.2 Sensitivity analysis. All models that included epigenetic
age estimates were repeated after estimates were adjusted for three
DNA methylation assessment variables: the plate used, the array used,
and the position of samples on the array. The adjusted epigenetic
age estimates were residuals from linear regressions where the
independent variables were the plate used, the array used, and the
position of samples on the array. These residuals were re-centred
on the previously observed mean estimate before inclusion in the
sensitivity analysis models.
4.3 Results
Table 4.1: Descriptive statistics for age and
physiological weathering measures
n Mean SD Skew Kurtosis
Age W1 1091 69.53 0.83 -0.05 -0.88
Age W2 866 72.49 0.71 -0.02 -0.84
Age W3 697 76.25 0.68 -0.05 -0.83
Age W4 550 79.32 0.62 0.06 -0.76
Allostatic load W1 1090 0.69 0.24 1.07 2.12
Allostatic load W2 866 0.71 0.24 1.17 3.17
Allostatic load W3 696 0.85 0.25 0.71 1.16
Allostatic load W4 549 0.87 0.26 0.62 0.48
Biological age W1 1041 68.83 3.50 0.22 -0.06
Biological age W2 815 71.02 3.57 0.23 0.22
Biological age W3 609 75.53 3.55 0.14 -0.04
Biological age W4 485 77.32 3.51 0.47 0.89
Extrinsic epigenetic age W1 906 76.00 7.15 -0.08 1.08
Extrinsic epigenetic age W2 801 77.52 7.00 0.16 1.45
Extrinsic epigenetic age W3 619 83.18 6.88 0.64 2.84
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Table 4.1: Descriptive statistics for age and
physiological weathering measures (continued)
n Mean SD Skew Kurtosis
Extrinsic epigenetic age W4 507 88.51 6.40 1.03 2.60
Intrinsic epigenetic age W1 906 68.57 8.17 0.24 2.37
Intrinsic epigenetic age W2 801 72.72 8.14 1.13 7.95
Intrinsic epigenetic age W3 619 77.47 7.97 1.76 13.11
Intrinsic epigenetic age W4 507 81.09 7.17 0.61 0.71
Telomere length W1 1070 4200.51 559.67 1.00 2.65
Telomere length W2 844 3966.30 737.84 1.55 7.33
Telomere length W3 691 3738.69 686.06 0.05 2.81
Note.
Telomere length is in base pairs.
Table 4.1 contains descriptive statistics for the model variables.
Allostatic load showed slight mean increases between Waves 1 and 2
as well as between Waves 3 and 4, but a much sharper increase was
observed between Waves 2 and 3. Similarly, the increase in biological
age means between Waves 2 and 3 was over double the Wave 1-2 and
Wave 3-4 increases. The changes in the other physiological weathering
means were more consistent across waves, with the exception of the
small mean increase in extrinsic epigenetic age between Waves 1 and
2. The three age-linked physiological weathering display different
patterns of relations to chronological age. Mean biological age was
slightly lower than the mean chronological age at all waves. Mean
extrinsic epigenetic age was notably higher than mean chronological
age at all waves. Mean intrinsic epigenetic age was slightly lower
than mean chronological age at Wave 1, but slightly higher than mean
chronological age at Waves 2-4.
Across all waves, the mean age acceleration was -1.14 years for
biological age, 0.32 years for intrinsic epigenetic age and 6.63 years for
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extrinsic epigenetic age.
There was considerably more spread in epigenetic age estimates than
biological age estimates. The epigenetic age standard deviations were
typically around twice the biological age standard deviation, with
intrinsic epigenetic age consistently being the measure with the widest
spread.
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AL W1 .03 .04 .04 .03 .03 .04 .05 .03 .04 .04 .04 .03 .04 .04 .04 .03 .03 .04
AL W2 .45 .03 .04 .03 .03 .04 .05 .04 .04 .04 .04 .04 .04 .04 .04 .03 .03 .04
AL W3 .31 .46 .04 .04 .04 .04 .05 .04 .04 .04 .04 .04 .04 .04 .04 .04 .04 .04
AL W4 .27 .40 .47 .04 .04 .05 .05 .05 .04 .05 .04 .05 .04 .05 .04 .04 .04 .04
BA W1 .19 .10 .07 .03 .03 .03 .04 .03 .04 .04 .05 .03 .04 .04 .05 .03 .04 .04
BA W2 .10 .13 .09 .03 .70 .03 .04 .04 .04 .04 .05 .04 .04 .04 .05 .04 .04 .04
BA W3 .04 .05 .14 .01 .58 .66 .04 .04 .04 .04 .05 .04 .04 .04 .05 .04 .04 .04
BA W4 -.03 .05 .07 .05 .56 .59 .66 .05 .05 .05 .05 .05 .05 .05 .05 .05 .05 .05
EEA W1 .08 .00 -.02-.03 .03 .07 -.01 .11 .03 .04 .04 .03 .04 .04 .05 .03 .04 .04
EEA W2 .04 .02 .02 -.02 .01 .05 .04 .07 .52 .03 .04 .04 .03 .04 .04 .04 .04 .04
EEA W3 -.01 -.01 -.02-.06.04 .00 .06 .08 .56 .72 .03 .04 .04 .04 .05 .04 .04 .04
EEA W4 -.01 .01 -.06.00 .02 .06 .09 .08 .62 .62 .73 .05 .04 .04 .04 .04 .04 .05
IEA W1 .05 -.02.00 -.02.04 .08 .00 .04 .38 .22 .22 .24 .03 .04 .04 .03 .04 .04
IEA W2 .05 .01 -.03 .00 .02 .03 -.03 .01 .21 .38 .34 .31 .59 .03 .03 .04 .04 .04
IEA W3 .02 .00 -.03-.05.00 -.04.00 .01 .18 .31 .41 .32 .61 .76 .03 .04 .04 .04
IEA W4 -.02 .01 -.03-.05 .05 .06 .11 .06 .21 .27 .28 .38 .57 .68 .77 .04 .04 .05
TL W1 -.04.07 .05 .06 -.05-.03 .01 .04 .05 .04 -.05 .01 .00 -.01 -.08.04 .03 .03
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TL W2 -.02.06 .07 .04 -.04-.02-.03 .05 .03 -.02-.07 .02 .02 -.03-.03 .09 .52 .02
TL W3 .06 .09 .10 .05 .00 .00 -.03 .04 -.03-.08-.13 -.05-.03-.03-.02 .03 .48 .79
Note.
Lower triangle contains pairwise Pearson’s correlations (n range = 286-1070). Upper triangle
contains standard errors for the correlations. AL = allostatic load. BA = biological age. EEA =
extrinsic epigenetic age. IEA = intrinsic epigenetic age. TL = telomere length. W = Wave.
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Table 4.2 contains correlations for the physiological weathering
measures. The mean lag 1 correlations for each measure were: .46
for allostatic load; .68 for biological age; .65 for extrinsic epigenetic
age; .71 for intrinsic epigenetic age; and .65 for telomere length. The
mean lag 2 correlations for each measure were: .36 for allostatic load;
.58 for biological age; .59 for extrinsic epigenetic age; .65 for intrinsic
epigenetic age; and .48 for telomere length, for which only one lag
2 correlation was available. The lag 3 (Wave 1-Wave 4) correlations
for each measure were: .27 for allostatic load; .56 for biological
age; .62 for extrinsic epigenetic age; and .57 for intrinsic epigenetic
age. In summary, there were strong longitudinal correlations for all
physiological weathering measures except allostatic load, which had
the weakest lag 1 correlation and showed the most marked decreases
when the correlation lag was increased. The only measure that did not
show consistent correlation decreases as the lag increased was extrinsic
epigenetic age, which had the second-weakest lag 1 correlation but the
strongest lag 3 correlation.
The mean absolute correlation between different contemporaneously
measured physiological weatheringmeasures, excluding the correlations
between the two epigenetic age measures, was .06 at Wave 1, .04 at
Wave 2, .06 at Wave 3, and .05 at Wave 4. After further excluding
the correlations between allostatic load and biological age, the mean
absolute correlation was .04 at Wave 1, .03 at Wave 2, .05 at Wave 3,
and .05 at Wave 4.
4.3.1 One process latent growth curve models
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Table 4.3: Unconditional one process MAR model results:
Growth factor means and variances
Estimate SE p-value
AL i mean 0.682 0.007 < 0.001
AL i variance 0.029 0.004 < 0.001
AL s mean 0.021 0.001 < 0.001
AL s variance 0.0003 0.0001 < 0.001
BA i mean 68.76 0.11 < 0.001
BA i variance 9.29 0.56 < 0.001
BA s mean 0.95 0.01 < 0.001
BA s variance 0.05 0.01 < 0.001
EEA i mean 74.80 0.24 < 0.001
EEA i variance 29.60 2.33 < 0.001
EEA s mean 1.37 0.03 < 0.001
IEA i mean 68.82 0.24 < 0.001
IEA i variance 41.04 5.46 < 0.001
IEA s mean 1.27 0.03 < 0.001
IEA s variance 0.05 0.04 0.274
TL i mean 4.192 0.017 < 0.001
TL i variance 0.185 0.026 < 0.001
TL s mean -0.068 0.003 < 0.001
TL s variance 0.005 0.001 < 0.001
Note.
AL = allostatic load. BA = biological age.
EEA = extrinsic epigenetic age. i = intercept
[growth factor]. IEA = intrinsic epigenetic
age. s = slope [growth factor]. TL = telomere
length.
Table 4.3 contains growth factor mean and variance estimates from
latent growth curve models that did not include covariates. One such
model was fitted for each physiological weathering variable. Here, the
intercept growth factor means represent the average levels at baseline
and the slope growth factor means represent the average changes per
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year. The intercept and slope variances represent the variability in
baseline levels and trajectories respectively.
Table 4.9 contains model fit statistics for all models fitted. The fit of
the unconditional models helps to tell us whether a linear trajectory
describes the progression of these physiological weathering measures
well. Good fit was observed for all allostatic load and intrinsic epigenetic
age models as well as for the biological age and telomere length models
with covariates. Poor fit was observed for all extrinsic epigenetic age
models. As noted in the table, the extrinsic epigenetic age slope and
Wave 3 telomere length variances were initially estimated as negative
and so they (and covariances involving the extrinsic epigenetic age
slope) were fixed at zero in these and subsequent models.
The slope means and variances in the one process models address
research question 2, which concerns the rates of change over time in
these physiological weathering measures. The allostatic load slope
mean is positive, which means that the average participant’s biomarker
levels became more extreme over the course of the study. The increase
was relatively modest: the average participant’s average biomarker
moved 0.021 SD further away from the Wave 1 mean of the biomarker
each year, which accumulates to an average 0.21 SD deviation over
a 10-year period. There was, though, notable variation in individual
slopes.
Due to model fitting problems, telomere length was rescaled into
kilobase pairs. The telomere length slope mean tells us that the
average loss was estimated at 68 base pairs per year, and the slope
variance suggests there was substantial variability in the rates of loss.
Biological age tracked closely with chronological age; each chronological
year, the average participant’s biological age increased around 1 year,
and there was substantial variation in the biological age trajectories.
However, according to intrinsic and extrinsic epigenetic age, participants
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were ageing much faster. According to intrinsic epigenetic age, the
average participant aged an additional 99 days each year, while
according to extrinsic epigenetic age, ageing was even faster, with the
average participant ageing an additional 135 days each year. The models
did not confirm that there was substantial variability in epigenetic age
trajectories: the extrinsic epigenetic age slope variance had to be fixed
to zero to successfully fit the model, and the intrinsic epigenetic age
variance had a large standard error relative to its size.
Table 4.4: Conditional one process MAR model results:
Growth factor estimates and regressions on sex
Estimate SE p-value
AL i mean 0.683 0.010 < 0.001
AL i variance 0.028 0.003 < 0.001
AL i on male regression -0.003 0.014 0.852
AL s mean 0.0214 0.0016 < 0.001
AL s variance 0.0003 0.0001 < 0.001
AL s on male regression -0.0005 0.0022 0.807
BA i mean 69.02 0.15 < 0.001
BA i variance 8.57 0.55 < 0.001
BA i on male regression -0.56 0.20 0.006
BA s mean 0.85 0.02 < 0.001
BA s variance 0.03 0.01 0.002
BA s on male regression 0.21 0.03 < 0.001
EEA i mean 73.01 0.31 < 0.001
EEA i variance 26.22 2.23 < 0.001
EEA i on male regression 3.45 0.4 < 0.001
EEA s mean 1.32 0.03 < 0.001
EEA s on male regression 0.09 0.05 0.055
IEA i mean 68.37 0.36 < 0.001
IEA i variance 39.42 5.37 < 0.001
IEA i on male regression 0.88 0.49 0.070
IEA s mean 1.24 0.04 < 0.001
IEA s variance 0.04 0.04 0.355
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Table 4.4: Conditional one process MAR model results:
Growth factor estimates and regressions on sex (continued)
Estimate SE p-value
IEA s on male regression 0.04 0.05 0.386
TL i mean 4.072 0.022 < 0.001
TL i variance 0.170 0.024 < 0.001
TL i on male regression 0.237 0.033 < 0.001
TL s mean -0.052 0.004 < 0.001
TL s variance 0.005 0.001 < 0.001
TL s on male regression -0.031 0.006 < 0.001
Note.
AL = allostatic load. BA = biological age. EEA = extrinsic
epigenetic age. i = intercept [growth factor]. IEA =
intrinsic epigenetic age. s = slope [growth factor]. TL
= telomere length.
Table 4.4 contains results from conditional latent growth curve models
which included statistical control for within-wave age differences and
sex effects on the growth factors. One such model was fitted for each
physiological weathering variable. The extrinsic and intrinsic epigenetic
age models also added statistical control for DNA methylation batch
effects at Waves 2 and 3. Here, the growth factor means are the
estimates for a female who was the mean age of assessment at each
wave. To obtain the growth factor mean estimates for males, add the
estimate for the relevant regression on male.
Biological age and extrinsic epigenetic age gave different answers as to
which sex had aged faster at baseline. On average, males were almost
3.5 years older than females in extrinsic epigenetic age, while for
biological age, females were slightly over 7 months older than males.
However, the biological age slope indicates that males aged faster than
females during the course of the study. Every 12 months, the average
female increased only around 10 months in biological age, while the
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average male experienced biological age acceleration as they increased
around 13 months in biological age.
The pattern of level and change for telomere length was similar to the
pattern for biological age. Males had telomeres 237 base pairs longer
at baseline, but they lost 83 base pairs each year, compared to 52 base
pairs for females.
For the other growth factors, there were no notable sex differences.
Table 4.5: Conditional one process NMAR model
results: Growth factor estimates and regressions on sex
Estimate SE p-value
AL i mean 0.655 0.012 < 0.001
AL i variance 0.028 0.003 < 0.001
AL i on male regression -0.001 0.014 0.927
AL s mean 0.0235 0.0017 < 0.001
AL s variance 0.0003 0.0001 < 0.001
AL s on male regression -0.0008 0.0022 0.721
BA i mean 68.36 0.18 < 0.001
BA i variance 8.13 0.52 < 0.001
BA i on male regression -0.55 0.20 0.006
BA s mean 0.87 0.02 < 0.001
BA s variance 0.03 0.01 0.002
BA s on male regression 0.20 0.03 < 0.001
EEA i mean 72.19 0.35 < 0.001
EEA i variance 26.07 2.2 < 0.001
EEA i on male regression 3.52 0.40 < 0.001
EEA s mean 1.39 0.03 < 0.001
EEA s on male regression 0.08 0.05 0.106
IEA i mean 68.31 0.39 < 0.001
IEA i variance 39.39 5.31 < 0.001
IEA i on male regression 0.86 0.49 0.083
IEA s mean 1.23 0.04 < 0.001
67
Table 4.5: Conditional one process NMAR model
results: Growth factor estimates and regressions on sex
(continued)
Estimate SE p-value
IEA s variance 0.04 0.04 0.359
IEA s on male regression 0.04 0.05 0.464
TL i mean 4.069 0.026 < 0.001
TL i variance 0.170 0.024 < 0.001
TL i on male regression 0.238 0.033 < 0.001
TL s mean -0.051 0.004 < 0.001
TL s variance 0.005 0.001 < 0.001
TL s on male regression -0.031 0.006 < 0.001
Note.
AL = allostatic load. BA = biological age. EEA = extrinsic
epigenetic age. i = intercept [growth factor]. IEA =
intrinsic epigenetic age. s = slope [growth factor]. TL =
telomere length.
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Table 4.6: Conditional one process NMAR model
results: Pattern-mixture model results
Beta SE p-value
AL i on d2 regression 0.064 0.020 0.001
AL i on d3 regression 0.086 0.022 < 0.001
AL i on d4 regression 0.028 0.020 0.176
AL s on d2/d3 regression -0.0137 0.0067 0.040
AL s on d4 regression -0.0009 0.0037 0.800
BA i on d2 regression 1.48 0.27 < 0.001
BA i on d3 regression 1.43 0.31 < 0.001
BA i on d4 regression 1.11 0.30 < 0.001
BA s on d2/d3 regression -0.17 0.07 0.018
BA s on d4 regression 0.06 0.04 0.140
EEA i on d2 regression 2.48 0.56 < 0.001
EEA i on d3 regression 1.8 0.59 0.002
EEA i on d4 regression 1.58 0.66 0.016
EEA s on d2/d3 regression -0.69 0.16 < 0.001
EEA s on d4 regression -0.16 0.09 0.065
IEA i on d2 regression -0.33 0.61 0.588
IEA i on d3 regression 0.48 0.73 0.508
IEA i on d4 regression 0.22 0.88 0.801
IEA s on d2/d3 regression -0.14 0.17 0.405
IEA s on d4 regression 0.19 0.09 0.039
TL i on d2 regression 0.005 0.042 0.901
TL i on d3 regression 0.028 0.047 0.549
TL s on d2/d3 regression -0.018 0.018 0.326
Note.
AL = allostatic load. BA = biological age. d2-d4 = binary
dummy variables coded as 1 if a participant dropped out
at the corresponding wave (2-4) and 0 otherwise. EEA
= extrinsic epigenetic age. i = intercept [growth factor].
IEA = intrinsic epigenetic age. s = slope [growth factor].
TL = telomere length.
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Tables 4.5 and 4.6 contain the results from conditional models that
added dummy variables for dropout (d2-d4 for Waves 2-4), which were
coded as 1 if the participant dropped out at that wave and 0 if they
did not. One such model was fitted for each physiological weathering
variable. Table 4.5 contains estimates for parameters that were also in
the previous set of models, while Table 4.6 contains estimates for the
dummy variable regressions that were added to the models. In these
models, the growth factor means are the estimates for a female who
did not drop out. To obtain estimates for an average male and/or a
participant who dropped out at a given wave, add the relevant regression
estimate(s).
Those who dropped out at Wave 2 or 3 had higher baseline allostatic
load, biological age and extrinsic epigenetic age. However, they had
flatter slopes (i.e., slower ageing) for biological age and extrinsic
epigenetic age.
Those who dropped out at Wave 4 also had higher baseline biological
age and extrinsic epigenetic age, as well as a flatter extrinsic epigenetic
age slope. However, they also had a steeper slope for intrinsic epigenetic
age.
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4.3.2 Parallel process latent growth curve models
Figure 4.2: Parallel process model results: Growth factor correlations
from the MAR model with IEA. Results are from one model; pairings
are displayed separately for clarity. Correlation estimates between
the growth factors are shown, with the associated standard errors in
parentheses. AL = allostatic load. BA = biological age. IEA = intrinsic
epigenetic age. TL = telomere length.
We fitted parallel process latent growth curve models to test the
associations between levels and trajectories in allostatic load, biological
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age, epigenetic age, and telomere length. We fitted separate models
using the two epigenetic age measures. The MAR and NMAR models
with intrinsic epigenetic age fit better than the models using extrinsic
epigenetic age (see Table 4.9), so we chose to focus our interpretation
on the models with intrinsic epigenetic age as the epigenetic age
measure. Figure 4.2 contains the growth factor correlations from
the MAR model with intrinsic epigenetic age. In these models, the
intercept-intercept, intercept-slope and slope-slope correlations
addressed research questions 1, 3 and 4 respectively.
The two most closely related physiological weathering measures
were allostatic load and biological age. Their intercept-intercept
correlation indicated that at baseline, higher allostatic load was
moderately associated with older biological age (r [SE] = .28 [.05]). The
slope-slope correlation between the measures showed they tracked
closely over time: increases in allostatic load were strongly related to
accelerated biological ageing (r [SE] = .53 [.15]).
Higher allostatic load and older biological age at baseline were
moderately associated with smaller increases in allostatic load and
slower biological ageing, as indicated by the four intercept-slope
correlations.
At baseline, longer telomere length was associated with older biological
age, with a small effect size (r [SE] = -.09 [.05]). Longer telomere length
at baseline also had a small-to-moderate association with a greater
subsequent increase in allostatic load.
There were no correlations detected involving intrinsic epigenetic age.
Some estimates for the correlations with the intrinsic epigenetic age
slope were moderate in size, but standard errors for these correlations
were large, so more data would be required to powerfully test these
associations.
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Table 4.7: Parallel process model results: Growth factor
correlations from the MAR model with EEA
r SE p-value
AL i-AL s correlation -0.33 0.10 0.001
BA i-BA s correlation -0.31 0.08 < 0.001
TL i-TL s correlation 0.21 0.18 0.230
AL i-BA i correlation 0.28 0.05 < 0.001
AL i-EEA i correlation 0.10 0.05 0.036
AL i-TL i correlation -0.07 0.05 0.202
BA i-EEA i correlation 0.07 0.04 0.107
BA i-TL i correlation -0.09 0.05 0.050
EEA i-TL i correlation -0.08 0.07 0.226
AL s-BA s correlation 0.53 0.15 < 0.001
AL s-TL s correlation -0.05 0.08 0.541
BA s-TL s correlation 0.09 0.09 0.321
AL i-BA s correlation -0.27 0.11 0.018
AL i-TL s correlation 0.11 0.06 0.092
BA i-AL s correlation -0.20 0.08 0.011
BA i-TL s correlation -0.03 0.06 0.645
EEA i-AL s correlation -0.11 0.07 0.135
EEA i-BA s correlation -0.10 0.08 0.215
EEA i-TL s correlation -0.08 0.07 0.252
TL i-AL s correlation 0.18 0.08 0.037
TL i-BA s correlation 0.03 0.09 0.739
Note.
AL = allostatic load. BA = biological age. i
= intercept [growth factor]. EEA = extrinsic
epigenetic age. s = slope [growth factor]. TL
= telomere length.
Table 4.7 contains results from the MARmodel with extrinsic epigenetic
age, rather than intrinsic epigenetic age, as the epigenetic age measure.
Note that because the extrinsic epigenetic age slope had to be fixed
at zero, all covariances involving the extrinsic epigenetic age slope
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were also fixed at zero. At baseline, older extrinsic epigenetic age was
associated with higher allostatic load, with a small effect size (r [SE] =
.10 [.05]).
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4.3.2.1 Adding dummy variables for dropout
Figure 4.3: Parallel process model results: Growth factor correlations
from the NMAR model with IEA. Results are from one model; pairings
are displayed separately for clarity. Correlation estimates between
the growth factors are shown, with the associated standard errors in
parentheses. AL = allostatic load. BA = biological age. IEA = intrinsic
epigenetic age. TL = telomere length.
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Table 4.8: Parallel process model results: Growth factor
correlations from the NMAR model with EEA
r SE p-value
AL i-AL s correlation -0.31 0.10 0.002
BA i-BA s correlation -0.30 0.09 < 0.001
TL i-TL s correlation 0.21 0.18 0.230
AL i-BA i correlation 0.25 0.05 < 0.001
AL i-EEA i correlation 0.08 0.05 0.078
AL i-TL i correlation -0.07 0.05 0.198
BA i-EEA i correlation 0.04 0.04 0.307
BA i-TL i correlation -0.09 0.05 0.053
EEA i-TL i correlation -0.08 0.07 0.235
AL s-BA s correlation 0.52 0.15 0.001
AL s-TL s correlation -0.05 0.08 0.530
BA s-TL s correlation 0.08 0.09 0.357
AL i-BA s correlation -0.25 0.11 0.028
AL i-TL s correlation 0.11 0.06 0.088
BA i-AL s correlation -0.18 0.08 0.025
BA i-TL s correlation -0.03 0.06 0.553
EEA i-AL s correlation -0.10 0.07 0.183
EEA i-BA s correlation -0.09 0.08 0.274
EEA i-TL s correlation -0.08 0.07 0.230
TL i-AL s correlation 0.18 0.08 0.035
TL i-BA s correlation 0.03 0.09 0.716
Note.
AL = allostatic load. BA = biological age. i
= intercept [growth factor]. EEA = extrinsic
epigenetic age. s = slope [growth factor]. TL
= telomere length.
Growth factor correlations from the parallel process models that
assumed missing data were not missing at random are in Figure 4.3
(for the model with IEA) and Table 4.8 (for the model with EEA).
Results in these models were similar to the results in the missing
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at random models. Two baseline (intercept-intercept) correlations
that were marginally statistically significant in the missing at random
models were no longer statistically significant using an alpha of .05.
The first was the biological age-telomere length correlation (r [SE] =
-.09 [.05]; p = .052). The interpretation of this parameter did not
change based on the not missing at random models, as the correlation
was near-identical in size and had similar p-values in all models. The
second was the allostatic load-extrinsic epigenetic age correlation,
which was attenuated by around 20% (r [SE] = .08 [.04]; p = .078).
Some other correlations were also slightly attenuated, but not to
the extent that the changes affected broad conclusions about the
relationships. On the whole, the results of these models suggested that
the contemporaneous longitudinal relationships between physiological
weathering measures were not substantially biased by the measures’
relationships with dropout.
We also fitted sensitivity analysis models using epigenetic age estimates
pre-adjusted for three DNA methylation assessment variables. Results
in the sensitivity analysis models were near-identical, which showed




Table 4.9: Model fit statistics for physiological weathering
models
Model CFI RMSEA SRMR Notes
AL MAR unconditional 0.904 0.098 0.054
AL MAR conditional 0.905 0.051 0.028
AL NMAR conditional 0.901 0.045 0.037
BA MAR unconditional 0.914 0.141 0.065 Despite poor fit, this model produced reasonable estimates.
BA MAR conditional 0.917 0.074 0.038
BA NMAR conditional 0.927 0.060 0.042
EEA MAR unconditional 0.848 0.148 0.096 EEA slope variance was fixed to zero as it was initially estimated
as negative. Covariances involving the EEA slope were also fixed
to zero. These constraints was retained in subsequent models.
EEA MAR conditional 0.854 0.091 0.054
EEA NMAR conditional 0.873 0.074 0.065
IEA MAR unconditional 0.998 0.020 0.029
IEA MAR conditional 1.000 0.000 0.017
IEA NMAR conditional 0.998 0.010 0.028
TL MAR unconditional 0.948 0.147 0.078 Wave 3 telomere length variance was fixed at zero as it was
initially estimated as negative. This constraint was retained in
subsequent models.
TL MAR conditional 0.945 0.074 0.042
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Table 4.9: Model fit statistics for physiological weathering
models (continued)
Model CFI RMSEA SRMR Notes
TL NMAR conditional 0.945 0.064 0.036
Parallel processes MAR with IEA 0.947 0.041 0.032 BA and IEA values were divided by 20 to avoid model fitting
issues caused by variances being of very different sizes. This
transformation was also used in subsequent parallel process
models for BA, IEA and EEA.
Parallel processes NMAR with IEA 0.949 0.037 0.039
Parallel processes MAR with EEA 0.900 0.053 0.041
Parallel processes NMAR with EEA 0.909 0.047 0.049
Note.
For CFI and RMSEA, robust variants were used. AL = allostatic load. BA = biological age. CFI = comparative fit index. EEA = extrinsic
epigenetic age. IEA = intrinsic epigenetic age. RMSEA = root mean square error of approximation. SRMR = square root mean residual.
TL = telomere length.
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Table 4.9 contains model fit statistics for all models fitted. Across the
one process models, RMSEA and SRMR tended to change more than CFI
when covariates were added. All intrinsic epigenetic age models had
excellent fit, while all extrinsic epigenetic age models had poor fit.
Unconditional models for both biological age and telomere length had
poor fit according to RMSEA, but after covariates were added to these
models they had good fit. The unconditional allostatic load model
had borderline satisfactory fit, while conditional allostatic load models
had good fit according to RMSEA and SRMR but still had borderline
satisfactory fit according to the CFI.
The better fitting parallel process models were those with intrinsic
epigenetic age. The parallel process models with intrinsic epigenetic
age had good fit, while the parallel process models with extrinsic
epigenetic age had good fit according to RMSEA and SRMR but only
borderline satisfactory fit according to the CFI.
4.4 Discussion
Allostatic load, biological age, telomere length and epigenetic age
measures are all considered to index physiological weathering caused
by stress and/or ageing. All have been linked to important health
outcomes, including mortality. It is important, then, to understand
whether these measures are closely related and offer the same
information about physiological weathering, or only weakly linked,
in which case they mostly provide us with different information.
Our study tested the relationships between these measures. It went
beyond previous related research by having four waves of physiological
weathering data from an age-homogeneous older age sample. This
enabled us to model associated change in the measures during a
particular period in later life: between ages 70 and 79. We found
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that these measures differ in their distributions, their relationships
with sex, and their relationships with dropout. The two most closely
linked measures, both contemporaneously and longitudinally, were
allostatic load and biological age. Typically, however, estimates of
the contemporaneous and longitudinal associations between these
measures were strikingly small, which suggests that they tap different
aspects of stress- and age-related physiological weathering.
4.4.1 Physiological weathering distributions and
longitudinal changes
All physiological weathering measures tended to change in the expected
directions as the cohort aged. Changes were not homogeneous, though;
there was notable variability in individual trajectories for all measures
except intrinsic epigenetic age.
Interestingly, the three measures designed to track with age - biological
age, extrinsic epigenetic age, and intrinsic epigenetic age - related
differently to chronological age. Biological age tracked chronological
age the most closely. The average female experienced slightly
slowed ageing during the study, while the average male experienced
slight age acceleration. Unlike biological age, both epigenetic age
measures suggested that both the average male and the average
female experienced notable age acceleration over the course of the
study. Extrinsic epigenetic age further suggested that before baseline,
the average female had experienced considerable age acceleration and
the average male had experienced around that much age acceleration
again.
At each wave, biological age was approximately normally distributed,
like in the Dunedin Study (Belsky et al., 2015), while the epigenetic
age distributions had long tails, as some participants had epigenetic
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age estimates far above or below their chronological age. Both
allostatic load and telomere length were sometimes positively skewed,
meaning there were individuals with particularly high allostatic load
and particularly long telomere length.
4.4.2 How do the weathering measures relate to each
other?
Prior to this study, it was not clear how allostatic load and biological
age related over time. We found that changes in each were strongly
correlated: individuals who increased sharply in allostatic load were
more likely to experience accelerated biological ageing. We also found
correlations between higher baseline allostatic load and biological age
and less steep increases in allostatic load and biological age, although
these were likely partly the result of regression to the mean along with
both measures being positively skewed (see Barnett, van der Pols, &
Dobson, 2005 for a primer on regression to the mean).
At baseline, higher allostatic load was moderately correlated with older
biological age. The only previous sample to relate contemporaneously
measured allostatic load and biological age found that they had a strong
positive correlation rather than a moderate strength correlation, but
this study used a mixed-age sample with a minimum age of 30 and a
mean age of 49.6 (continuous allostatic load-biological age r = .571;
Levine & Crimmins, 2014). Further research using different samples,
and simulations based on different general population values, will help
to clarify how these measures’ relationships differ in age-homogeneous
versus mixed-age samples.
It is important to emphasise that because allostatic load scores
from different operationalisations are imperfectly correlated, the
relationships between allostatic load and other measures will vary
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based on the operationalisation used. Plus, because allostatic load
and biological age operationalisations share some biomarkers, it is
possible for allostatic load and biological age to correlate more strongly
than different operationalisations of allostatic load. For example,
Levine & Crimmins (2014) found that continuous allostatic load was
more strongly correlated with biological age than it was with two
cutoff-based measures of allostatic load. Interestingly, there are
patterns of inter- or intra-individual physiological differences that
similarly affect biological age estimates and continuous allostatic load
scores, but are unlikely to affect allostatic load scores based on sample
distributions. For example, consider a hypothetical individual in our
study whose HbA1c increased from 41 to 42 mmol/mol from Waves 1 to
2, moving them into the high risk range for diabetes (National Institute
for Health and Care Excellence, 2017). Their continuous allostatic load
score and their estimated biological age would increase, but in this
sample, all commonly used sample-based allostatic load scores would
not be affected. In summary, there are methodological reasons why
some operationalisations of allostatic load, including ours, might be
expected to be more closely related to biological age than others.
The present study also tested the relationship between allostatic
load and extrinsic epigenetic age, an epigenetic age measure that
incorporates additional blood cell composition data. We found that at
baseline, higher allostatic load was related to older extrinsic epigenetic
age, with a small effect size. This relationship seemed to be weaker in
participants who did not drop out of the study, as after dropout was
added to the model, this correlation was attenuated by about 20% and
was no longer statistically significant with an alpha of .05.
An unexpected finding was that longer telomere length at baseline was
consistently associated with a steeper subsequent increase in allostatic
load, with a small-to-moderate effect size. Previous studies had found
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that if there was any relationship, it was between shorter telomere
length and higher allostatic load (Ahrens et al., 2016; Révész et al.,
2014). Research has also associated shorter telomere length with HPA
axis dysregulation (e.g., Tomiyama et al., 2012; Gotlib et al., 2015)
and our allostatic load operationalisation did not use any HPA axis
biomarkers. It may be, then, that telomere length relates differently to
different components of allostatic load.
Strikingly small correlations were observed between measures that were
not calculated using some of the same data (i.e., all correlations except
allostatic load-biological age and extrinsic epigenetic age-intrinsic
epigenetic age). This suggests that they index different aspects of
stress and ageing and/or that they are noisy measures. It is notable
that the measures seemed to mostly index different aspects of stress
and ageing, considering that potential causal paths exist between some
of the measures. Consider telomere length and markers of biological
age. Telomere length has causal effects on biological age markers
of heart and lung function (Demanelis, Tong, & Pierce, 2019), while
inflammatory markers of biological age may shorten telomeres through
generating oxygen free radicals (Kirchner et al., 2017). Other causal
effects linking the two have also been posited (Blackburn et al., 2015).
Yet, in our latent growth curve models, estimates of the baseline
correlation between older biological age and shorter telomere length
were small (all rs = -0.09). The raw contemporaneous correlations
we observed between biological age and telomere length (-0.02 to
-0.05) were smaller than the baseline estimate from our models, and
very similar in size to the correlation observed by Belsky et al. (2018)
at age 38 (r = -.05). We also observed weak correlations between
biological age and intrinsic epigenetic age (r range = -0.03 to 0.06),
all of which were smaller than the modest correlation observed by
Belsky et al. (2018) at age 38 (r = .08). Our study replicates the weak
correlations reported by Belsky et al. (2018) in multiple waves of an
84
older age sample, and extends it: correlations between allostatic load
and extrinsic epigenetic age were also small.
It may be helpful to take a psychometric approach to considering
the strengths of these correlations. Method variance, such as wording
similarities in questionnaires, can contribute to the correlations between
psychometric items and so latent method factors are sometimes
included in factor analyses (Tomas & Oliver, 1999). In the present
study, method effects help to explain the strong correlations between
measures that share measurements (e.g., the two epigenetic age
measures) but they do not explain why most of the correlations are
small.
Constructs from item response theory may also help us to understand
the observed correlations. In item response theory, an item is difficult if
the participant must be high on the latent trait to have a positive answer
(Reise, Ainsworth, & Haviland, 2005). Also, items have information
functions that show how well they discriminate between individuals
across different levels of the latent trait (Reise et al., 2005). Here, it
could be that the different measures are not strongly correlated because
they have different difficulty levels for physiological weathering; for
example, epigenetic age could be more sensitive to weathering than
allostatic load. However, given the number of physiological processes
involved, it seems more likely that the correlations are low because
the measures mostly provide information about different physiological
processes.
In summary, physiological weathering measures calculated using some
of the same data tend to have moderate-to-strong associations with
each other, while those calculated using different data tend to be weakly
associated if they are associated at all. This suggests that they carry
mostly different information about the effects of stress and ageing.
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4.4.3 Strengths and limitations
Crucially, our study had four waves of data, collected over around 10
years, for allostatic load biomarkers, biological age biomarkers, and
DNA methylation, along with three waves of telomere length data. This
rich and rare data enabled us to conduct novel tests of the relationships
between associated changes in these measures. We used an older
age, age-homogeneous sample, which differentiated our study from
previous studies correlating these measures. In addition, our study
used pattern mixture modelling to check an assumption that is often
not tested, and these models showed our results were not notably
biased by participant dropout.
Our study also had limitations. Some of the standard errors for
associated change correlations were large, and so we were not able
to provide precise estimates of the relationships, or strong evidence
whether these relationships do or do not exist. Our allostatic load
measure lacked HPA axis biomarkers, and our biological age estimates
were calculated using fewer biomarkers than those in previous studies
(Belsky et al., 2015; Levine & Crimmins, 2014). In addition, while we
had four waves of data for almost all of the weathering measures, we
only had three waves of data for telomere length. Finally, it is worth
noting that while the use of an older age sample differentiated our
study from previous research, it also means that our results cannot be
generalised to other age groups.
4.4.4 Future directions
Considering that the measures studied here seem to provide mostly
different information about stress- and ageing-related physiological
weathering, a focus of future research should be clarifying the
pathways to different measures of physiological weathering as well
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as the pathways from the measures of physiological weathering to
adverse health outcomes, including mortality.
Future investigations of allostatic load and biological age measurement
should also consider using biomarkers measured more frequently
than once in a number of years. While some biomarkers used for
these measures are relatively stable throughout the day (e.g., CRP;
Meier-Ewert et al., 2001), others are less so (e.g., SBP; Pickering, 1990).
This could lead to the undesirable situation where an individual has a
rather different allostatic load level and/or biological age at different
times in the same day. Therefore, research should aim to understand
and incorporate the stress- and age-linked intraindividual variability
in indicators of allostatic load and biological age.
Epigenetic age measures will also benefit from further calibration using
large samples.
Future research comparing weathering measures should, if possible,
includemitochondrial health (Picard, Prather, et al., 2018). Mitochondrial
allostatic load may cause both broader physiological allostatic load and
cellular ageing (Picard et al., 2014), but it has not yet been confirmed
whether it is more strongly related to allostatic load summary scores
or other measures of physiological weathering.
4.4.5 Conclusion
We tested the longitudinal older age associations between five
physiological weathering measures: allostatic load, biological age,
extrinsic epigenetic age, intrinsic epigenetic age and telomere length.
Aside from the two epigenetic age measures, the most closely
related measures were allostatic load and biological age, which were
operationalised using most of the same biomarkers. Higher allostatic
load was moderately correlated with older biological age at baseline, and
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increases in allostatic load over time were strongly related to increased
biological age acceleration. Strikingly, most correlations between these
measures were small. This suggests that these measures provide
different information about the physiological weathering caused by
stress and ageing.
4.5 Coda
If allostatic load was very strongly related to other physiological
weathering measures (e.g., rs ≈ |.90|), this would suggest that
allostatic load and the other measures mostly index the same processes
of age-related physiological weathering. This would have meant that
associations with criterion variables would be similar. Additionally,
it would have suggested that allostatic load operationalisations may
need a calibration check to see if they more closely index stress- or
age-related physiological dysregulation. However, this study found
that allostatic load scores are not strongly related to epigenetic
age or telomere length and are mostly independent of biological
age estimates. Hence, allostatic load seems to mostly index different
aspects of physiological weathering to other measures. This finding sets
the foundation for the following two chapters, which will conduct novel
tests relating longitudinal changes in allostatic load to longitudinal




How do allostatic load and
cognitive ability relate over
time in the Lothian Birth Cohort
1936?
5.1 Introduction
Non-pathological cognitive ageing has a tremendous health cost (Deary
et al., 2009). Public health bodies are increasingly focusing efforts
on identifying and measuring risk factors for deleterious cognitive
ageing (e.g., Cambridge Institute of Public Health, 2016; Center for
Disease Control and Prevention, 2017). It is crucial that we improve
our understanding of how risk factors relate to cognitive ability and
decline in older age, because this has the potential to help researchers to
identify the mechanisms involved and help clinicians to assess and treat
their patients. A large body of literature has identified the physiological
effects of stress as being detrimental to health, including cognitive
functioning. However, there remains limited research investigating
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whether the cumulative effects of stress impact changes in cognitive
ability over time.
5.1.1 Possible mechanisms linking allostatic load and
cognitive ability
The association between allostatic load and cognitive ability likely
results from causal pathways in both directions and the effects of
common causes.
The brain is central to both the stress response and cognitive
functioning, so stress can affect both allostatic load and cognitive
ability. The primary mediators released during the stress response can
lead to allostatic load and can also affect cognitive ability through their
effects on the brain. For example, prolonged higher levels of cortisol
can affect levels of secondary outcome allostatic load markers and can
cause decreased brain area volumes (Echouffo-Tcheugui et al., 2018;
McEwen & Gianaros, 2011).
Researchers have tended to focus more on how allostatic load may
affect cognitive ability, but there are also potential causal pathways
from cognitive ability to allostatic load. For example, higher cognitive
ability is associated with a greater stress response (Ginty, Phillips, Der,
Deary, & Carroll, 2011; Ginty, Phillips, Roseboom, Carroll, & deRooij,
2012). There are also potential long-term effects: lower cognitive
ability is associated with harmful health behaviours (Gottfredson &
Deary, 2004), which are related to allostatic load (Forrester et al.,
2019). In sum, the potential causal paths involving allostatic load and
cognitive ability are myriad. The present study focuses on whether
allostatic load can be useful as an indicator of risk for deleterious
cognitive ageing, but its exploratory analyses may help to suggest
directions for future research focused on mechanisms.
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5.1.2 Allostatic load biomarkers and cognitive ability
Allostatic load’s putative biomarkers from various physiological
systems have been related to cognitive change in older age, although
not consistently for all biomarkers studied. Examples of biomarkers
linked to subsequent cognitive decline are higher midlife body mass
index, a metabolic marker (e.g., Dahl et al., 2013), higher blood
pressure, a cardiovascular marker (e.g., Elias, Wolf, D’Agostino, Cobb,
& White, 1993; Glynn et al., 1999), and higher levels of interleukin-6,
an inflammatory marker (e.g., Mooijaart et al., 2013; Economos et al.,
2013). The effect sizes observed in these studies have tended to be
small-to-moderate in size.
A smaller number of studies have investigated associations between
change in allostatic load biomarkers and change in cognitive ability.
Studies into such relationships have found, for example, that urinary
cortisol increases tracked with ~28 month memory declines in
women but not men, with a small-to-moderate effect size (n =
194, sample aged 70-79 years; Seeman et al., 1997), that systolic
blood pressure increases tracked with Mini-Mental State Examination
declines in normotensive Mexican-Americans over ~7 years, with
a moderate effect size (n = 2,859, sample aged 65+ years; Insel,
Palmer, Stroup-Benham, Markides, & Espino, 2005), and that extreme
longitudinal variation in C-reactive protein was related to cognitive
decline on the Modified Mini-Mental Status Exam in women (HR = 1.8)
and those without an APOE e4 allele (HR = 1.6), but not men or APOE
e4 allele carriers (Metti et al., 2014).
Studies that have not incorporated measures of allostatic load or
multisystem physiological dysregulation have nonetheless suggested
that risk for subsequent cognitive decline may be increased by the
presence of dysregulation in multiple biomarkers and across multiple
physiological systems. For example, studies have found that metabolic
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syndrome tends to better predict cognitive decline than single metabolic
markers, and that risk is heightened for those with metabolic syndrome
who also have high inflammation (Yaffe, 2007).
5.1.3 Allostatic load summary measures and cognitive
ability
Relatively few studies have investigated the relationships between
allostatic load summary measures and cognitive ability.
A few studies have found relationships between allostatic load and
contemporaneously measured cognitive ability. In the Midlife in the
United States study (MIDUS; n = 1,076; Mdn age = 57 y), allostatic
load was related to lower scores on contemporaneously measured
factors of episodic memory and executive function (Karlamangla et
al., 2014). Also, in the MacArthur Studies of Successful Aging, at
baseline in 1988 (N = 1,189; age range = 70-79 y), allostatic load had
small negative correlations with general cognitive ability (r = -.13)
and specific cognitive abilities (spatial ability, memory, and abstract
reasoning; r range = -.11 to -.09; Seeman et al., 1997). In the Social
Environment and Biomarkers of Aging Study (SEBAS; based in Taiwan;
n = 1,023 for cited studies; range of mean ages = 67-68 years), an
allostatic load profile involving dysregulation of cardiovascular and
metabolic biomarkers was related to a contemporaneously measured
cognitive summary variable (Seplaki, Goldman, Weinstein, & Lin, 2006).
Plus, allostatic load scored in some ways but not others was related to
worse contemporaneously measured temporal orientation (a cognitive
impairment test; Seplaki et al., 2005). The present study will use data
from the Lothian Birth Cohort 1936 (LBC1936), a cohort study with
a focus on cognitive ageing. Previous LBC studies have found small
negative associations between allostatic load and general cognitive
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ability at Waves 1 and 2 (Booth et al., 2015; Crook et al., 2018). At
Wave 2, allostatic load also had small negative associations with the
specific cognitive factors of knowledge and processing speed. and Wave
2 allostatic load also had a small negative association with age 11 IQ
(Booth et al., 2015).
Research has also investigated the longitudinal relationships between
allostatic load and cognitive ability measures. In the West of Scotland
Twenty-07 Study’s 1972-born cohort (N = 705), slower processing
speed at age 16 (measured by choice reaction time) had a small
correlation with higher allostatic load at age 36 (r = .13; Gale et al.,
2015). In the MacArthur Studies of Successful Aging, allostatic load
in 1988 was also modestly associated with memory decline between
1988 and 1991 (r = -.08), predicted change in general cognitive ability
between 1988 and 1996 (Seeman et al., 2001), and was moderately
correlated with 1998-1991 and 1991-1996 cognitive declines (canonical
r = .29; Karlamangla et al., 2002). However, in SEBAS, allostatic load
and non-clinical biomarker summary scores did not predict subsequent
cognitive impairment, nor subsequent decline in cognitive impairment
(n = 820; Goldman et al., 2006). The effect size estimate for the
association between allostatic load and cognitive impairment was
extremely small: one additional allostatic load biomarker in the top or
bottom 10% of sample values was associated with 0.01 more cognitive
tasks completely incorrectly (Goldman et al., 2006). The association
between cognitive impairment and a clinical biomarker summary score
was around twice as strong and was statistically significant, though the
effect size was still very small (Goldman et al., 2006). In the LBC1936,
Wave 1 allostatic load was related to general cognitive decline between
Waves 1 and 3 (mean ages 70 and 76; beta range when jointly estimated
across genotyptic groups = -.87 to to -.98; Crook et al., 2018).
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5.1.4 The present study
In the present study, we used latent growth curve modelling with
four waves of LBC1936 data to test contemporaneous and longitudinal
relationships between allostatic load and cognitive ability in older
age, from approximately 70 to 79 years. This enabled us to improve
understanding of how allostatic load and cognitive ability relate over
time, in particular by testing the relationship between change in
allostatic load and change in cognitive ability.
The overarching research question of the current study is: how do
allostatic load and cognitive ability relate over time? Specifically, we
will seek to address the following research questions:
1. Does initial (age 70) allostatic load relate to subsequent change
(between ages 70 and 79) in cognitive ability?
2. Does initial cognitive ability relate to subsequent change in
allostatic load?
3. Does change in allostatic load correlate with change in cognitive
ability?
We also fitted our latent growth curve model with age 11 cognitive
ability, coded as IQ scores, added as a predictor of older age level
and change in allostatic load and cognitive ability. This enabled us to
test the relationships age 11 IQ has with older age level and change in
allostatic load, and test whether the relationships between allostatic
load and cognitive ability in older age are affected by accounting for
age 11 cognitive ability.
4. Does age 11 IQ predict allostatic load at age 70 and change in
allostatic load between ages 70 and 79?
5. Does statistically controlling for the effects of age 11 IQ affect
the contemporaneous and longitudinal relationships between older
age allostatic load and older age cognitive ability?
94
Our main models tested these research questions in relation to
a factor of general cognitive ability. We also fitted exploratory
models investigating each of these research questions in relation to





5.2.1.1.1 Childhood cognitive ability. Most participants sat the
Moray House Test No. 12 on 4th June, 1947 as part of the Scottish
Mental Survey 1947. The Moray House Test No. 12 is a validated
intelligence test (Scottish Council for Research in Education, 1949). It
is a paper-and-pencil test, administered in groups, with 75 items of
various types, a 45-minute time limit, and a maximum possible score
of 76 (Scottish Council for Research in Education, 1949). We used
Moray House Test No. 12 scores from the Scottish Mental Survey 1947
that have previously been corrected for age at the time assessment and
converted to age 11 IQ scores.
5.2.1.1.2 Older age cognitive ability. The cognitive tests taken by
the LBC1936 have previously been detailed (Deary et al., 2007). We
used data from the following cognitive ability tests:
• the National Adult Reading Test (NART; a test of word
recognition and pronunciation, requires pronouncing 50 irregular
words; Nelson & Willison, 1991);
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• verbal fluency total score (a test of executive function, requires
listing as many words as possible beginning with a given letter
[here C, F, and L] in a one minute period; Lezak, Howieson, Loring,
Hannay, & Fischer, 2004);
• the Wechsler Test of Adult Reading (WTAR; another test of
word recognition and pronunciation, also requires pronouncing 50
irregular words; Holdnack, 2001);
• block design (a test of non-verbal reasoning, requires reproducing
a design using blocks; Wechsler, 1998a);
• digit span backwards (a test of working memory, requires recall
of increasingly long lists of numbers in reverse order; Wechsler,
1998b);
• letter-number sequencing (a test of working memory, requires
recall of increasingly long lists of letters and numbers, with
numerical order recall of the numbers followed by alphabetical
order recall of the letters; Wechsler, 1998a);
• matrix reasoning (a test of non-verbal reasoning, items require
choosing the option that correctly completes the pattern in a
matrix; Wechsler, 1998a);
• spatial span forwards (a test of non-verbal learning and
memory, requires participants to repeat a sequence of block
touches; Wechsler, 1998b);
• spatial span backwards (a test of non-verbal learning and
memory, requires participants to observe a sequence of block
touches and then enact the sequence in reverse order; Wechsler,
1998b);
• digit symbol coding (a test of processing speed, requires entering
symbols next to numbers according to a digit-symbol code, with
a time limit of two minutes; Wechsler, 1998a);
• inspection time (a test of processing speed, requires identifying
the longer of two briefly displayed vertical lines on trials with
96
display times from 6ms to 200ms; Deary et al., 2004);
• simple reaction time (a test of processing speed, requires pressing
a key as quickly as possible after a stimulus appears; Deary, 2001);
• choice reaction time (a test of processing speed, requires pressing
the correct numbered key [1, 2, 3, or 4] as quickly as possible after
the matching stimulus appears; Deary, 2001);
• symbol search (a test of processing speed, requires identifying
whether either of two target symbols appears in a row of symbols,
with items completed up to a time limit of two minutes; Wechsler,
1998a);
• logical memory immediate recall (a test of immediate verbal
declarative memory, requires immediate recall of a story with
25 elements, with there being two stories and the second story
delivered twice; Wechsler, 1998b);
• logical memory delayed recall (a test of delayed verbal
declarative memory, requires delayed recall of the two stories
from the logical memory immediate recall test; Wechsler, 1998b);
• verbal paired associates immediate recall (a test of verbal
learning and memory in which participants hear unrelated word
pairs, before being given the first of the pair and being asked to
recall the second; Wechsler, 1998b);
• and verbal paired associates delayed recall (a test of verbal
learning and memory in which participants are given the first word
of the word pairs from the verbal paired associates immediate
recall test and asked to recall the second; Wechsler, 1998b).
5.2.2 Data exclusion criteria
Participants were excluded if, during a structured interview, they
self-reported having dementia. Participants were also excluded if they
had an abnormal score on the Mini-Mental State Examination (MMSE;
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Folstein, Folstein, & McHugh, 1975) for their level of education, as such
scores were taken as indicating possible cognitive impairment due to
pathological cognitive ageing. Educational level was collected as part
of a structured interview at Wave 1, where participants were asked how
many years of full-time formal education they had. We used Mitchell’s
(2013, p. 37) “education-adjusted cut-off points for an abnormal
score[:] <21 for patients with a basic school education, <23 for a high
school education, and <24 for graduate/university education.”
5.2.3 Statistical analysis
We followed a two-step approach in the current study. First, we
established plausible latent variable measurement models for the
cognitive ability tests and assessed the similarity of this model across
the four waves via measurement invariance testing. Following this, we
fitted latent growth curve models to the cognitive and allostatic load
data across waves in order to test our research hypotheses.
5.2.3.1 Cognitive ability measurement models
In our study preregistration (Crook et al., 2017b), we originally planned
to fit second-order latent growth curve models using a bifactor
cognitive ability model previously applied to cross-sectional LBC1936
data (Booth, Bastin, et al., 2013; Booth et al., 2015). In this model,
each of the 18 cognitive tests loads of a general factor as well as on
a specific cognitive factor, namely knowledge, non-verbal reasoning,
processing speed or verbal memory. However, latent growth curve
models based on this model structure did not converge. Our second
planned approach was to fit latent growth curve models using the
same set of five cognitive factors, but instead of including the factor
structure in the model, the growth model would be applied to factor
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scores from the longitudinal confirmatory factor analysis model for the
bifactor model. However, this model structure did not produce models
with satisfactory fit (see Section 5.3.1).
Hence, we fitted models using the final contingency model structure
from our preregistration. In our models, there was a single general
cognitive ability factor in which scores from the following seven tests
loaded on the general factor at each wave: block design, digit symbol
coding, letter-number sequencing, matrix reasoning, symbol search,
logical memory delayed recall, and the WTAR.
To identify the model, the variances of the cognitive ability factors were
fixed at 1.
5.2.3.1.1 Wave 1 measurement model fit. For our Wave 1 cognitive
ability measurement model, fit index results beyond the following
thresholds were taken to indicate satisfactory fit (Schermelleh-Engel,
Moosbrugger, & Müller, 2003; van de Schoot, Lugtig, & Hox, 2012):
confirmatory fit index (CFI) ≥ .95; root mean square error of
approximation (RMSEA) ≤ .08; standardised root mean square residual
(SRMR) ≤ .10. As suggested cutoffs for the CFI differ (Schermelleh-Engel
et al., 2003; van de Schoot et al., 2012), the following CFI range will
indicate borderline satisfactory fit: .95 > CFI ≥ .90. We planned
that if, on balance, the initial model did not have acceptable fit, the
model would be modified based on modification indices, with the
modifications that would produce the greatest improvement in fit
made one at a time until the model has acceptable fit. Note that
while modification indices can be used to improve model fit, they
can lead to overfitting and the introduction of nonsense parameters,
particularly where there is not an empirical basis for the proposed
model modifications (Bollen & Noble, 2011). In the present study,
some suggested modifications did not make substantive sense and/or
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affected the core structure of the model; we decided not to consider
these modifications.
The robust variants of the CFI and RMSEA were used throughout.
5.2.3.1.2 Longitudinal measurement model. After a model with
acceptable fit to the Wave 1 data was found, data from Waves 2-4
were added to the model. In the longitudinal measurement models,
we included correlations between the different waves of the general
cognitive ability factor as well as correlated residuals across waves for
each cognitive test (e.g., all waves of symbol search residuals were
allowed to correlate). Measurement invariance of the cognitive factors
across waves was then tested. Measurement invariance was assessed
by sequentially adding equivalence constraints to the measurement
models and comparing model fit at each step.
The following sequence of models was fitted:
1. Configural invariance: Cognitive tests are associated with the same
factor across waves.
2. Metric invariance: Factor indicator loadings constrained to be equal
across waves.
3. Strong invariance: Factor indicator intercepts constrained to be
equal across waves.
4. Strict invariance: Factor indicator residuals and correlated residuals
constrained to be equal across waves.
5.2.3.1.3 Longitudinal measurement invariance testing. To assess
whether measurement invariance held, we considered various model fit
indices. First, following Chen (2007), in testing themetric constraints (δ
models 1 and 2), differences of ≥ -.010 in CFI, ≥ .015 in RMSEA or ≥ .030
in SRMR, were taken as indicative of noninvariance. In testing for strong
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and strict invariance, differences of ≥ -.010 in CFI, supplemented by a
difference of ≥ .015 in RMSEA or a change of ≥ .010 in SRMR were taken
to indicate noninvariance. We also consulted the Akaike Information
Criterion and the Bayesian Information Criterion, for which an increase
was taken to indicate noninvariance (van de Schoot et al., 2012). For
completeness, we also considered the chi-square test, for which p ≤
.05 indicated noninvariance. However, note that the chi-square test
is highly sensitive to sample size as well as distributional assumption
violations (Chen, 2007). In large samples like the one here, it tends to
over-reject models with acceptable fit (Chen, 2007).
As these various fit measures have their own advantages and
disadvantages, we considered all of them when deciding whether,
on balance, invariance was achieved at each stage. We planned that
if the model comparisons testing weak, strong, or strict factorial
invariance suggest that full measurement invariance (invariance of
all the constrained parameters) was not achieved, we would consult
modification indices to find and make fit-improving changes to the
model so that partial measurement invariance (invariance of some of
the constrained parameters) could be achieved.
Following the guidance of Widaman, Ferrer, & Conger (2010), in our
latent growth curve models we interpreted the results relating to
cognitive factors that had at least strong longitudinal invariance, that
is, invariance of factor indicator loadings and intercepts across waves.
5.2.3.2 Latent growth curve models
Figure 5.1 shows the general specification of the dual change latent
growth curve models. Note that for general cognitive ability, the latent
growth curve indicators were the latent general cognitive ability factor
at each wave, rather than an observed score.
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Figure 5.1: Allostatic load-general cognitive ability latent growth curve
model specification. A-C are labelled paths described in the text. AL
= allostatic load. BD = block design. g = general cognitive ability. i =
intercept. MR = matrix reasoning. s = slope. W = wave.
Correlations between the intercept and slope growth factors tested
our primary research questions. The correlation between the allostatic
load intercept and cognitive ability slope (path A in Figure 5.1) tested
question 1. The correlation between the cognitive ability intercept and
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the allostatic load slope (path B) tested question 2. The correlation
between the allostatic load slope and the cognitive ability slope (path
C) tested question 3.
To address our final two research questions, age 11 IQ was added to
the model as a predictor of all growth factors. The regressions of the
allostatic load intercept and slope on age 11 IQ tested question 4. To
answer the question 5, we assessed how the growth factor correlations
differed between models with and without age 11 IQ.
5.2.3.2.1 Exploratory analyses. The bifactor models we intended
to use for our confirmatory models used the results from 18 cognitive
tests. These bifactor models included a general factor and four
specific cognitive factors. However, as these models did not fit, we
used contingency models that modelled the results from only seven
cognitive tests. To investigate how allostatic load relates over time
to specific cognitive abilities, we fitted additional exploratory models.
For each of the 18 cognitive tests, we fitted four latent growth curve
models: the MAR main model; a MAR model with age 11 IQ as a
predictor of all growth factors; and NMAR versions of those two
models, which used to the same pattern-mixture modelling approach
as our confirmatory models.
Please note that these were exploratory models that were not
preregistered and were planned after the main analyses had
commenced. These models should not be taken as strongly confirming




Table 5.1: Descriptive statistics for age, allostatic load and
cognitive ability tests
n Mean SD Skew Kurtosis
Age W1 1088 69.53 0.83 -0.04 -0.88
Age W2 861 72.49 0.71 -0.01 -0.83
Age W3 685 76.24 0.67 -0.05 -0.81
Age W4 536 79.32 0.62 0.08 -0.74
AL W1 1087 0.69 0.24 1.07 2.15
AL W2 861 0.71 0.24 1.17 3.17
AL W3 684 0.85 0.25 0.71 1.13
AL W4 535 0.87 0.25 0.59 0.45
NART W1 1086 34.53 8.09 -0.52 -0.25
NART W2 859 34.47 8.05 -0.57 0.00
NART W3 684 35.09 7.99 -0.64 0.09
NART W4 533 35.76 8.06 -0.64 0.03
Verbal fluency W1 1084 42.46 12.51 0.31 -0.12
Verbal fluency W2 860 43.22 12.89 0.24 0.03
Verbal fluency W3 685 43.04 12.66 0.28 0.10
Verbal fluency W4 534 43.95 13.18 0.07 -0.24
WTAR W1 1086 41.06 7.11 -0.94 0.53
WTAR W2 859 41.09 6.81 -0.89 0.55
WTAR W3 683 41.15 7.00 -1.12 1.42
WTAR W4 533 41.76 6.91 -1.14 1.22
Block design W1 1082 33.83 10.31 0.25 -0.27
Block design W2 859 33.71 10.06 0.48 0.11
Block design W3 679 32.39 9.79 0.36 0.25
Block design W4 523 31.48 9.36 0.51 0.39
Digit span backwards W1 1087 7.74 2.26 0.51 -0.12
Digit span backwards W2 861 7.83 2.28 0.29 -0.09
Digit span backwards W3 683 7.81 2.36 0.30 -0.38
Digit span backwards W4 535 7.62 2.15 0.39 -0.13
Letter-number sequencing W1 1076 10.95 3.13 0.17 0.01
Letter-number sequencing W2 858 10.94 3.06 0.26 0.35
Letter-number sequencing W3 678 10.51 2.98 0.21 0.41
Letter-number sequencing W4 524 10.17 2.79 0.35 0.40
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Table 5.1: Descriptive statistics for age, allostatic load and
cognitive ability tests (continued)
n Mean SD Skew Kurtosis
Matrix reasoning W1 1083 13.52 5.12 -0.03 -1.00
Matrix reasoning W2 858 13.22 4.95 -0.04 -1.00
Matrix reasoning W3 677 13.10 4.90 0.01 -0.93
Matrix reasoning W4 523 13.03 5.00 0.09 -0.95
Spatial span forwards W1 1083 7.68 1.64 -0.18 -0.37
Spatial span forwards W2 858 7.64 1.66 -0.06 -0.47
Spatial span forwards W3 678 7.59 1.62 -0.08 -0.32
Spatial span forwards W4 524 7.42 1.60 -0.06 -0.39
Spatial span backwards W1 1081 7.05 1.73 0.02 -0.13
Spatial span backwards W2 856 7.08 1.60 -0.10 -0.13
Spatial span backwards W3 678 7.07 1.58 -0.06 -0.38
Spatial span backwards W4 524 6.76 1.58 0.01 -0.12
Digit symbol W1 1083 56.66 12.90 0.04 -0.21
Digit symbol W2 858 56.47 12.30 0.03 -0.14
Digit symbol W3 674 54.12 12.66 -0.03 -0.10
Digit symbol W4 524 51.64 12.73 -0.06 -0.05
Inspection time W1 1038 112.18 10.98 -0.79 1.91
Inspection time W2 834 111.28 11.78 -1.22 4.12
Inspection time W3 645 110.30 12.44 -0.76 1.09
Inspection time W4 461 107.06 13.58 -1.15 2.90
SRT mean W1 1082 0.28 0.06 2.18 7.79
SRT mean W2 860 0.28 0.05 1.94 6.86
SRT mean W3 677 0.28 0.05 1.60 4.28
SRT mean W4 531 0.29 0.05 1.35 2.79
CRT mean W1 1081 0.64 0.09 0.96 2.38
CRT mean W2 860 0.65 0.09 1.15 3.94
CRT mean W3 675 0.68 0.10 0.84 1.53
CRT mean W4 531 0.70 0.11 1.01 2.32
Symbol search W1 1081 24.79 6.24 0.04 0.40
Symbol search W2 857 24.67 6.13 -0.32 0.74
Symbol search W3 675 24.81 6.26 -0.13 0.66
Symbol search W4 517 22.98 6.41 -0.13 0.72
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Table 5.1: Descriptive statistics for age, allostatic load and
cognitive ability tests (continued)
n Mean SD Skew Kurtosis
Logical memory immediate recall W1 1085 44.23 10.30 -0.33 -0.13
Logical memory immediate recall W2 859 45.77 10.15 -0.44 0.30
Logical memory immediate recall W3 681 46.02 10.69 -0.40 0.05
Logical memory immediate recall W4 533 45.19 11.08 -0.59 0.80
Logical memory delayed recall W1 1084 27.37 7.99 -0.40 0.01
Logical memory delayed recall W2 859 28.79 7.94 -0.58 0.46
Logical memory delayed recall W3 679 28.98 8.55 -0.60 0.44
Logical memory delayed recall W4 531 28.36 8.76 -0.63 0.60
VPA immediate recall W1 1057 20.24 7.41 -0.40 -0.73
VPA immediate recall W2 842 20.84 7.66 -0.50 -0.72
VPA immediate recall W3 659 20.19 7.70 -0.43 -0.72
VPA immediate recall W4 496 20.92 7.64 -0.54 -0.53
VPA delayed recall W1 1048 6.17 2.03 -0.97 -0.01
VPA delayed recall W2 840 6.39 2.02 -1.25 0.66
VPA delayed recall W3 658 6.25 2.07 -1.13 0.36
VPA delayed recall W4 493 6.32 2.06 -1.20 0.50
Age 11 IQ 1028 100.00 14.99 -0.80 0.92
Note.
AL = allostatic load. CRT = choice reaction time. NART = National Adult Reading
Test. SRT = simple reaction time. VPA = verbal paired associates. W = wave.
WTAR = Wechsler Test of Adult Reading.
Table 5.1 contains descriptive statistics for the study variables. The
allostatic load mean increased throughout the waves, with the biggest
jump in means being between Waves 2 and 3. However, there was
substantial variability in scores at all waves. The cognitive tests
displayed different patterns of change. For example, the WTAR mean
increased across waves while the matrix reasoning mean decreased
across waves. Block design, digit symbol coding and letter-number
sequencing each showed little change in means between Waves 1 and
2, followed by gradual decline from Waves 2 to 4.
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5.3.1 Measurement models: longitudinal CFA and
unconditional latent growth curve models
We began by fitting measurement models using a bifactor cognitive
ability model previously identified in this sample (Booth et al., 2013;
2015). Bifactor longitudinal measurement models had satisfactory fit
well. However, when we fitted the unconditional bifactor latent growth
curve model, the model did not converge. We then fitted models based
on our first contingency model structure, in which growth factors
reflected the level and change in the factor scores from the bifactor
longitudinal measurement model. This model did not have satisfactory
fit: CFI = 0.63, RMSEA = 0.23; SRMR = 0.18.
Finally, we fitted models based on our last contingency model structure,
in which seven cognitive tests loaded on to a general cognitive factor
and there were no specific cognitive factors. Table 5.2 contains the
models fitted using this model structure and the CFI, RMSEA and
SRMR for each model. Based on modification indices for the Wave
1 measurement model for this structure, we added four correlated
residuals: digit symbol coding with symbol search, block design with
matrix reasoning, logical memory delayed recall with WTAR, and block
design with symbol search. In the longitudinal measurement models
for this structure, we had to free the intercepts for Wave 4 block design
and WTAR to achieve partial measurement invariance. However, the
latent growth curve model based on this model had a negative variance
for Wave 4 general cognitive ability. After this variance was fixed to
zero, the model only barely achieved satisfactory fit: CFI = 0.95; RMSEA
= 0.05; SRMR = 0.09. Hence, following Ferrer, Balluerka, & Widaman
(2008), we tested measurement invariance within an unconditional
latent growth curve model framework to see if the same model was
identified as the best fitting or if a better fitting model could be found.
Initially, we compared models with different reference indicators but
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no further constraints. Again, the Wave 4 general cognitive ability
variance was consistently negative and had to be fixed at zero. The
best fitting model used letter-number sequencing as the reference
indicator, so it was used as the reference indicator in all subsequent
models. To achieve partial measurement invariance in these models,
four intercepts had to be freely estimated: Wave 4 block design, Wave
3 and Wave 4 WTAR, and Wave 1 delayed recall. These modifications to
the measurement model were found via assessing modification indices
and the results from models without intercepts constrained. No other
modifications had to be made to achieve measurement invariance.
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Table 5.2: Cognitive ability measurement model fit statistics
CFI RMSEA SRMR
LCFA: Initial longitudinal measurement model with configural invariance 0.973 0.039 0.054
LCFA: Added invariance of loadings 0.965 0.044 0.224
LCFA: Add invariance of intercepts 0.951 0.050 0.111
LCFA: Freed Wave 4 block design intercept 0.951 0.050 0.111
LCFA: Freed Wave 4 WTAR intercept 0.961 0.045 0.075
LCFA: Freed Wave 4 symbol search intercept 0.961 0.045 0.075
LCFA: Added invariance of residuals 0.958 0.045 0.078
LCFA: Added invariance of correlated residuals 0.956 0.045 0.080
LGCM: Inital model based on final longitudinal measurement model 0.950 0.048 0.087
LGCM: Configural invariance, block design as reference indicator 0.973 0.039 0.055
LGCM: Configural invariance, digit symbol coding as reference indicator 0.971 0.041 0.054
LGCM: Configural invariance, letter-number sequencing as reference indicator 0.973 0.039 0.055
LGCM: Configural invariance, matrix reasoning as reference indicator 0.973 0.039 0.055
LGCM: Configural invariance, symbol search as reference indicator 0.970 0.041 0.055
LGCM: Configural invariance, delayed logical memory recall as reference indicator 0.971 0.041 0.055
LGCM: Configural invariance, WTAR as reference indicator 0.973 0.039 0.054
LGCM: Retained letter-number sequencing as reference indicator, added invariance of loadings 0.972 0.039 0.060
LGCM: Added invariance of intercepts 0.949 0.051 0.104
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Table 5.2: Cognitive ability measurement model fit statistics
(continued)
CFI RMSEA SRMR
LGCM: Freed Wave 4 block design intercept 0.950 0.051 0.101
LGCM: Freed Wave 4 WTAR intercept 0.955 0.048 0.082
LGCM: Freed Wave 3 WTAR intercept 0.959 0.046 0.071
LGCM: Freed Wave 4 logical memory delayed recall intercept 0.962 0.044 0.069
LGCM: Added invariance of residuals 0.960 0.044 0.072
LGCM: Added invariance of correlated residuals 0.958 0.044 0.072
Note.
CFI and RMSEA are robust variants. CFI = comparative fit index. LCFA = longitudinal confirmatory factor analysis. LGCM
= latent growth curve model. RMSEA = root mean square error of approximation. SRMR = standardised root mean square
residual. WTAR = Wechsler Test of Adult Reading.
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The final unconditional latent growth curve model for general cognitive
ability had satisfactory fit and fitted better than the unconditional latent
growth curve model based on the longitudinal measurement model:
CFI = 0.96; RMSEA = 0.04; SRMR = 0.07. Standardised loadings in
the general cognitive ability measurement part of the model ranged
from 0.49 to 0.74 in absolute size. There was notable variation in
baseline level (intercept mean estimate [SE] = 0.005 [0.027]; intercept
variance estimate [SE] = 0.38 [0.03]). On average, general cognitive
ability declined gradually over time (slope mean estimate [SE] = -0.041
[0.002]), although there was notable variation in individual trajectories
(slope variance estimate [SE] = 0.0003 [0.0001]). Baseline level and
subsequent trajectory were not statistically significantly correlated (r
[SE] = -0.02 [0.09]).
The final unconditional latent growth curve model for allostatic load did
not have satisfactory fit: CFI = 0.90; RMSEA = 0.10; SRMR = 0.06. There
was notable variability in allostatic load at baseline (intercept mean
estimate [SE] = 0.68 [0.01]; intercept variance estimate [SE] = 0.029
[0.004]). On average, allostatic load gradually increased over time
(slope mean estimate [SE] = 0.021 [0.001]), although as with general
cognitive ability, there was notable variation in individual trajectories
(slope variance estimate [SE] = 0.00033 [0.00007]). Higher baseline
allostatic load was related to a flatter trajectory in allostatic load, with
a moderate strength effect size (r [SE] = -0.31 [0.10]).
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5.3.2 Allostatic load-general cognitive ability latent
growth curve models
Figure 5.2: Allostatic load-general cognitive ability MAR model growth
factor correlations. Correlations are displayed, with their standard errors
in parentheses. AL = allostatic load. g = general cognitive ability.
Figure 5.2 contains results from latent growth curve models that
modelled the initial level and trajectories over time for both general
cognitive ability and allostatic load. There was a small negative
correlation between the intercept growth factors (r [SE] = -0.13
[0.04]), which means that lower general cognitive ability was related
to higher allostatic load levels at age 70. The allostatic load intercept
and slope were moderately negatively correlated (r [SE] = -0.31 [0.10]),
which means that those with higher allostatic load at baseline had less
steep increases (or were more likely to decrease) in allostatic load over
time.
Research question 1 was addressed by the correlation between the
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allostatic load intercept (allostatic load at age 70) and the general
cognitive ability slope (change in general cognitive ability between
ages 70 and 79). Research question 2 was addressed by the correlation
between the general cognitive ability intercept (general cognitive
ability at age 70) and the allostatic load slope (change in allostatic
load between ages 70 and 79). Both of these correlations were very
small and their standard errors were large relative to the parameter
estimates. Hence, we did not find that age 70 allostatic load relates to
subsequent change in general cognitive ability, nor did we find that age
70 general cognitive ability relates to subsequent change in allostatic
load.
Research question 3 was addressed by the correlation between the two
slopes. This research question asked about the association between
changes in allostatic load and general cognitive ability between ages
70 and 79. The allostatic load and general cognitive ability slopes had
a small-to-moderate negative correlation, but this correlation had a
large standard error and was not statistically significant (r [SE] = -0.17
[0.13]), so further research is required on associated longitudinal change
in allostatic load and general cognitive ability.
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5.3.2.1 Not missing at random parallel process latent growth
curve models
Figure 5.3: Allostatic load-general cognitive ability NMARmodel growth
factor correlations. Correlations are displayed, with their standard errors
in parentheses. AL = allostatic load. g = general cognitive ability.
Figure 5.3 contains results from allostatic load-general cognitive ability
latent growth curve models that assumedmissing data were not missing
at random after the data in the model was taken into account. Here,
binary dummy variables (d2-d4) that indicated if a participant dropped
out at Waves 2-4 respectively. Compared to those who did not drop out,
those who dropped out at Wave 2 had 0.70 SD lower general cognitive
ability (SE = 0.09) and 0.40 SD higher allostatic load at baseline (SE
= 0.11), while those who dropped out at Wave 3 had 0.56 SD lower
general cognitive ability (SE = 0.09) and 0.47 SD higher allostatic load
at baseline (SE = 0.13). Also, those who dropped out at Wave 2 or 3 had
0.68 SD steeper decline in general cognitive ability (SE = 0.36). Those
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who dropped out at Wave 4 had 0.40 SD lower general cognitive ability
at baseline (SE = 0.09) and 0.50 SD steeper decline in general cognitive
ability (SE = 0.23).
Notably, the correlation between the allostatic load and general
cognitive ability intercepts was attenuated in this model and was no
longer statistically significant with an alpha of .05 (r [SE] = -0.08
[0.04]). This suggests that the correlation between allostatic load and
general cognitive ability at age 70 is partly driven by participants who
dropped out at Waves 2-4.
5.3.3 Adding control for age 11 IQ
Table 5.3: Allostatic load-general cognitive ability
MAR model results after controlling for age 11 IQ
Estimate SE p-value
g i regression on age 11 IQ 0.73 0.02 < 0.001
g s regression on age 11 IQ -0.19 0.07 0.007
AL i regression on age 11 IQ -0.05 0.04 0.197
AL s regression on age 11 IQ 0.04 0.06 0.477
AL i-g i correlation -0.13 0.05 0.006
AL s-g s correlation -0.17 0.14 0.226
AL i-g s correlation -0.08 0.11 0.479
AL s-g i correlation -0.01 0.08 0.894
AL i-AL s correlation -0.31 0.10 0.003
g i-g s correlation 0.29 0.12 0.021
Note.
Regression betas standardised on all variables. AL
= allostatic load; g = general cognitive ability; i =
intercept; s = slope.
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Table 5.3 contains results from the missing at random model after age
11 IQ was added as a predictor of all four growth factors. Age 11 IQ was
strongly positively related to general cognitive ability at age 70 (β [SE]
= 0.73 [0.02]). It had a weak but statistically significant relationship
with greater cognitive decline between ages 70 and 79 (β [SE] = -0.19
[0.07]).
Research question 4 asked about the relationships of age 11 IQ with
allostatic load at age 70 and change allostatic load from age 70 to 79.
It was addressed by the regressions of the allostatic load intercept and
slope on age 11 IQ. These regression estimates were small and their
confidence intervals were wide, so age 11 IQ was not related to older
age level and change in allostatic load.
Research question 5 asked whether statistically controlling for age
11 IQ would change the relationships between older age allostatic
load and general cognitive ability. It was addressed by comparing the
intercept and slope correlation estimates from this model to those from
the model without statistical control for age 11 IQ. Comparing these
estimates revealed that control for age 11 IQ did not change the older
age relationships between allostatic load and general cognitive ability.
The correlation between the allostatic load and general cognitive ability
intercepts did not notably change (r [SE] = -0.13 [0.05]) and nor did
any of the other correlations between the growth factors.
5.3.3.1 Not missing at random model with control for age 11 IQ
Table 5.4: Allostatic load-general cognitive ability
NMAR model results after controlling for age 11 IQ
Estimate SE p-value
g i regression on age 11 IQ 0.71 0.02 < 0.001
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Table 5.4: Allostatic load-general cognitive ability
NMAR model results after controlling for age 11 IQ
(continued)
Estimate SE p-value
g s regression on age 11 IQ -0.21 0.07 0.002
AL i regression on age 11 IQ -0.03 0.04 0.536
AL s regression on age 11 IQ 0.02 0.06 0.674
AL i-g i correlation -0.08 0.05 0.071
AL s-g s correlation -0.17 0.14 0.218
AL i-g s correlation -0.06 0.11 0.581
AL s-g i correlation -0.03 0.08 0.663
AL i-AL s correlation -0.30 0.11 0.005
g i-g s correlation 0.29 0.13 0.021
Note.
Regression betas standardised on all variables. AL
= allostatic load; g = general cognitive ability; i =
intercept; NMAR = not missing at random; s = slope.
Table 5.4 contains results from the model that retained statistical
control for age 11 IQ and added dummy variables for dropout. This
addition resulted in only one notable difference in results. It was the
same as the difference between the MAR and NMAR models that did
not have control for age 11 IQ: the correlation between the allostatic
load and general cognitive ability intercepts was attenuated and was
no longer statistically significant (r [SE] = -0.08 [0.05]).
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5.3.4 Exploratory latent growth curve models relating
allostatic load and specific cognitive tests
Table 5.5: Allostatic load and specific cognitive variables:
Exploratory MAR model growth factor correlations
r SE p-value
AL i-block design i correlation -0.08 0.04 0.087
AL s-block design s correlation 0.08 0.15 0.624
AL i-block design s correlation -0.18 0.13 0.162
AL s-block design i correlation -0.03 0.07 0.650
block design i-s correlation -0.33 0.08 < 0.001
AL i-digit-symbol coding i correlation -0.18 0.04 < 0.001
AL s-digit-symbol coding s correlation -0.10 0.09 0.267
AL i-digit-symbol coding s correlation -0.02 0.08 0.785
AL s-digit-symbol coding i correlation 0.12 0.07 0.083
digit-symbol coding i-s correlation -0.12 0.07 0.069
AL i-letter-number sequencing i correlation -0.04 0.05 0.400
AL s-letter-number sequencing s correlation -0.06 0.12 0.615
AL i-letter-number sequencing s correlation -0.01 0.09 0.898
AL s-letter-number sequencing i correlation -0.03 0.07 0.682
letter-number sequencing i-s correlation -0.34 0.08 < 0.001
AL i-matrix reasoning i correlation -0.09 0.05 0.072
AL s-matrix reasoning s correlation -0.05 1.40 0.970
AL i-matrix reasoning s correlation 0.03 1.05 0.978
AL s-matrix reasoning i correlation -0.01 0.08 0.943
matrix reasoning i-s correlation 0.16 1.71 0.926
AL i-symbol search i correlation -0.11 0.05 0.026
AL s-symbol search s correlation -0.50 0.21 0.017
AL i-symbol search s correlation 0.05 0.14 0.737
AL s-symbol search i correlation 0.05 0.07 0.488
symbol search i-s correlation -0.03 0.16 0.863
AL i-logical memory delayed recall i correlation -0.07 0.05 0.102
AL s-logical memory delayed recall s correlation -0.01 0.12 0.919
AL i-logical memory delayed recall s correlation -0.06 0.09 0.549
AL s-logical memory delayed recall i correlation 0.10 0.07 0.156
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Table 5.5: Allostatic load and specific cognitive variables:
Exploratory MAR model growth factor correlations
(continued)
r SE p-value
logical memory delayed recall i-s correlation 0.01 0.08 0.907
AL i-WTAR i correlation -0.07 0.04 0.092
AL s-WTAR s correlation -0.02 0.14 0.871
AL i-WTAR s correlation -0.02 0.12 0.883
AL s-WTAR i correlation 0.08 0.06 0.191
WTAR i-s correlation 0.00 0.10 0.998
AL i-NART i correlation -0.06 0.04 0.186
AL s-NART s correlation -0.09 0.13 0.489
AL i-NART s correlation 0.00 0.10 0.977
AL s-NART i correlation 0.07 0.06 0.278
NART i-s correlation -0.09 0.09 0.300
AL i-verbal fluency i correlation -0.09 0.04 0.031
AL s-verbal fluency s correlation -0.37 0.16 0.026
AL i-verbal fluency s correlation 0.06 0.12 0.618
AL s-verbal fluency i correlation 0.15 0.07 0.031
verbal fluency i-s correlation -0.09 0.09 0.324
AL i-digit span backwards i correlation -0.01 0.05 0.853
AL s-digit span backwards s correlation 0.20 0.27 0.449
AL i-digit span backwards s correlation -0.31 0.25 0.209
AL s-digit span backwards i correlation -0.06 0.07 0.355
digit span backwards i-s correlation -0.21 0.15 0.144
AL i-spatial span forwards i correlation -0.01 0.06 0.865
AL s-spatial span forwards s correlation 0.38 0.45 0.398
AL i-spatial span forwards s correlation -0.01 0.24 0.956
AL s-spatial span forwards i correlation -0.09 0.09 0.280
spatial span forwards i-s correlation 0.19 0.27 0.486
AL i-spatial span backwards i correlation -0.09 0.06 0.116
AL s-spatial span backwards s correlation 0.11 0.38 0.773
AL i-spatial span backwards s correlation -0.19 0.35 0.590
AL s-spatial span backwards i correlation -0.06 0.09 0.514
spatial span backwards i-s correlation 0.20 0.31 0.512
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Table 5.5: Allostatic load and specific cognitive variables:
Exploratory MAR model growth factor correlations
(continued)
r SE p-value
AL i-inspection time i correlation -0.04 0.05 0.403
AL s-inspection time s correlation -0.26 0.53 0.631
AL i-inspection time s correlation -0.50 0.84 0.551
AL s-inspection time i correlation -0.01 0.08 0.939
inspection time i-s correlation 0.98 2.02 0.629
AL i-SRT i correlation 0.06 0.05 0.208
AL s-SRT s correlation -0.12 0.17 0.475
AL i-SRT s correlation 0.03 0.13 0.838
AL s-SRT i correlation 0.04 0.08 0.621
SRT i-s correlation -0.20 0.18 0.251
AL i-CRT i correlation 0.13 0.05 0.005
AL s-CRT s correlation 0.02 0.13 0.908
AL i-CRT s correlation 0.12 0.11 0.293
AL s-CRT i correlation -0.02 0.07 0.819
CRT i-s correlation 0.32 0.16 0.042
AL i-logical memory immediate recall i correlation -0.06 0.05 0.184
AL s-logical memory immediate recall s correlation 0.06 0.11 0.605
AL i-logical memory immediate recall s correlation -0.04 0.09 0.681
AL s-logical memory immediate recall i correlation 0.12 0.07 0.114
logical memory immediate recall i-s correlation -0.04 0.08 0.576
AL i-Verbal Paired Associates I i correlation -0.05 0.04 0.204
AL s-Verbal Paired Associates I s correlation -0.13 0.10 0.208
AL i-Verbal Paired Associates I s correlation -0.08 0.08 0.326
AL s-Verbal Paired Associates I i correlation 0.10 0.07 0.130
Verbal Paired Associates I i-s correlation -0.18 0.08 0.021
AL i-Verbal Paired Associates II i correlation -0.08 0.04 0.084
AL s-Verbal Paired Associates II s correlation -0.15 0.12 0.220
AL i-Verbal Paired Associates II s correlation 0.01 0.09 0.929
AL s-Verbal Paired Associates II i correlation 0.12 0.07 0.092
Verbal Paired Associates II i-s correlation -0.12 0.10 0.265
AL i-knowledge i correlation -0.03 0.04 0.447
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Table 5.5: Allostatic load and specific cognitive variables:
Exploratory MAR model growth factor correlations
(continued)
r SE p-value
AL s-knowledge s correlation 0.06 0.11 0.571
AL i-knowledge s correlation 0.02 0.08 0.815
AL s-knowledge i correlation 0.01 0.06 0.870
knowledge i-s correlation -0.04 0.07 0.549
AL i-nonverbal reasoning i correlation -0.02 0.05 0.595
AL s-nonverbal reasoning s correlation 0.44 0.41 0.287
AL i-nonverbal reasoning s correlation -0.14 0.20 0.473
AL s-nonverbal reasoning i correlation -0.15 0.07 0.041
nonverbal reasoning i-s correlation -0.87 0.52 0.095
AL i-processing speed i correlation -0.12 0.05 0.012
AL s-processing speed s correlation -0.04 0.10 0.657
AL i-processing speed s correlation -0.03 0.08 0.670
AL s-processing speed i correlation -0.02 0.07 0.754
processing speed i-s correlation -0.08 0.07 0.257
AL i-verbal memory i correlation -0.03 0.04 0.541
AL s-verbal memory s correlation -0.06 0.13 0.658
AL i-verbal memory s correlation -0.04 0.10 0.685
AL s-verbal memory i correlation 0.02 0.07 0.714
verbal memory i-s correlation -0.43 0.08 < 0.001
Note.
AL = allostatic load; i = intercept; s = slope.
We fitted separate exploratory latent growth curve models relating
allostatic load growth factors to growth factors for each of 18 cognitive
tests and four specific cognitive factors. Table 5.5 contains the
results from these models when data were assumed to be missing
at random. Most correlations between allostatic load and cognitive
growth factors were not statistically significant, although there were
some notable relationships. Higher allostatic load at baseline was
related to poorer verbal fluency (r [SE] = -0.09 [0.04]), as well as
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slower contemporaneously measured processing speed (r [SE] = -0.12
[0.05]) and worse performance on two processing speed tasks: digit
symbol coding (r [SE] = -0.18 [0.04]) and choice reaction time (r [SE]
= 0.13 [0.05]; higher choice reaction time indicates slower processing
and therefore worse performance). Increase in allostatic load over time
was related to decline on the symbol search test (r [SE] = -0.50 [0.21]),
which is also a test of processing speed, as well as decline on a verbal
fluency task, which taps executive function (r [SE] = -0.37 [0.16]).
Finally, better baseline nonverbal reasoning was related to having a
lower allostatic load slope (i.e., less increase or more decrease; r [SE]
= -0.15 [0.07]), while better baseline verbal fluency was related to
having a higher allostatic load slope (i.e., more increase; r [SE] = 0.15
[0.07]).
Table 5.6: Allostatic load and specific cognitive variables:
Exploratory MAR model growth factor correlations after
controlling for age 11 IQ
r SE p-value
AL i-block design i correlation -0.06 0.05 0.219
AL s-block design s correlation 0.10 0.16 0.543
AL i-block design s correlation -0.21 0.14 0.126
AL s-block design i correlation -0.07 0.07 0.331
block design i-s correlation -0.20 0.10 0.052
AL i-digit-symbol coding i correlation -0.18 0.04 < 0.001
AL s-digit-symbol coding s correlation -0.11 0.09 0.263
AL i-digit-symbol coding s correlation -0.03 0.08 0.743
AL s-digit-symbol coding i correlation 0.12 0.07 0.098
digit-symbol coding i-s correlation -0.11 0.07 0.127
AL i-letter-number sequencing i correlation -0.01 0.05 0.780
AL s-letter-number sequencing s correlation -0.06 0.12 0.655
AL i-letter-number sequencing s correlation -0.03 0.09 0.770
AL s-letter-number sequencing i correlation -0.07 0.08 0.392
letter-number sequencing i-s correlation -0.28 0.09 0.002
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Table 5.6: Allostatic load and specific cognitive variables:
Exploratory MAR model growth factor correlations after
controlling for age 11 IQ (continued)
r SE p-value
AL i-matrix reasoning i correlation -0.07 0.05 0.151
AL s-matrix reasoning s correlation -0.04 0.49 0.930
AL i-matrix reasoning s correlation -0.01 0.38 0.986
AL s-matrix reasoning i correlation -0.03 0.08 0.708
matrix reasoning i-s correlation -0.02 0.44 0.970
AL i-symbol search i correlation -0.10 0.05 0.055
AL s-symbol search s correlation -0.50 0.21 0.015
AL i-symbol search s correlation 0.04 0.14 0.787
AL s-symbol search i correlation 0.04 0.08 0.582
symbol search i-s correlation 0.07 0.19 0.716
AL i-logical memory delayed recall i correlation -0.05 0.05 0.286
AL s-logical memory delayed recall s correlation -0.01 0.12 0.928
AL i-logical memory delayed recall s correlation -0.06 0.09 0.514
AL s-logical memory delayed recall i correlation 0.10 0.07 0.204
logical memory delayed recall i-s correlation 0.07 0.09 0.480
AL i-WTAR i correlation -0.05 0.04 0.197
AL s-WTAR s correlation -0.02 0.15 0.884
AL i-WTAR s correlation -0.03 0.12 0.830
AL s-WTAR i correlation 0.07 0.07 0.300
WTAR i-s correlation -0.05 0.10 0.646
AL i-NART i correlation -0.03 0.04 0.473
AL s-NART s correlation -0.09 0.13 0.503
AL i-NART s correlation -0.01 0.10 0.900
AL s-NART i correlation 0.04 0.06 0.499
NART i-s correlation -0.17 0.09 0.061
AL i-verbal fluency i correlation -0.08 0.04 0.065
AL s-verbal fluency s correlation -0.37 0.17 0.024
AL i-verbal fluency s correlation 0.06 0.12 0.632
AL s-verbal fluency i correlation 0.15 0.07 0.032
verbal fluency i-s correlation -0.07 0.10 0.465
AL i-digit span backwards i correlation 0.02 0.05 0.708
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Table 5.6: Allostatic load and specific cognitive variables:
Exploratory MAR model growth factor correlations after
controlling for age 11 IQ (continued)
r SE p-value
AL s-digit span backwards s correlation 0.18 0.23 0.426
AL i-digit span backwards s correlation -0.29 0.20 0.140
AL s-digit span backwards i correlation -0.10 0.07 0.173
digit span backwards i-s correlation -0.16 0.16 0.312
AL i-spatial span forwards i correlation 0.00 0.06 0.941
AL s-spatial span forwards s correlation 0.33 0.36 0.352
AL i-spatial span forwards s correlation -0.01 0.22 0.949
AL s-spatial span forwards i correlation -0.11 0.09 0.229
spatial span forwards i-s correlation 0.21 0.26 0.419
AL i-spatial span backwards i correlation -0.08 0.06 0.197
AL s-spatial span backwards s correlation 0.11 0.43 0.794
AL i-spatial span backwards s correlation -0.23 0.43 0.603
AL s-spatial span backwards i correlation -0.08 0.10 0.421
spatial span backwards i-s correlation 0.37 0.35 0.290
AL i-inspection time i correlation -0.04 0.05 0.497
AL s-inspection time s correlation -0.40 1.28 0.756
AL i-inspection time s correlation -0.66 2.00 0.743
AL s-inspection time i correlation -0.01 0.08 0.889
inspection time i-s correlation 1.23 4.30 0.775
AL i-SRT i correlation 0.05 0.05 0.334
AL s-SRT s correlation -0.12 0.17 0.455
AL i-SRT s correlation 0.04 0.13 0.761
AL s-SRT i correlation 0.06 0.09 0.524
SRT i-s correlation -0.16 0.19 0.394
AL i-CRT i correlation 0.12 0.05 0.010
AL s-CRT s correlation 0.02 0.13 0.881
AL i-CRT s correlation 0.11 0.11 0.297
AL s-CRT i correlation 0.00 0.08 0.950
CRT i-s correlation 0.31 0.16 0.050
AL i-logical memory immediate recall i correlation -0.04 0.05 0.434
AL s-logical memory immediate recall s correlation 0.05 0.11 0.631
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Table 5.6: Allostatic load and specific cognitive variables:
Exploratory MAR model growth factor correlations after
controlling for age 11 IQ (continued)
r SE p-value
AL i-logical memory immediate recall s correlation -0.04 0.09 0.683
AL s-logical memory immediate recall i correlation 0.11 0.08 0.151
logical memory immediate recall i-s correlation -0.03 0.09 0.764
AL i-Verbal Paired Associates I i correlation -0.04 0.05 0.387
AL s-Verbal Paired Associates I s correlation -0.13 0.10 0.185
AL i-Verbal Paired Associates I s correlation -0.08 0.08 0.333
AL s-Verbal Paired Associates I i correlation 0.10 0.07 0.171
Verbal Paired Associates I i-s correlation -0.20 0.08 0.012
AL i-Verbal Paired Associates II i correlation -0.06 0.05 0.174
AL s-Verbal Paired Associates II s correlation -0.16 0.13 0.199
AL i-Verbal Paired Associates II s correlation 0.01 0.09 0.919
AL s-Verbal Paired Associates II i correlation 0.11 0.07 0.112
Verbal Paired Associates II i-s correlation -0.15 0.11 0.172
AL i-knowledge i correlation -0.02 0.04 0.724
AL s-knowledge s correlation 0.06 0.11 0.615
AL i-knowledge s correlation 0.03 0.08 0.746
AL s-knowledge i correlation -0.01 0.06 0.895
knowledge i-s correlation -0.13 0.07 0.085
AL i-nonverbal reasoning i correlation -0.02 0.05 0.727
AL s-nonverbal reasoning s correlation 0.43 0.40 0.276
AL i-nonverbal reasoning s correlation -0.15 0.20 0.456
AL s-nonverbal reasoning i correlation -0.16 0.07 0.032
nonverbal reasoning i-s correlation -0.85 0.49 0.080
AL i-processing speed i correlation -0.11 0.05 0.014
AL s-processing speed s correlation -0.05 0.10 0.616
AL i-processing speed s correlation -0.03 0.08 0.727
AL s-processing speed i correlation -0.02 0.07 0.734
processing speed i-s correlation -0.09 0.07 0.210
AL i-verbal memory i correlation -0.03 0.04 0.523
AL s-verbal memory s correlation -0.06 0.13 0.621
AL i-verbal memory s correlation -0.03 0.10 0.742
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Table 5.6: Allostatic load and specific cognitive variables:
Exploratory MAR model growth factor correlations after
controlling for age 11 IQ (continued)
r SE p-value
AL s-verbal memory i correlation 0.03 0.07 0.698
verbal memory i-s correlation -0.43 0.08 < 0.001
Note.
AL = allostatic load; i = intercept; s = slope.
Table 5.6 contains growth factor correlations from exploratory models
with age 11 IQ added as a prediction of all growth factors. Results were
similar after controlling for age 11 IQ. The correlation between verbal
fluency and allostatic load at baseline was slightly attenuated and was
no longer statistically significant (r [SE] = -0.08 [0.04]).
Table 5.7: Allostatic load and specific cognitive variables:
Exploratory NMAR model growth factor correlations
r SE p-value
AL i-block design i correlation -0.04 0.04 0.358
AL s-block design s correlation 0.09 0.16 0.562
AL i-block design s correlation -0.21 0.13 0.113
AL s-block design i correlation -0.05 0.07 0.432
block design i-s correlation -0.31 0.09 < 0.001
AL i-digit-symbol coding i correlation -0.14 0.04 0.001
AL s-digit-symbol coding s correlation -0.10 0.10 0.299
AL i-digit-symbol coding s correlation -0.02 0.08 0.757
AL s-digit-symbol coding i correlation 0.09 0.07 0.166
digit-symbol coding i-s correlation -0.11 0.07 0.085
AL i-letter-number sequencing i correlation 0.00 0.05 0.943
AL s-letter-number sequencing s correlation -0.05 0.13 0.689
AL i-letter-number sequencing s correlation -0.03 0.10 0.773
AL s-letter-number sequencing i correlation -0.06 0.07 0.423
letter-number sequencing i-s correlation -0.34 0.08 < 0.001
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Table 5.7: Allostatic load and specific cognitive variables:
Exploratory NMAR model growth factor correlations
(continued)
r SE p-value
AL i-matrix reasoning i correlation -0.05 0.05 0.352
AL s-matrix reasoning s correlation 0.14 3.01 0.964
AL i-matrix reasoning s correlation -0.14 3.02 0.963
AL s-matrix reasoning i correlation -0.03 0.08 0.676
matrix reasoning i-s correlation 0.25 5.96 0.967
AL i-symbol search i correlation -0.07 0.05 0.148
AL s-symbol search s correlation -0.52 0.23 0.022
AL i-symbol search s correlation 0.04 0.15 0.803
AL s-symbol search i correlation 0.03 0.07 0.688
symbol search i-s correlation 0.02 0.18 0.909
AL i-logical memory delayed recall i correlation -0.03 0.05 0.553
AL s-logical memory delayed recall s correlation -0.01 0.13 0.956
AL i-logical memory delayed recall s correlation -0.06 0.09 0.505
AL s-logical memory delayed recall i correlation 0.07 0.07 0.328
logical memory delayed recall i-s correlation 0.04 0.08 0.618
AL i-WTAR i correlation -0.05 0.04 0.238
AL s-WTAR s correlation -0.02 0.14 0.876
AL i-WTAR s correlation 0.00 0.12 0.967
AL s-WTAR i correlation 0.07 0.06 0.271
WTAR i-s correlation -0.04 0.09 0.689
AL i-NART i correlation -0.04 0.04 0.402
AL s-NART s correlation -0.09 0.13 0.470
AL i-NART s correlation 0.02 0.10 0.845
AL s-NART i correlation 0.05 0.06 0.378
NART i-s correlation -0.12 0.08 0.148
AL i-verbal fluency i correlation -0.07 0.04 0.086
AL s-verbal fluency s correlation -0.38 0.17 0.027
AL i-verbal fluency s correlation 0.07 0.12 0.561
AL s-verbal fluency i correlation 0.14 0.07 0.046
verbal fluency i-s correlation -0.10 0.09 0.274
AL i-digit span backwards i correlation 0.02 0.05 0.632
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Table 5.7: Allostatic load and specific cognitive variables:
Exploratory NMAR model growth factor correlations
(continued)
r SE p-value
AL s-digit span backwards s correlation 0.22 0.28 0.429
AL i-digit span backwards s correlation -0.35 0.27 0.196
AL s-digit span backwards i correlation -0.08 0.07 0.228
digit span backwards i-s correlation -0.19 0.16 0.230
AL i-spatial span forwards i correlation 0.02 0.06 0.704
AL s-spatial span forwards s correlation 0.38 0.39 0.334
AL i-spatial span forwards s correlation -0.04 0.22 0.842
AL s-spatial span forwards i correlation -0.12 0.09 0.183
spatial span forwards i-s correlation 0.23 0.24 0.336
AL i-spatial span backwards i correlation -0.05 0.06 0.369
AL s-spatial span backwards s correlation 0.14 0.38 0.702
AL i-spatial span backwards s correlation -0.24 0.37 0.509
AL s-spatial span backwards i correlation -0.09 0.09 0.342
spatial span backwards i-s correlation 0.28 0.28 0.325
AL i-inspection time i correlation -0.01 0.05 0.836
AL s-inspection time s correlation -0.31 0.76 0.685
AL i-inspection time s correlation -0.57 1.24 0.644
AL s-inspection time i correlation -0.02 0.08 0.749
inspection time i-s correlation 1.17 2.99 0.695
AL i-SRT i correlation 0.03 0.05 0.533
AL s-SRT s correlation -0.14 0.17 0.414
AL i-SRT s correlation 0.05 0.13 0.724
AL s-SRT i correlation 0.06 0.08 0.447
SRT i-s correlation -0.18 0.19 0.327
AL i-CRT i correlation 0.10 0.05 0.044
AL s-CRT s correlation 0.02 0.14 0.880
AL i-CRT s correlation 0.11 0.11 0.322
AL s-CRT i correlation 0.01 0.07 0.937
CRT i-s correlation 0.36 0.17 0.031
AL i-logical memory immediate recall i correlation -0.02 0.05 0.724
AL s-logical memory immediate recall s correlation 0.07 0.12 0.550
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Table 5.7: Allostatic load and specific cognitive variables:
Exploratory NMAR model growth factor correlations
(continued)
r SE p-value
AL i-logical memory immediate recall s correlation -0.05 0.09 0.619
AL s-logical memory immediate recall i correlation 0.08 0.07 0.250
logical memory immediate recall i-s correlation -0.01 0.08 0.856
AL i-Verbal Paired Associates I i correlation -0.02 0.04 0.634
AL s-Verbal Paired Associates I s correlation -0.13 0.10 0.211
AL i-Verbal Paired Associates I s correlation -0.08 0.08 0.324
AL s-Verbal Paired Associates I i correlation 0.08 0.07 0.228
Verbal Paired Associates I i-s correlation -0.18 0.08 0.021
AL i-Verbal Paired Associates II i correlation -0.04 0.05 0.380
AL s-Verbal Paired Associates II s correlation -0.16 0.13 0.219
AL i-Verbal Paired Associates II s correlation 0.01 0.09 0.937
AL s-Verbal Paired Associates II i correlation 0.10 0.07 0.168
Verbal Paired Associates II i-s correlation -0.10 0.11 0.348
AL i-knowledge i correlation -0.04 0.04 0.423
AL s-knowledge s correlation 0.07 0.12 0.569
AL i-knowledge s correlation 0.01 0.08 0.868
AL s-knowledge i correlation 0.01 0.06 0.836
knowledge i-s correlation -0.03 0.08 0.646
AL i-nonverbal reasoning i correlation -0.01 0.05 0.890
AL s-nonverbal reasoning s correlation 0.47 0.47 0.310
AL i-nonverbal reasoning s correlation -0.19 0.23 0.421
AL s-nonverbal reasoning i correlation -0.16 0.07 0.029
nonverbal reasoning i-s correlation -0.88 0.59 0.132
AL i-processing speed i correlation -0.10 0.05 0.032
AL s-processing speed s correlation -0.05 0.10 0.591
AL i-processing speed s correlation -0.02 0.08 0.819
AL s-processing speed i correlation -0.03 0.07 0.663
processing speed i-s correlation -0.09 0.07 0.193
AL i-verbal memory i correlation -0.02 0.05 0.731
AL s-verbal memory s correlation -0.06 0.13 0.626
AL i-verbal memory s correlation -0.04 0.10 0.676
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Table 5.7: Allostatic load and specific cognitive variables:
Exploratory NMAR model growth factor correlations
(continued)
r SE p-value
AL s-verbal memory i correlation 0.02 0.07 0.766
verbal memory i-s correlation -0.43 0.08 < 0.001
Note.
AL = allostatic load; i = intercept; NMAR = not missing at random; s = slope.
Table 5.7 contains growth factor correlations from the exploratory
models which added dummy variables for dropout. The results were
similar. Again, the correlation between verbal fluency and allostatic
load at baseline was slightly attenuated and was no longer statistically
significant (r [SE] = -0.07 [0.04]).
Table 5.8: Allostatic load and specific cognitive variables:
Exploratory NMAR model growth factor correlations after
controlling for age 11 IQ
r SE p-value
AL i-block design i correlation -0.03 0.05 0.478
AL s-block design s correlation 0.10 0.16 0.516
AL i-block design s correlation -0.23 0.14 0.102
AL s-block design i correlation -0.08 0.07 0.250
block design i-s correlation -0.19 0.11 0.076
AL i-digit-symbol coding i correlation -0.15 0.04 0.001
AL s-digit-symbol coding s correlation -0.10 0.10 0.289
AL i-digit-symbol coding s correlation -0.03 0.08 0.735
AL s-digit-symbol coding i correlation 0.10 0.07 0.162
digit-symbol coding i-s correlation -0.10 0.07 0.160
AL i-letter-number sequencing i correlation 0.02 0.05 0.687
AL s-letter-number sequencing s correlation -0.05 0.13 0.700
AL i-letter-number sequencing s correlation -0.04 0.10 0.709
AL s-letter-number sequencing i correlation -0.08 0.08 0.276
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Table 5.8: Allostatic load and specific cognitive variables:
Exploratory NMAR model growth factor correlations after
controlling for age 11 IQ (continued)
r SE p-value
letter-number sequencing i-s correlation -0.27 0.09 0.004
AL i-matrix reasoning i correlation -0.04 0.05 0.414
AL s-matrix reasoning s correlation 0.01 0.44 0.981
AL i-matrix reasoning s correlation -0.05 0.35 0.894
AL s-matrix reasoning i correlation -0.05 0.08 0.553
matrix reasoning i-s correlation 0.00 0.44 0.998
AL i-symbol search i correlation -0.07 0.05 0.165
AL s-symbol search s correlation -0.53 0.23 0.020
AL i-symbol search s correlation 0.03 0.15 0.819
AL s-symbol search i correlation 0.03 0.08 0.689
symbol search i-s correlation 0.12 0.21 0.567
AL i-logical memory delayed recall i correlation -0.02 0.05 0.761
AL s-logical memory delayed recall s correlation -0.01 0.13 0.952
AL i-logical memory delayed recall s correlation -0.07 0.10 0.490
AL s-logical memory delayed recall i correlation 0.07 0.08 0.350
logical memory delayed recall i-s correlation 0.10 0.10 0.310
AL i-WTAR i correlation -0.05 0.04 0.221
AL s-WTAR s correlation -0.02 0.15 0.882
AL i-WTAR s correlation 0.00 0.12 0.989
AL s-WTAR i correlation 0.07 0.07 0.292
WTAR i-s correlation -0.07 0.10 0.472
AL i-NART i correlation -0.03 0.04 0.505
AL s-NART s correlation -0.09 0.13 0.477
AL i-NART s correlation 0.01 0.10 0.902
AL s-NART i correlation 0.05 0.06 0.476
NART i-s correlation -0.18 0.09 0.043
AL i-verbal fluency i correlation -0.07 0.04 0.100
AL s-verbal fluency s correlation -0.38 0.17 0.024
AL i-verbal fluency s correlation 0.07 0.12 0.552
AL s-verbal fluency i correlation 0.15 0.07 0.035
verbal fluency i-s correlation -0.08 0.10 0.435
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Table 5.8: Allostatic load and specific cognitive variables:
Exploratory NMAR model growth factor correlations after
controlling for age 11 IQ (continued)
r SE p-value
AL i-digit span backwards i correlation 0.04 0.05 0.435
AL s-digit span backwards s correlation 0.19 0.24 0.418
AL i-digit span backwards s correlation -0.31 0.21 0.128
AL s-digit span backwards i correlation -0.11 0.07 0.137
digit span backwards i-s correlation -0.14 0.16 0.383
AL i-spatial span forwards i correlation 0.03 0.06 0.629
AL s-spatial span forwards s correlation 0.34 0.33 0.308
AL i-spatial span forwards s correlation -0.04 0.21 0.857
AL s-spatial span forwards i correlation -0.12 0.09 0.170
spatial span forwards i-s correlation 0.24 0.24 0.320
AL i-spatial span backwards i correlation -0.05 0.06 0.416
AL s-spatial span backwards s correlation 0.13 0.41 0.746
AL i-spatial span backwards s correlation -0.26 0.44 0.548
AL s-spatial span backwards i correlation -0.10 0.10 0.318
spatial span backwards i-s correlation 0.42 0.35 0.226
AL i-inspection time i correlation -0.01 0.05 0.877
AL s-inspection time s correlation -0.49 2.19 0.824
AL i-inspection time s correlation -0.80 3.50 0.819
AL s-inspection time i correlation -0.03 0.08 0.744
inspection time i-s correlation 1.56 7.51 0.836
AL i-SRT i correlation 0.03 0.05 0.611
AL s-SRT s correlation -0.14 0.17 0.413
AL i-SRT s correlation 0.05 0.13 0.696
AL s-SRT i correlation 0.07 0.09 0.418
SRT i-s correlation -0.14 0.20 0.469
AL i-CRT i correlation 0.09 0.05 0.054
AL s-CRT s correlation 0.02 0.14 0.861
AL i-CRT s correlation 0.11 0.11 0.325
AL s-CRT i correlation 0.01 0.08 0.875
CRT i-s correlation 0.35 0.17 0.037
AL i-logical memory immediate recall i correlation 0.00 0.05 0.953
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Table 5.8: Allostatic load and specific cognitive variables:
Exploratory NMAR model growth factor correlations after
controlling for age 11 IQ (continued)
r SE p-value
AL s-logical memory immediate recall s correlation 0.06 0.12 0.583
AL i-logical memory immediate recall s correlation -0.05 0.09 0.631
AL s-logical memory immediate recall i correlation 0.09 0.08 0.266
logical memory immediate recall i-s correlation 0.00 0.09 0.991
AL i-Verbal Paired Associates I i correlation -0.01 0.05 0.756
AL s-Verbal Paired Associates I s correlation -0.14 0.10 0.186
AL i-Verbal Paired Associates I s correlation -0.08 0.08 0.335
AL s-Verbal Paired Associates I i correlation 0.08 0.07 0.244
Verbal Paired Associates I i-s correlation -0.20 0.08 0.012
AL i-Verbal Paired Associates II i correlation -0.03 0.05 0.464
AL s-Verbal Paired Associates II s correlation -0.17 0.13 0.196
AL i-Verbal Paired Associates II s correlation 0.01 0.10 0.923
AL s-Verbal Paired Associates II i correlation 0.10 0.07 0.167
Verbal Paired Associates II i-s correlation -0.14 0.11 0.229
AL i-knowledge i correlation -0.03 0.04 0.465
AL s-knowledge s correlation 0.06 0.12 0.593
AL i-knowledge s correlation 0.02 0.08 0.835
AL s-knowledge i correlation 0.01 0.06 0.931
knowledge i-s correlation -0.12 0.08 0.101
AL i-nonverbal reasoning i correlation 0.00 0.05 0.946
AL s-nonverbal reasoning s correlation 0.47 0.45 0.299
AL i-nonverbal reasoning s correlation -0.19 0.23 0.413
AL s-nonverbal reasoning i correlation -0.16 0.07 0.025
nonverbal reasoning i-s correlation -0.86 0.55 0.115
AL i-processing speed i correlation -0.10 0.05 0.033
AL s-processing speed s correlation -0.06 0.10 0.573
AL i-processing speed s correlation -0.02 0.08 0.843
AL s-processing speed i correlation -0.03 0.07 0.658
processing speed i-s correlation -0.10 0.07 0.166
AL i-verbal memory i correlation -0.02 0.05 0.719
AL s-verbal memory s correlation -0.07 0.13 0.613
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Table 5.8: Allostatic load and specific cognitive variables:
Exploratory NMAR model growth factor correlations after
controlling for age 11 IQ (continued)
r SE p-value
AL i-verbal memory s correlation -0.04 0.10 0.698
AL s-verbal memory i correlation 0.02 0.07 0.757
verbal memory i-s correlation -0.43 0.08 < 0.001
Note.
AL = allostatic load; i = intercept; NMAR = not missing at random; s = slope.
Table 5.8 contains growth factor correlations from exploratory models
with dummy variables for dropout and statistical control for age 11
IQ. Results were similar to the missing at random exploratory models
controlling for age 11 IQ. The only difference in the pattern of statistical
significance was that baseline allostatic load was not statistically
significantly related to slower baseline choice reaction time (r [SE] =
0.09 [0.05]).
5.4 Discussion
In this study, we fitted latent growth curve models to investigate how
allostatic load relates to cognitive ability in older age. Four waves
of data were collected between ages 70 and 79. General cognitive
ability was modelled as a latent factor based on seven cognitive tests,
which enabled fine-grained analysis of non-pathological cognitive
ageing. We replicated a relationship between contemporaneously
measured allostatic load and poorer general cognitive ability. The
effect size was relatively small, but similar to those observed in some
other samples (e.g., Seeman et al., 1997). However, we found that
baseline allostatic load was higher in those who dropped out at Wave
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2 or 3 and baseline general cognitive ability was poorer in those who
dropped out at Wave 2, 3 or 4. When this was controlled for, the
relationship between contemporaneously measured allostatic load and
poorer general cognitive ability was attenuated by around a third.
This suggests that the correlation at baseline was partly driven by
participants with higher allostatic load and poorer general cognitive
ability who went on to drop out of the study at Waves 2-4, many of
whom dropped out due to poor health or mortality. It could be that the
correlation is affected by a threshold effect, whereby the relationship
is stronger beyond certain high levels of allostatic load, or low levels
of general cognitive ability. Overall, it seems that this relationship is
relatively weak overall and is weaker, if it exists at all, in older adults
who are in better health.
We also fitted models in which the growth factors, which represented
baseline and change in allostatic load and general cognitive ability in
older age, were regressed on age 11 IQ. Previous studies in this sample
have found that higher age 11 IQ had a small-to-moderate association
with lower allostatic load at age 73 (LBC1936 Wave 2; Booth et al.,
2015; Ritchie et al., 2017) and that there was no significant association
between age 73 allostatic load and general cognitive change between
ages 11 and 73 (Booth et al., 2015). In a novel test, we did not find
there was a relationship between age 11 IQ and older age change in
allostatic load. In these models, the growth factor correlation estimates
were similar to those from models without age 11 IQ. This means that
poorer general cognitive change between age 11 and age 70 was related
to allostatic load at age 70, with a small effect size. Another way
of thinking about this relationship is that at age 70, those who had
lower general cognitive ability than was expected based on their age 11
IQ tended to have higher allostatic load. This association could have
emerged in various ways. It could be that these individuals’ allostatic
load was also higher at age 11, and/or that causal links between allostatic
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load and general cognitive ability have affected each other between ages
11 and 70, and/or that other variables have affected change in general
cognitive ability between ages ~11 and 70 as well as allostatic load up
to age 70. Further longitudinal research is required to clarify these
relationships. Again, after dropout was controlled for, the correlation
was attenuated by around a third, which suggested that it was boosted
by participants who dropped out at Waves 2-4.
This study also tested how change in allostatic load and change in
cognitive ability relate over time. This relationship was estimated as
small-to-moderate and negative, but there was a wide confidence
interval around the estimate, so the result was inconclusive. More data
is required to clarify this relationship.
Originally, we intended to fit a bifactor latent growth curve model to
investigate how allostatic load relates to general as well as specific
factors of cognitive ability. This bifactor model did not converge, so
our confirmatory analyses tested relationships only with a factor of
general cognitive ability. Hence, to assess how allostatic load relates
to specific cognitive ability factors and test results, we conducted
exploratory analyses. These analyses were not preregistered and so
they should not be thought of confirming or denying any hypotheses,
but rather as providing additional results that can provide the basis for
confirmatory tests in other samples. The results from these models
suggested that the relationship between allostatic load and processing
speed should be a focus of future research. At age 70, higher allostatic
load was related to slower processing speed (measured on a specific
factor extracted from a bifactor cognitive ability measurement model)
as well as poorer performance on two processing speed tests: digit
symbol coding and choice reaction time. Additionally, increase in
allostatic load between was related to steeper decline in performance
on a symbol search task, another test of processing speed. To better
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understand this relationship, future research could investigate it at a
tighter timescale, such as with hours or days rather than years between
measurements. Brain white matter may help us to understand the
mechanisms underlying the relationship. White matter transports
nerve impulses throughout the brain and so its structure is related to
processing speed (Kuznetsova et al., 2016). Aspects of white matter
structure have been found to be related to allostatic load (Booth et
al., 2015; Ottino-González et al., 2018; Savransky et al., 2017). A
previous LBC1936 study did not find that the relationship between
allostatic load and processing speed was mediated by total white
matter volume (Booth et al., 2015), so it may be that more narrow
white matter measures must be measured to detect the effects or
simply that any effect sizes involved are very small. Although some of
our exploratory analyses pointed towards future focuses for research, it
is worth noting that most of the exploratory analysis correlations had
very small-to-small estimates and had standard errors that were large
relative to their estimates.
Overall, our study suggests that while there are relationships between
allostatic load and cognitive ability measures, the effect sizes involved
tend to be small. Hence, allostatic load summary scores will likely have
limited utility as a marker of risk for cognitive ageing.
5.4.1 Strengths and limitations
Different aspects of the study had advantages and disadvantages.
A strength of the study is that gold-standard intelligence tests were
administered. These tests assess a broad range of ability and do
not have problematic floor or ceiling effects, which meant that we
were able to assess how allostatic load relates to non-pathological
cognitive ability and cognitive ageing. Additionally, using structural
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equation modelling enabled us to separate reliable variance from noise,
which increased the statistical power of our confirmatory analyses.
A limitation of our modelling approach is that the bifactor latent
growth curve model we intended to use was too complex and would
not converge.
A further strength of our study is that cognitive ability was tested at age
11, which enabled us to test associations with cognitive change between
ages 11 and 70, as well as to test the relationship between age 11 IQ and
allostatic load in older age.
Our study benefitted from allostatic load being measured at four waves,
which enabled us to measure relationships between change in allostatic
load and initial level and change in cognitive measures. We calculated
allostatic load using the z score method, which preserves the continuous
nature of biomarkers and has been favoured in a comparison of allostatic
load operationalisation methods (Seplaki et al., 2005). A limitation of
our allostatic load operationalisation is that no HPA axis biomarkers
were included, as these were not measured in this study.
Our sample size was large enough to enable a structural equation
modelling approach with measurement invariance testing, and
reasonable statistical power for some pathways, but it was not
large enough to offer adequate power for some pathways, including
many involving change over time.
An additional strength of our study is that we fitted models using both
the missing at random and not missing at random assumptions about
the missing data. More often, studies assume that the missing data are
missing at random and do not fit models that assume the missing data
are not missing at random. Comparing models fitted using the different
assumptions enabled us to assess how our results related to participant
dropout.
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5.4.2 Directions for future research
Our study provided a novel test of dual change in allostatic load and
general cognitive ability. This parameter, though, was imprecisely
estimated, so further tests with larger samples and more time points
are required to clarify this relationship. Statistical power to detect
correlated change can increase substantially with each additional
measurement, particularly when there have been fewer than 10
measurements (Hertzog, Lindenberger, Ghisletta, & Oertzen, 2006). It
may also be profitable for researchers to rerun longitudinal analyses
after new waves of data are released, so that the estimates are updated
and the precision of the estimates is increased.
As noted above, a limitation of our study is that no HPA axis markers
were used as indicators of allostatic load. It would be informative to
compare our results to those from another study with a comparable
design that did use HPA axis markers as indicators of allostatic load.
Such a study could compare the results of models using two different
allostatic load operationalisations: one calculated with HPA axis
markers and one without. The study could then test whether the
relationship between allostatic load and cognitive ability is stronger,
weaker or similar when HPA axis markers are used.
The results of our non-preregistered exploratory analyses could provide
the basis for preregistered confirmatory analyses. Future studies, then,
could attempt to confirm the association between allostatic load and
measures of processing speed in other samples.
Future longitudinal studies should carefully consider how participant
dropout relates to the levels and trajectories of allostatic load and
cognitive ability, as well how it relates to the relationships being
assessed. To find out why modelling dropout affects the relationship
between allostatic load and general cognitive ability, future studies
could use threshold regression to find out whether the relationship
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changes beyond certain levels of each variable, and/or quantile
regression to test the strength of the association at different levels
of each variable. The present study benefitted from the use of
pattern-mixture modelling, which assumes that missing data are not
missing at random. Future research may wish to take this or another
approach, such as one that also models the reasons for dropout.
5.4.3 Conclusion
In summary, this study tested the relationship of allostatic load and
cognitive ability between ages 70 and 79. Our study went beyond
previous research by measuring both allostatic load and cognitive
ability at four waves, which meant that we could test associated
change relationships. We found that allostatic load was associated
with lower general cognitive ability at age 70, with a small effect size.
However, this association was partly driven by participants dropped out
at Waves 2-4 and it was attenuated by around a third after dropout
was taken into account. We also found that allostatic load at age 70
was related to poorer general cognitive change between ages 11 and
70, with a small effect size. Regarding specific cognitive ability factors,
exploratory analyses suggested that allostatic load may be related
to slower processing speed. Finally, the association between dual
change in allostatic load and general cognitive ability was estimated as
small-to-moderate and negative but it was estimated imprecisely, so
further research is required to clarify this relationship.
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Chapter 6
How do allostatic load and
depressive symptoms relate
over time in the Lothian Birth
Cohort 1936?
6.1 Introduction
In late life, depressive symptoms are common (Luppa et al., 2012)
and often occur in conjunction with physical ill health (Büchtemann,
Luppa, Bramesfeld, & Riedel-Heller, 2012). It has been suggested
that understanding the relationship between summary measures of
allostatic load and depressive symptoms could help explicate the
potential mediating role of allostatic load in the relationship between
depression and adverse physical health outcomes (Penninx, 2017).
Further, it has been put forward that understanding the relationship
between allostatic load and depressive symptoms could help to improve
the diagnosis and treatment of depressive symptoms and physiological
dysregulation, enabling more personalised and effective treatment
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(Lopresti et al., 2014). However, despite such suggestions, few studies
to date have investigated the relationship between allostatic load and
depressive symptoms, and even fewer have tested this relationship
longitudinally.
Here, we will first introduce allostatic load and depressive symptoms.
Then, we will discuss previous cross-sectional and longitudinal
research relating allostatic load and depressive symptoms. Finally, we
will introduce the present study, which will test the contemporaneous
and longitudinal relationships between allostatic load and depressive
symptoms in older age.
6.1.1 Depressive symptoms
Depressive symptoms include low mood, low energy, hopelessness,
irritability and suicidality (National Health Service, 2016). Depressive
disorders are a major public health issue (Cassano & Fava, 2002; Marcus,
Yasamy, van Ommeren, Chisholm, & Saxena, 2012) and non-clinical
levels of depressive symptoms are thought to “[represent] a less severe
manifestation of the same disorder” (Luppa et al., 2012, p. 217). It is
important, therefore, to study depressive symptoms as a continuous
variable. Compared to earlier in life, in older age “less severe forms of
depression seem to be far more frequent” (Büchtemann et al., 2012,
p. 177). One of the main variables related to the development of
depressive symptoms in older age is physical ill health (Büchtemann et
al., 2012).
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6.1.2 Allostatic load biomarkers and depressive
symptoms
In efforts to better understand the relationship between depressive
symptoms and physical ill health, research has investigated the
relationships between depressive symptoms and physiological markers.
It is well established that certain putative allostatic load biomarkers
tend to be dysregulated in people with depression. This includes
endocrine (Murri et al., 2014), inflammatory (Valkanova et al., 2013),
and metabolic (Marazziti et al., 2014) biomarkers. Physiological
dysregulation in people with depression is not uniform, as profiles of
dysregulation differ between subtypes of depression (Lamers et al.,
2013). One study found that compared to control participants and
those with severe melancholic depression (characterised by lowered
appetite and decreased weight), participants with severe atypical
depression (which is characterised by excessive eating and increased
weight) had higher inflammation and greater metabolic dysregulation
(Lamers et al., 2013). Also, those with severe melancholic depression
had higher cortisol production during the waking period and a higher
diurnal cortisol slope than control participants and those with severe
atypical depression (Lamers et al., 2013).
6.1.3 Allostatic load summary scores and
contemporaneously measured depressive
symptoms
Allostatic load summary measures have been statistically significantly
related to contemporaneously measured depressive symptoms in
several studies. For example, in a small sample of 58 older adults aged
52-80 in Quebec, Canada, allostatic load explained 20% of the variance
143
in depressive symptoms (data from the Douglas Hospital Longitudinal
Study of Normal and Pathological Aging; participants were healthy at
baseline in 1988, this contemporaneous relationship was tested using
1994 data; Juster et al., 2011). Also, a clinically relevant effect was
found in a sample of 125 community-dwelling older adults aged 67
to 94, where allostatic load was found to be related to depressive
symptoms in adjusted models and the effect size was “comparable (but
opposite in direction) to that of antidepressant use” (data from former
participants of the Mindfulness to Improve Elders’ Immune and Health
Status [MIEIHS] study; Kobrosly et al., 2014, p. 223). In sum, strong
effects have been reported in smaller samples. However, while studies
using larger samples have also reported finding a relationship between
allostatic load and depressive symptoms, they have reported smaller
effect sizes than small sample studies.
In a larger sample of 705 adults in the 1972-born cohort of the West
of Scotland Twenty-07 Study, allostatic load had a small correlation
with depressive symptoms at age 36 (r = .167; Gale et al., 2015).
Plus, in a sample of 958 adults in Taiwan (M [SD] age = 68 [8]
y), models adjusted for age and sex with different allostatic load
operationalisations predicted between 2.9% and 5.0% of the variance
in depressive symptoms (Social Environment and Biomarkers of Aging
Study [SEBAS]; Seplaki et al., 2005). Finally, in a large sample of
2405 older adults aged 60 and above in the United States, allostatic
load had a small relationship with depressive symptoms in adjusted
models (data from the National Health and Nutrition Examination
Survey [NHANES] 2005-2008; Kobrosly et al., 2013). In a fully
adjusted model, having 1 additional allostatic load biomarker beyond
a clinical cutoff point was associated with a score 0.23 higher on the
Patient Health Questionnaire-9, which measures depressive symptoms
(nine-item questionnaire with a possible score range of 0-27; Kobrosly
et al., 2013). To summarise, allostatic load summary measures have
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consistently been related to contemporaneously measured depressive
symptoms, although the effect sizes reported have been smaller in
studies using larger samples.
6.1.4 Allostatic load summary scores and
subsequently measured depressive symptoms
Little research to date has investigated how allostatic load and
depressive symptoms relate over time.
In the aforementioned sample in Taiwan, baseline allostatic load
predicted depressive symptoms measured three years later, and
this relationship remained statistically significant after adjusting for
baseline depressive symptoms and other baseline health covariates (n
= 926; Goldman et al., 2006). In this study, 1 additional allostatic
biomarker in the highest or lowest sample decile predicted a score 0.41
higher on the CES-D-10 (the 10-item Center for Epidemiologic Studies
Depression Scale, which has a possible score range of 0-30; Goldman et
al., 2006). The effect size, though, was roughly halved after controlling
for baseline CES-D and other baseline health covariates, as then the
same increase predicted a score 0.20 higher on the CES-D-10 (Goldman
et al., 2006). The relationship between allostatic load and subsequently
measured depressive symptoms was not always statistically significant,
though, in the aforementioned small-sample Quebec-based study.
Allostatic load explained 7% of the variance in depressive symptoms
measured three years later (n = 58), but only 1% of the variance in
depressive symptoms measured six years later (beta non-significant; n
= 32; Juster et al., 2011).
Research has only very recently begun to study how allostatic load
predicts responses to depression medication. A recent study measured
baseline allostatic load in 67 healthy controls and 34 participants
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with depression who were about to under go eight weeks of selective
serotonin reuptake inhibitor (SSRI) treatment (Hough et al., 2017).
Compared to healthy controls and participants with depression who
experienced more than 50% improvement in depression, there was
higher baseline allostatic load in participants with depression who
experienced lower than 50% improvement in depression severity
during treatment (Hough et al., 2017).
Research has not yet fully explored how allostatic load and depressive
symptoms relate over time in older age. Notably, the relationship
between change in allostatic load and change in depressive symptoms
has not been tested, and nor has the relationship between depressive
symptoms and subsequent change in allostatic load.
6.1.5 The present study
In the present study, we fitted latent growth curve models to data from
the Lothian Birth Cohort (LBC1936) study, which hasmeasured allostatic
load and depressive symptoms in a large sample at approximately ages
70, 73, 76 and 79. The main question being asked in this study is: how
do allostatic load and depressive symptoms relate over time?
The first two specific research questions being asked in this study are:
1. How strongly do allostatic load and depressive symptoms relate at
age 70?
2. Does allostatic load at age 70 relate to change in depressive
symptoms between ages 70 and 79?
The sample size of the LBC1936 enabled our study to more precisely
estimate contemporaneous relationships than many previous studies
(research question 1). The LBC1936 study data also enabled us to
investigate the relationship between allostatic load and change in
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subsequently measured depressive symptoms over more time points
and a longer period of time than previous studies (research question
2). Also, crucially, having four waves of data for both variables
enabled us to ask research questions about two previously unexplored
relationships:
3. Do depressive symptoms at age 70 relate to change in allostatic
load between ages 70 and 79?
4. Between ages 70 and 79, does change in allostatic load correlate
with change in depressive symptoms?
Previous research suggests that plausibly, the correlations involved are
more likely to be positive, meaning higher allostatic load is related
to more depressive symptoms. Plausible effect sizes are between





Depressive symptoms were measured using the Hospital Anxiety and
Depression Scale-Depression (HADS-D) subscale (Zigmond & Snaith,
1983). The HADS-D has seven items, which are scored from zero to
three using different ordinal response options (Zigmond & Snaith,
1983). Because the HADS-D was designed to be used in nonpsychiatric
hospital inpatient settings, the questions focus on anhedonia symptoms
and do not cover somatic symptoms, such as insomnia and fatigue
(Zigmond & Snaith, 1983). In our models, we used the total HADS-D
score, which is the sum of the item scores.
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6.2.2 Statistical analysis
Figure 6.1: Allostatic load-depressive symptoms latent growth curve
model specification. A-D are labelled paths described in the text. AL =
allostatic load. DS = depressive symptoms. i = intercept. s = slope. W
= wave.
In this study, the parallel process latent growth curve models included
growth factors for two variables: allostatic load and depressive
symptoms. Figure 6.1 shows the general specification of the dual
change latent growth curve models.
Research question 1 was tested by the intercept-intercept correlation
(path A in Figure 6.1). The next two research questions were tested
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by the intercept-slope correlations. Question 2 was tested by the
correlation between the allostatic load intercept and the depressive
symptoms slope (path B). Question 3 was tested by the correlation
between depressive symptoms intercept and the allostatic slope tested
question 3 (path C). Finally, question 4 was tested by the correlation
between the allostatic load and depressive symptoms slopes (path D).
6.3 Results
Table 6.1: Descriptive statistics for age, allostatic load
and depressive symptoms
n Mean SD Skew Kurtosis
Age W1 1091 69.53 0.83 -0.05 -0.88
Age W2 866 72.49 0.71 -0.02 -0.84
Age W3 697 76.25 0.68 -0.05 -0.83
Age W4 550 79.32 0.62 0.06 -0.76
Allostatic load W1 1090 0.69 0.24 1.07 2.12
Allostatic load W2 866 0.71 0.24 1.17 3.17
Allostatic load W3 696 0.85 0.25 0.71 1.16
Allostatic load W4 549 0.87 0.26 0.62 0.48
HADS-D W1 1086 2.80 2.23 1.35 2.30
HADS-D W2 865 2.63 2.22 1.37 1.95
HADS-D W3 696 2.88 2.32 1.22 1.24
HADS-D W4 548 2.98 2.34 1.35 2.35
Note.
HADS-D = Hospital Anxiety and Depression Scale -
Depression subscale.
Table 6.1 contains descriptive statistics for age, allostatic load and
depressive symptoms at each wave. The allostatic load mean increased
only very slightly between Waves 1 and 2 and between Waves 3 and
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4, with the largest increase by far being between Waves 2 and 3. The
depressive symptoms mean decreased between Waves 1 and 2 but
increased between Waves 2 and 4.
Table 6.2: Allostatic load and depressive symptoms
correlations
AL W1 AL W2 AL W3 AL W4 DS W1 DS W2 DS W3 DS W4
AL W1 < .001 < .001 < .001 < .001 .03 .24 .83
AL W2 .45 (.03) < .001 < .001 .14 .12 .24 .29
AL W3 .31 (.04) .46 (.03) < .001 .74 .83 .24 .74
AL W4 .27 (.04) .40 (.04) .47 (.04) .12 .24 .34 .30
DS W1 .13 (.03) .09 (.03) .04 (.04) .11 (.04) < .001 < .001 < .001
DS W2 .11 (.03) .09 (.03) .03 (.04) .10 (.04) .65 (.03) < .001 < .001
DS W3 .08 (.04) .09 (.04) .09 (.04) .08 (.04) .62 (.03) .68 (.03) < .001
DS W4 .02 (.04) .09 (.04) .06 (.04) .08 (.04) .61 (.03) .62 (.03) .72 (.03)
Note.
Lower triangle contains pairwise Pearson’s correlations, with standard errors in
parentheses (n range = 536-1090). Upper triangle contains p-values for the
correlations. AL = allostatic load. DS = depressive symptoms. W = Wave.
Table 6.2 contains correlations between the allostatic load and
depressive symptoms variables. Allostatic load levels at adjacent
waves were moderately-to-strongly positively correlated, while
allostatic load levels at non-adjacent waves were moderately positively
correlated. Depressive symptoms at different waves were strongly
positively correlated. Contemporaneously measured allostatic load and
depressive symptoms had a modest positive correlation. Allostatic load
and depressive symptoms variables measured at different waves had
positive correlations. all of which were small or very small in size.
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6.3.1 One process latent growth curve models
Table 6.3: Unconditional one process MAR model
results for allostatic load and depressive symptoms:
Growth factor means and variances
Estimate SE p-value
AL i mean 0.682 0.007 < 0.001
AL i variance 0.029 0.004 < 0.001
AL s mean 0.0211 0.0012 < 0.001
AL s variance 0.0003 0.0001 < 0.001
HADS-D i mean 2.73 0.07 < 0.001
HADS-D i variance 3.45 0.31 < 0.001
HADS-D s mean 0.039 0.008 < 0.001
HADS-D s variance 0.014 0.005 0.003
Note.
AL = allostatic load. HADS-D = Hospital Anxiety
and Depression Scale - Depression subscale. i
= intercept [growth factor]. s = slope [growth
factor].
Table 6.3 contains the growth factor means and variances from the
unconditional allostatic load and depressive symptoms growth curve
models. As these models were unconditional, no covariates were
included. Here, the intercept mean represents the average level at
baseline (age 70) and the slope mean represents the average change per
year between ages 70 and 79, while the variances represent individual
variation around the mean levels and trajectories. Notably, the average
participant increased in allostatic load and depressive symptoms over
the course of the study, but there was significant variation in the
trajectories observed for both variables.
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Table 6.4: Conditional one process MAR model results
for allostatic load and depressive symptoms: Growth
factor and regression estimates
Estimate SE p-value
AL W1 on age W1 regression 0.008 0.009 0.369
AL W2 on age W2 regression 0.024 0.011 0.022
AL W3 on age W3 regression 0.045 0.014 0.001
AL W4 on age W4 regression 0.005 0.017 0.755
AL i on male regression -0.015 0.082 0.852
AL s on male regression -0.031 0.127 0.807
HADS-D W1 on age W1 regression 0.07 0.07 0.364
HADS-D W2 on age W2 regression 0.26 0.09 0.004
HADS-D W3 on age W3 regression 0.27 0.11 0.011
HADS-D W4 on age W4 regression 0.22 0.12 0.076
HADS-D i on male regression 0.09 0.07 0.206
HADS-D s on male regression -0.13 0.13 0.302
AL i mean 0.683 0.010 < 0.001
AL i variance 0.028 0.003 < 0.001
AL s mean 0.0214 0.0016 < 0.001
AL s variance 0.0003 0.0001 < 0.001
HADS-D i mean 2.65 0.09 < 0.001
HADS-D i variance 3.44 0.31 < 0.001
HADS-D s mean 0.047 0.012 < 0.001
HADS-D s variance 0.014 0.005 0.003
Note.
AL = allostatic load. HADS-D = Hospital Anxiety and Depression
Scale - Depression subscale. i = intercept [growth factor]. s =
slope [growth factor]. Regressions on male are estimates with
the latent variables standardised and the male variable coded
as 1 for males and 0 for females. For all other parameters, raw
estimates are provided.
Table 6.4 contains the results from conditional models, which added sex
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as a time-invariant covariate of the growth factors and age at each wave
as a time-varying covariate of the corresponding allostatic load and
depressive symptoms variables. Here, the intercept and slope means
represent the estimates for a female participant who was the average
age of observation at each wave, and the male regression coefficients
can be used to obtain the estimates for other participant profiles. Within
Waves 2 and 3, older age at the time of testing was modestly related to
higher allostatic load and more depressive symptoms. Other covariates
did not have notable effects.
Table 6.5: Conditional one process NMAR model
results for allostatic load and depressive symptoms:
Pattern-mixture model regressions, growth factor
means and growth factor variances
Estimate SE p-value
AL i on d2 regression 0.38 0.11 0.001
AL i on d3 regression 0.50 0.13 < 0.001
AL i on d4 regression 0.16 0.12 0.171
AL s on d2/d3 regression -0.73 0.32 0.023
AL s on d4 regression -0.05 0.20 0.800
HADS-D i on d2 regression 0.35 0.10 0.001
HADS-D i on d3 regression 0.19 0.10 0.062
HADS-D i on d4 regression 0.03 0.10 0.791
HADS-D s on d2/d3 regression 0.11 0.34 0.747
HADS-D s on d4 regression 0.44 0.23 0.062
AL i mean 0.655 0.012 < 0.001
AL i variance 0.028 0.003 < 0.001
AL s mean 0.0235 0.0017 < 0.001
AL s variance 0.0003 0.0001 < 0.001
HADS-D i mean 2.45 0.11 < 0.001
HADS-D i variance 3.36 0.31 < 0.001
HADS-D s mean 0.047 0.012 < 0.001
HADS-D s variance 0.014 0.005 0.004
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Note.
AL = allostatic load. HADS-D = Hospital Anxiety and
Depression Scale - Depression subscale. i = intercept [growth
factor]. s = slope [growth factor]. Growth factor means
and variances are raw estimates. Regressions are estimates
with the latent variables standardised and the d2-d4 dummy
variables coded as 1 for those who dropped out at Waves 2-4
respectively and 0 otherwise.
Table 6.5 contains the results from models that assumed that missing
data were not missing at random. These were pattern-mixture models
in which the growth factors were regressed on dummy variables d2-d4
that were coded as 1 if the participant dropped out at the corresponding
wave and 0 otherwise. The regressions of the slope growth factors on d2
and d3 were constrained to equality to identify the models. The dropout
variable regressions have been standardised on the latent variables, so
the estimates presented are in standard deviation units.
Note that here, the growth factor means are the expected values
for participants who did not drop out. Dropping out at Wave 2 or 3
was related to having higher allostatic load at Wave 1 (alternatively
phrased, participants with higher allostatic load at Wave 1 were more
likely to drop out at Wave 2 or 3). These participants also had a
much lower allostatic load slope (i.e., a flatter or even declining
trajectory), although this parameter had a wide confidence interval.
This could seem a counter-intuitive finding. However, it becomes more
interpretable after considering that the mean allostatic load only rose
slightly between Waves 1 and 2 before a large rise between Waves 2
and 3, where these participants had at least some missing data.
Additionally, dropping out at Wave 2 was related to scoring higher on
depressive symptoms at Wave 1.
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6.3.2 Parallel process latent growth curve models
Figure 6.2: Allostatic load-depressive symptoms MAR model growth
factor correlations. Correlations are displayed, with their standard errors
in parentheses. AL = allostatic load. DS = depressive symptoms.
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Figure 6.3: Allostatic load-depressive symptoms NMAR model growth
factor correlations. Correlations are displayed, with their standard errors
in parentheses. AL = allostatic load. DS = depressive symptoms.
Figures 6.2 and 6.3 display the results from parallel process latent
growth curvemodels with theMAR and NMAR assumptions respectively.
The growth factor correlations were similar in the MAR and NMAR
models. Initial level in allostatic load was moderately correlated with a
more negative (i.e., flatter rather than increasing) allostatic load slope.
The intercept-intercept correlation addresses research question 1 about
contemporaneous relationships at age 70. At baseline, higher allostatic
load was associated with reporting more depressive symptoms, with a
small-to-moderate effect size. Research questions 2-4 were addressed
by the other three growth factor correlations in the model. All of these
estimates were small and had standard errors that were large relative
to the parameter estimates. Our results suggested that allostatic load
and depressive symptoms are not strongly related over time.
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Table 6.6: Model fit statistics for allostatic load and
depressive symptoms
Model CFI RMSEA SRMR
AL MAR unconditional 0.904 0.098 0.054
AL MAR conditional 0.905 0.051 0.028
AL NMAR conditional 0.901 0.045 0.037
HADS-D MAR unconditional 0.985 0.063 0.033
HADS-D MAR conditional 0.991 0.025 0.018
HADS-D NMAR conditional 0.985 0.027 0.030
Parallel process MAR 0.964 0.037 0.026
Parallel process NMAR 0.959 0.035 0.038
Note.
AL = allostatic load. CFI = comparative fit index. HADS-D =
Hospital Anxiety and Depression Scale - Depression subscale.
RMSEA = root mean square error of approximation. SRMR =
square root mean residual. For CFI and RMSEA, robust variants
were used.
Table 6.6 contains model fit statistics from all models fitted. The
unconditional allostatic load model had borderline satisfactory fit. The
conditional allostatic load models had good fit according to the RMSEA
and SRMR, but borderline satisfactory fit according to the CFI. The
depressive symptoms and parallel process models had excellent fit.
6.4 Discussion
Our study investigated the contemporaneous and longitudinal
relationships between allostatic load and depressive symptoms in
older age. Importantly, our study had a large, age-homogeneous
sample and four waves of data for both measures. This enabled us to
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conduct a novel test of the relationship between change in allostatic
load and change in depressive symptoms.
We found that at baseline, higher allostatic load was correlated with
reporting more depressive symptoms, with a small-to-moderate effect
size. This replicated previous findings but was one of the smaller
published estimates of the effect, in line with the estimates from other
studies that have used larger samples (Kobrosly et al., 2013; Seplaki et
al., 2005).
We also refitted our model assuming missing data were not missing
at random. We found that those who dropped out at Wave 2 and 3
had higher allostatic load and reported more depressive symptoms at
baseline. In this model, the baseline correlation between allostatic
load and depressive symptoms was of a similar size and remained
statistically significant with an alpha of .05. This suggests that the
baseline correlation was not strongly driven by participants, perhaps in
poorer health, who later dropped out of the study.
Furthermore, we also provided unadjusted correlations between
contemporaneously measured allostatic load and depressive symptoms
at each of four waves. Higher allostatic load was correlated with
reporting depressive symptoms at each wave, but the effect size was
consistently small (r range = .08 to .13).
Our novel test of the relationship between change in allostatic load
and change in depressive symptoms produced small positive estimates.
Standard errors for these tests were wide and the relationship was not
statistically significant. Our results suggest that there is not a strong
dual change relationship. Further research using larger samples and
improved measures is required to determine the presence and strength
of this relationship.
The correlation table for allostatic load and depressive symptoms at
Waves 1-4 in our study provides places for comparison with some
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previous longitudinal studies. Goldman et al. (2006) and Juster et al.
(2011) found that allostatic load was related to depressive symptoms
measured three years later, with a moderate strength effect size. In
our study, the waves also had roughly three-year gaps. Regarding
the lagged relationships, Wave 1 and 2 allostatic load were correlated
with Wave 2 and 3 depressive symptoms respectively, although both
correlations had small effect sizes. However, Wave 3 allostatic load and
Wave 4 depressive symptoms were not significantly correlated.
Previously, Juster et al. (2011) found that allostatic load explained 1%
of the variance in depressive symptoms measured six years later. This
test was in a small sample of only 32 and the relationship was not
statistically significant (Juster et al., 2011). In our study, the correlations
between allostatic load and depressive symptoms measured six years
later had a similarly small effect size (rs = .08 and .09), but due to our
larger sample size they were statistically significant with an alpha of
.05. Note that the correlation is likely non-zero and positive: whether
it is found to be statistically significance depends in part on the sample
size of the study. Studies should focus not on confirming the presence
of the relationship, but instead on clarifying its strength.
Altogether, the results of our study echo previous results that higher
allostatic load is related to greater depressive symptomatology.
However, like other studies that have used larger samples, we found
the relationship consistently had only a small effect size. In their
study, Juster et al. (2011) posited that “using the AL index could
allow for the development of individualized interventions in order to
prevent the emergence and/or maintenance of depressive symptoms”
(Juster et al., 2011, p. 363). Our results suggest that allostatic
load assessments would only have a modest contribution to such
interventions. Considering the cost of measuring many allostatic load
markers, it is unlikely that the widespread administration of allostatic
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load tests would be a cost-effective depressive symptoms prevention
strategy. If allostatic load biomarkers are to be useful in treating
depressive symptoms, it may be as part of an approach that considers
patterns of physiological dysregulation and depressive symptoms,
rather than the overall levels of each (Lamers et al., 2013). Methods
that consider the differential risk conferred by different biomarkers,
unlike most allostatic load operationalisations, could also help to
improve prediction of depressive symptoms and bolster prevention
efforts. For example, a recent study applied machine learning to
cohort study and identified additional novel biomarkers associated with
depressive symptoms (Dipnall et al., 2016), including the allostatic
load biomarker serum glucose (Juster et al., 2010). Machine learning
could likely be effectively applied to predicting depressive symptoms
electronic health records; a well-calibrated algorithm would be able to
use the data to improve prediction more than the modest benefits in
prediction given by an allostatic load summary measure.
6.4.1 Strengths and limitations
Our study benefitted from having four waves of longitudinal data for
both allostatic load and depressive symptoms. This enabled us to
fit bivariate latent growth curve models that went beyond previous
research by testing the relationship between change in allostatic load
and change in depressive symptoms.
Furthermore, using full information maximum likelihood estimation
enabled us to use all our data and avoid producing biased estimates,
which can result from complete case analyses (Enders, 2010). We also
fitted pattern-mixture models that assumed data were not missing at
random, which showed that some growth factor estimates differed for
participants who dropped out of the study, but also confirmed that our
estimates of allostatic load-depressive symptoms relationships were
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not biased by including these participants in our models.
A limitation of our study is that the biomarker panel used to
operationalise allostatic load did not have any HPA axis markers,
nor any primary mediators of the stress response. The biomarkers used
were instead secondary outcomes (biomarkers whose levels change in
response to primary mediator changes) and were mostly metabolic or
cardiovascular biomarkers.
A further limitation is that only sum scores were available for our
depressive symptoms measure, the HADS-D, which precluded analysing
allostatic load’s relationships with specific symptoms and groups of
symptoms. This also precluded analysis methods that require item-
and interitem-level data, such as factor analysis. Additionally, the
combined HADS has been criticised for having a latent structure that
varies based on the methods used to detect it (Cosco, Doyle, Ward, &
McGee, 2012) and for primarily measuring general distress rather than
depression and anxiety, as its subscales are intended to do (Norton,
Cosco, Doyle, Done, & Sacker, 2013). This may in part be due to
four problematic items that seem to measure restlessness rather than
anxiety or depression (Straat, van der Ark, & Sijtsma, 2013).
6.4.2 Directions for future research
Our study used an age-homogeneous sample who were observed
between approximately 70 to 79 years old. This means our study has a
strong focus on the relationships between allostatic load and depressive
symptoms in people’s seventies, but our findings may not generalise
to other age groups. As stress affects allostatic load and depressive
symptoms throughout the lifespan (Danese & McEwen, 2012), the
relationship between allostatic load and depressive symptoms is likely
to also be found in childhood and earlier adulthood. However, the
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effect size may vary depending on age. Future studies using mixed-age
samples could investigate this possibility by testing whether the
contemporaneous and longitudinal relationships between allostatic
load and depressive symptoms are moderated by age.
Future studies on the allostatic load-depressive symptoms relationships
should aim to clarify the presence and strength of their dual change
relationship by usingmore data points than were used in this study. This
could involve having more participants and/or having both measures at
more time points (Hertzog et al., 2006).
Our study, and others, have used gaps of around three years between
measures. It would be beneficial to study this relationship at
different timescales, for example with hours, days or weeks between
measurements, rather than years. For example, a recent stress
reactivity study collected cortisol and stress questionnaire data up
to 10 times a day for six consecutive days (Vaessen et al., 2018). A
similar approach could be taken with depressive symptoms items and
multiple allostatic load biomarkers being measured throughout the day
and throughout the week, to better understand how the two relate on
shorter timescales.
In addition, future research would benefit from analysing specific
symptoms and subcategories of symptoms, as some previous research
has done (e.g, Kobrosly et al., 2013), to further clarify which depressive
symptoms allostatic load is more strongly related to.
6.4.3 Conclusion
In summary, we replicated the contemporaneous relationship between
higher allostatic load and more depressive symptoms in a large sample
of older age adults. In line with previous large studies, the effect size
was small. Using four waves of data over ~10 years, we conducted
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a novel test of the correlation between change in allostatic load and
change in depressive symptoms. The estimate was positive but small
and not statistically significant, which suggested the two variables
do not have a strong dual change relationship. Raw correlations
showed that higher allostatic load was associated with more depressive
symptoms being reported around three years later in two out of three
cases, replicating previous associations. Higher allostatic load was also
associated with more depressive symptoms being reported around six
years later. Effect sizes for these correlations were consistently small.
Altogether, our study confirms some relationships between allostatic
load and depressive symptoms, but suggests the relationship is less
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The modest effect sizes in the previous two studies suggest that
allostatic load summary scores offer limited clinical utility for cognitive
ageing and depressive symptoms. However, as we have noted, the
allostatic load model could still prove fruitful for clinicians assessing
risk for these conditions. It may be that markers of HPA axis activity
and function will be the most important in leveraging the allostatic
load model. However, the previous studies were limited in that no HPA
axis markers were available to be used in the calculation of allostatic
load scores. In this chapter, the final study of this thesis will test older
age associations between the levels and dynamics of an important HPA
axis marker - cortisol - and cognitive ability.
Furthermore, the clinical utility of the allostatic load model for cognitive
ageing will be enhanced if moderating variables can be found that help
to identify mechanisms and improve prediction. Previously, we used
data from the LBC1936 and found that APOE e4 allele possession did not
deleteriously moderate the relationships of allostatic load, depressive
symptoms, and neuroticism with cognitive ability and subsequent
cognitive change (Crook et al., 2018). However, while previous research
had reported APOE e4-by-cortisol interactions, our study used an
allostatic load measure that did not incorporate any measures of
cortisol (Crook et al., 2018). The 36-Day Sample, a different follow-up
study of the Scottish Mental Survey 1947, collected salivary cortisol
data in older age, which enables us to attempt replication of previous
APOE e4-by-cortisol results. Hence, the present study will test whether
APOE e4 allele possession moderates the relationships of cortisol,
depressive symptoms, and neuroticism with cognitive ability.
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7.2 Introduction
Cognitive ageing is an increasingly important public health issue (Deary
et al., 2009). It is therefore crucial that researchers attempt to better
understand risk factors for adverse cognitive outcomes in older age,
including how they are modified.
7.2.1 APOE e4, neuroticism, depressive symptoms and
cortisol levels: How they relate to each other
and to cognitive ability
Four such risk factors are the e4 allele of the apolipoprotein E (APOE)
gene (Davies et al., 2015, 2014), depressive symptomatology (Chodosh,
Miller-Martinez, Aneshensel, Wight, & Karlamangla, 2010; Dotson,
Resnick, & Zonderman, 2008; Ganguli, Du, Dodge, Ratcliff, & Chang,
2006; Salthouse, 2014), neuroticism (Luchetti, Terracciano, Stephan,
& Sutin, 2016) and various measures of cortisol levels (Beluche et al.,
2010; Franz et al., 2011; Lee et al., 2007), each of which has been
linked to worse cognitive ability in cross-sectional research using older
age samples. In addition, longitudinal studies have related cognitive
decline to APOE e4 (Davies et al., 2014), neuroticism (Luchetti et
al., 2016), cortisol levels (Franz et al., 2011; Li et al., 2006), and,
in some (Chodosh, Kado, Seeman, & Karlamangla, 2007; Dotson et
al., 2008; Paterniti, Verdier-Taillefer, Dufouil, & Alpérovitch, 2002;
Sachs-Ericsson, Joiner, Plant, & Blazer, 2005; Wilson et al., 2002;
Wilson, Leon, Bennett, Bienias, & Evans, 2004) but not all studies
(Bunce, Batterham, Mackinnon, & Christensen, 2012; Chodosh et al.,
2010; Ganguli et al., 2006), depressive symptomatology.
As well as being related to cognitive ability, neuroticism, depressive
symptoms, and cortisol levels have been linked to each other.
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Neuroticism is a normal-range personality trait which encompasses
various closely related facets, including the tendency to depression
(Costa Jr. & McCrae, 1995). Higher neuroticism is a risk factor for
depressive disorders (Kotov, Gamez, Schmidt, & Watson, 2010). Some
studies have found high neuroticism to be related to higher levels
of cortisol secretion (Nater, Hoppmann, & Klumb, 2010; Portella,
Harmer, Flint, Cowen, & Goodwin, 2005), although others have
reported no relationship (Riese, Rijsdijk, Rosmalen, Snieder, & Ormel,
2009; see the introduction of Garcia-Banda et al., 2014 for a brief
review). Depression has been related to muted as well as greater
cortisol awakening responses (Chida & Steptoe, 2009), a flatter diurnal
cortisol slope (Adam et al., 2017), to increased cortisol in response to
psychological stress (Burke, Fernald, Gertler, & Adler, 2005), and to
high cortisol levels in older individuals (Murri et al., 2014) but not in
a set of mixed-age samples (Knorr, Vinberg, Kessing, & Wetterslev,
2010).
7.2.2 Cortisol: Differentiating measures
The aforementioned studies relating cortisol to other variables used
different cortisol measures. Some measures assess overall cortisol
exposure over a sustained period (e.g., urinary cortisol, half a day
or a day; hair cortisol, periods of months), some test cortisol levels
at a particular time of day or during a particular event (e.g., waking
cortisol, evening cortisol, during a lab visit), and some measures aim
to quantify particular dynamics of cortisol secretion (e.g., the cortisol
awakening response, the diurnal cortisol slope, responses to stress;
Nicolson, 2008; Russell, Koren, Rieder, & van Uum, 2012). Here, we
will consider what cortisol is, what cortisol measures are used and how
these measures, which index various aspects of cortisol secretion, have
different relationships with cognitive ability.
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Cortisol is the primary glucocorticoid hormone in humans (Kirschbaum
& Hellhammer, 1989). Cortisol secretion is heightened in response to
stress or challenge and varies according to the time of day (Kirschbaum
& Hellhammer, 1989). Chronic under- or over-secretion of cortisol can
be harmful to health (McEwen, 1998).
Generally, higher cortisol production has been associated with lower
cognitive ability (Franz et al., 2011; Lee et al., 2007; Li et al., 2006;
but see Fonda, Bertrand, O’Donnell, Longcope, & McKinlay, 2005). The
relationship between cortisol and cognition may be partially mediated
by the effects cortisol has on the brain. One specific example is
that the relationship between cortisol and declarative memory may
be mediated through effects on the hippocampus. Experiments have
found that increasing cortisol can negatively affect declarative memory,
which the hippocampus is crucial for (Quervain, Roozendaal, Nitsch,
McGaugh, & Hock, 2000; Squire, 1992). Plus, higher cortisol was
related, although weakly, to lower hippocampal volume in a recent
meta-analysis of late-life depression patients and controls (Geerlings &
Gerritsen, 2017). This effect has also been observed within individuals.
A small longitudinal study into the treatment of Cushing’s syndrome,
which is caused by prolonged and excessive glucocorticoid exposure
(Newell-Price, Bertagna, Grossman, & Nieman, 2006), found that
lowering patients’ cortisol levels can lead to their hippocampal volume
increasing (Starkman et al., 1999 ns = 18 for plasma cortisol, 17 for
urinary cortisol). Other effects on the brain may also help to explain
relationships with cognitive ability. Effects of cortisol on the prefrontal
cortex may partially mediate the relationships cortisol has with working
memory and executive function (Lupien, Gillin, & Hauger, 1999;
McCormick, Lewis, Somley, & Kahan, 2007; Qin, Hermans, van Marle,
Luo, & Fernández, 2009). Additionally, higher cortisol in response to a
stressor has been related to reduced brain white matter integrity (Cox,
Bastin, et al., 2015).
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Although higher cortisol levels are typically linked to lower cognitive
ability, studies relating morning cortisol to cognitive ability have
reported both positive and negative relationships (Beluche et al., 2010;
Comijs et al., 2010; Evans et al., 2011; Geoffroy, Hertzman, Li, & Power,
2012; Kuningas et al., 2007; MacLullich et al., 2005; Stawski et al.,
2011), as well as null results. Methodological differences may partially
explain the variety of results from studies relating morning cortisol
and cognitive measures, including different cognitive domains being
researched and cortisol samples being collected at different points
during the morning (Beluche et al., 2010; Comijs et al., 2010; Evans
et al., 2011; Geoffroy et al., 2012; Kuningas et al., 2007; MacLullich
et al., 2005; Stawski et al., 2011). On multiple occasions, higher
morning cortisol has been found to be related to better executive
functioning (Evans et al., 2011; Stawski et al., 2011), but worse general
cognitive functioning, slower processing speed, (Kuningas et al., 2007;
MacLullich et al., 2005) and lower verbal fluency (Beluche et al., 2010;
Geoffroy et al., 2012). Relationships with memory in both directions
have been reported (Evans et al., 2011; Geoffroy et al., 2012).
Aspects of the dynamics of cortisol secretion, such as the cortisol
awakening response and the diurnal cortisol slope, have also been
studied in relation to cognitive ability. In a person with a healthy
salivary cortisol diurnal pattern, salivary cortisol levels are high
immediately after waking, then rise higher to a peak reached after
around 30 to 45 minutes, before declining gradually to much lower
levels by the end of the day (Adam & Kumari, 2009). A greater cortisol
awakening response, that is, a larger increase in cortisol levels in the
30-45 minutes after waking, has been linked to higher cognitive ability
(e.g., Stawski et al., 2011; Ennis, Moffat, & Hertzog, 2016; Evans et al.,
2011; Evans, Hucklebridge, Loveday, & Clow, 2012; Law, Evans, Thorn,
Hucklebridge, & Clow, 2015; but see Almela, van der Meij, Hidalgo,
Villada, & Salvador, 2012). In addition, a flatter diurnal cortisol slope,
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that is, a smaller decline from morning to evening cortisol levels, has
been related to worse performance on some cognitive measures (e.g.,
Stawski et al., 2011; Evans et al., 2011; but see the null result in Hidalgo,
Almela, Pulopulos, & Salvador, 2016) and greater cognitive decline
on some measures (e.g., Beluche et al., 2010; but see the null result
using serum cortisol in Comijs et al., 2010), although these studies
included null results for relationships with other cognitive domains. In a
previous study of cortisol measures and cognitive ability in the 36-Day
Sample, most of the associations that were statistically significant
suggested higher cortisol levels were related to higher cognitive ability,
although the associations were no longer significant after correction
for multiple testing (Harris, Cox, Brett, Deary, & MacLullich, 2017).
In a male subsample of the Lothian Birth Cohort 1936, which like
the 36-Day-Sample has followed up Scottish Mental Survey 1947
participants in older age, cognitive change since age 11 was related
to reactive cortisol after a cognitive test but unrelated to the diurnal
cortisol slope (Cox, MacPherson, et al., 2015).
7.2.3 Does APOE e4 moderate the relationships of
neuroticism, depressive symptoms and cortisol
levels with cognitive ability and decline?
The aforementioned relationships of neuroticism, depressive symptoms
and cortisol levels with cognitive outcomes may be moderated by
possession of the APOE e4 allele.
Studies using the Ginkgo Evaluation of Memory study sample have
suggested that APOE e4 moderates the deleterious effect of neuroticism
on cognitive ability and decline in older age, such that the effect is
greater in e4 allele carriers (Dar-Nimrod, Chapman, Franks, et al.,
2012; Dar-Nimrod, Chapman, Robbins, et al., 2012). In addition, some
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studies in other samples have suggested that in e4 carriers, depressive
symptomatology is more strongly related to subsequent mild cognitive
impairment risk (Geda et al., 2006), dementia risk (Irie et al., 2008;
Karlsson et al., 2015; Kim et al., 2011) and non-pathological cognitive
decline (Corsentino, Sawyer, Sachs-Ericsson, & Blazer, 2009; Niti,
Yap, Kua, & Ng, 2009; Rajan, Wilson, Skarupski, Leon, & Evans,
2014). However, our recent study found no e4-by-neuroticism or
e4-by-depressive symptoms moderation when testing associations
with contemporaneously measured cognitive ability and subsequent
cognitive decline (Crook et al., 2018). Also, a 2010 study reported no
e4-by-depressive symptomsmoderation in models predicting cognitive
decline (Köhler et al., 2010), and a 2015 study used a large sample
(n > 18,000) and found no e4-by-depression or e4-by-psychological
distress symptoms moderations in models predicting various cognitive
test scores (Luciano et al., 2015).
Studies have also suggested that the effect of cortisol on cognitive
ability may be greater in e4 carriers (Gerritsen et al., 2011; Lee et
al., 2008; Singh-Manoux et al., 2014). In models predicting various
cognitive test scores, interactions of e4 status with the following
cortisol measures have been observed: pretest cortisol, AUC cortisol
during study visit, morning cortisol, diurnal cortisol slope and evening
cortisol (Gerritsen et al., 2011; Lee et al., 2008). Also, one study found
that flatness of diurnal cortisol slope and high bedtime cortisol were
related to verbal fluency decline in APOE e4 carriers (Singh-Manoux
et al., 2014). However, this study conducted analyses stratified by
genotype and the APOE-by-cortisol interaction was not formally tested
(Singh-Manoux et al., 2014).
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7.2.4 The present study
In the present study, we investigate the main effects of neuroticism,
depressive symptoms and cortisol levels on cognitive ability and
cognitive change, as well as the moderation of these effects by APOE e4
allele possession. Data from the 36-Day Sample enabled us to test the
main effects on older age cognition of depressive symptoms, a latent
neuroticism factor, and various cortisol measures from three salivary
samples across the course of a day. Participants were genotyped for
APOE, which enabled us to test the moderation of those effects by
APOE e4 status. Several cognitive tests were administered in older age,
which allowed the estimation of associations with both a latent general
cognitive ability factor and with aspects of cognitive ability unique to
individual tests. Additionally, we were able to fit our models controlling
for age 11 IQ to represent cognitive change over an average of 67 years.
Some previous studies have reported non-significant effects. However,
it was not clear whether these non-significant results provided evidence
for the lack of an effect or were inconclusive as to the presence of an
effect. To overcome this limitation, we used a Bayes factor approach.
For each effect of interest, we calculated Bayes factors to quantify the
relative strength of evidence for the null hypothesis, which assumed no
relationship, and the alternative hypothesis, which was based on effect
estimates from previous research (see Section 7.3.4).
We hypothesised that higher cognitive ability would be related to
greater morning cortisol production and change (waking cortisol,
cortisol awakening response, total cortisol production during the
waking period), while lower cognitive ability would be related to
depressive symptoms, neuroticism, and greater cortisol production
and change over the entire waking day (total cortisol production
during the waking day, diurnal cortisol slope). Regarding the
gene-by-environment moderation of these relationships, we
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hypothesised that all relationships of cognitive ability measures
with cortisol measures, depressive symptoms, and neuroticism would
be more negative in APOE e4 allele carriers.
7.3 Methods
7.3.1 Participants
The study used the 36-Day Sample, a cohort who participated in the
Scottish Mental Survey 1947 (SMS1947) as well as related sociological
data collection. The sample has been followed up in older age to study
healthy ageing (n range for our models = 280-332; M [SD] age in years
at time of cognitive testing = 78.2 [0.9]).
The SMS1947 tested the intelligence of almost all children born in
1936 who were attending school in Scotland (Scottish Council for
Research in Education, 1949). In all, 70,805 children took the Moray
House Test No. 12, a validated intelligence test (Scottish Council
for Research in Education, 1949). Further sociological data were
collected from the 36-Day Sample (n = 7,380), children born on
the first three days of each month. Further data still was collected
from a subset of the 36-Day Sample known as the 6-Day-Sample
(n = 1,208), children born on the first day of all evenly numbered
month, who were followed up almost annually until 1963 (Scottish
Council for Research in Education, 1949). These samples have been
followed up in older age to investigate influences on old-age cognitive
and physical health. The 6-Day-Sample was traced in 2012, where
possible, using the United Kingdom National Health Service Central
Register (NHSCR). Those still living in Great Britain (n = 634), along
with one emigrant, were recruited and sent a home questionnaire.
Later in 2012 and in 2013, those who chose to participate further were
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sent a physical testing kit with associated instructions (n = 174; 92
females). Some participants also went on to take a phone interview
(n = 131; 72 females). The members of the 36-Day Sample who were
not part of the 6-Day-Sample, also known as the 30-Day-Sample,
were traced using the NHSCR in 2013 and those still living in Great
Britain were invited to participate in the study. Further participants
from the 30-Day-Sample then answered the home questionnaire (n =
548; 253 females), underwent physical testing in 2014 (n = 249; 99
females) and took a phone interview (n = 234; 96 females). Further
details about the tracing and recruitment stages for the follow-up of
the 36-Day Sample has been detailed elsewhere (Brett & Deary, 2014;
Deary & Brett, 2015; Harris, Brett, Deary, & Starr, 2016).
7.3.2 Measures
7.3.2.1 Demographic information
Sex and date of birth were recorded at the time of the SMS1947. Dates
of subsequent data collection were noted so that participants’ ages could
be computed.
7.3.2.2 Genotyping
Participants collected their own saliva sample using Oragene OG-500
kits (DNA Genotek, Ottawa, ON, Canada), from which DNA was
extracted. The single nucleotide polymorphisms rs7412 and rs429358
were genotyped to determine APOE genotype. This was done using
TaqMan technology by the Wellcome Trust Clinical Research Facility
Genetics Core at the Western General Hospital in Edinburgh, UK.
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7.3.2.3 Cortisol
Each participant self-collected three saliva samples over the course of
a single day using a Salivette kit (Sarstedt, Rommelsdorf, Germany).
They were instructed to provide samples upon awakening, 45 minutes
later and at 10:00pm that day, and to record the times that each
sample was taken on a questionnaire. Cortisol samples were sent to
the University of Dresden for assaying. They were initially placed in a
centrifuge and revolved at 3000 revolutions per minute for 5 minutes at
4°C, before they were frozen at -80°C. Cortisol levels were measured at
the University of Dresden with an IBL-Hamburg (Hamburg, Germany)
immunoassay kit that uses chemiluminescence detection. The practical
lower sensitivity limit was 0.3 nmol/l and values lower than this were
assigned based on interpolation of the standard curve.
7.3.2.4 Neuroticism
The 6-Day Sample completed a 50-item International Personality
Item Pool questionnaire (“Administering IPIP measures, with a
50-item sample questionnaire,” n.d.) based on Goldberg’s Big Five
factor markers (Goldberg, 1992). The 30-Day Sample completed
the 20-item Mini-International Personality Item Pool questionnaire
(Donnellan, Oswald, Baird, & Lucas, 2006). The four emotional
stability/neuroticism items contained in both scales were used to
measure neuroticism. Participants responded on a Likert scale from
“Very Inaccurate” to “Accurate” how well the statements in the items
described them, with responses scored from 1 to 5.
7.3.2.5 Disease and medication information
The home questionnaire asked participants whether they had various
medical conditions and asked them to indicate any unlisted health
176
problems or illnesses they had. Participants were also asked to list all
medications they were currently taking and the associated doses.
7.3.2.6 Depressive symptoms
The Hospital Anxiety and Depression Scale-Depression subscale
(HADS-D; Zigmond & Snaith, 1983) was administered during the phone
interview to assess participants’ depressive symptoms during the
previous week. This subscale has seven items, each with four ordinal
response options. Each item is scored from 0 to 3, so the possible range
of HADS-D scores is 0 to 21.
7.3.2.7 Cognitive ability
All participants sat the Moray House Test No. 12 (MHT) at age 11 on June
4, 1947 as part of the SMS1947. The MHT is a validated intelligence
test that contains various types of items (Scottish Council for Research
in Education, 1933). To remove the effect of age at the time of the
SMS1947 on MHT scores, we fitted a linear regression of MHT scores
on age at the time of the SMS1947. The residuals from this regression
were used as the age 11 IQ variable in hypothesis-testing models.
We used scores from the following cognitive tests that were
administered during the phone interview: the National Adult Reading
Test (NART; Nelson & Willison, 1991), which tests participants’
pronunciations of irregularly pronounced words; a semantic fluency
test, which required naming as many animals as possible in one minute;
the total number of words recalled on five immediate recall trials on the
Rey Auditory Verbal Learning Test (RAVLT; Schmidt, 1996), a memory
test that requires recall of sets of unrelated words (15 words per trial,
maximum possible score of 75); the total number of words recalled
on the RAVLT delayed recall trial (maximum possible score of 15); the
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Symbol Digit Modalities Test (SDMT; Smith, 1982), a time-limited
test of processing speed that requires matching numbers and abstract
symbols based on a provided key (120 symbol-digit matches to make,
time limit of 90 seconds); and Raven’s Standard Progressive Matrices
(Raven, Raven, & Court, 2000), a nonverbal reasoning test that requires
participants to complete increasingly complex matrices by identifying
patterns (60 items, time limit of 20 minutes).
7.3.3 Statistical analysis
As our interest was in non-pathological cognitive ageing, the 4
genotyped participants who indicated they had Parkinson’s disease or
dementia and provided cognitive test data were excluded from analyses.
Further, the 13 genotyped participants who provided cognitive test data
while using glucocorticoid medication were excluded from analyses
involving cortisol.
We used R Version 3.3.0 (R Core Team, 2016) for data cleaning,
visualisation and statistical analysis. This was facilitated by the R
packages memisc (Elff, 2016), psych (Revelle, 2016), plyr (Wickham,
2011), likert (Bryer & Speerschneider, 2015), gvlma (Pena & Slate,
2014), MplusAutomation (Hallquist & Wiley, 2014) and Hmisc (Harrell
Jr, Charles Dupont, & others., 2016). Latent variable measurement
models and hypothesis testing models were fitted with Mplus Version
7.4 (Muthén & Muthén, n.d.). We assumed missing data were missing
at random. Hence, we used full information maximum likelihood
estimation, as it has been found to perform well when data are
missing at random (Enders, 2010). Mardia’s tests indicated there was
some multivariate skewness in the general cognitive ability tests, and
some multivariate skewness and kurtosis in the neuroticism items, so
robust standard errors were computed in all models using a sandwich
estimator.
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Bayes factors were calculated using an R script (Christie, 2011). This
script is a modified version of a previous R script (Baguley & Kaye, 2010)
that emulates an online Bayes factor calculator (Dienes, 2008).
7.3.3.1 Cortisol measures
Following previous research, we made adjustments to cortisol variable
values so that the variable distributions were approximately normal.
Raw cortisol values more than three standard deviations from the mean
when values were log-transformed were changed to values that were
three standard deviations from the mean on the log-transformed scale
(Stalder et al., 2016). We then attempted to normalise the distributions
of the cortisol variables using square-root, log and various power-based
transformations. The most effective at producing normally distributed
cortisol variables was a transformation previously recommended for
cortisol time series values (Miller & Plessow, 2013). The formula used
was the following, where c’ is the transformed cortisol variable and c is
the raw cortisol variable: c’ = (c0.26 - 1)/0.26
In our hypothesis testing models, we used four different area under
the curve (AUC) cortisol measures calculated with established formulae
(Pruessner, Kirschbaum, Meinlschmid, & Hellhammer, 2003). Measures
calculated with respect to the ground are affected by the difference
between samples as well as how far the samples are from zero, while
measures calculated with respect to the increase are only affected by
the difference between samples (Pruessner et al., 2003). Measures
with respect to the increase index the dynamics of cortisol secretion,
while measures with respect to the ground index both the dynamics
and the amount of cortisol secretion. By studying all four of these
measures, we can tease apart relationships involving the dynamics
and amount of cortisol secretion, in the morning as well as across the
entire waking day.” We also used waking cortisol in our hypothesis
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testing models, because other key studies investigating cortisol and
e4-by-cortisol effects investigated waking cortisol, while they had
different timings than our study for other cortisol samples (Gerritsen
et al., 2011; Singh-Manoux et al., 2014; Stawski et al., 2011). Two of
the AUC measures used the first two samples, and two used the first
and third samples. The AUC measures were:
• cortisol awakening response (CAR): AUC with respect to the
increase between the first two samples
• total cortisol production during the waking period (TCPWP):
AUC with respect to the ground (zero) for the first two samples
• diurnal cortisol slope (DCS): AUC with respect to the increase
between the first and the third sample
• total cortisol production during the waking day (TCPWD): AUC
with respect to the ground (zero) for the first and third samples
The varying time differences between samples were adjusted for
by multiplying each individual’s AUC value by the minimum time
difference in the sample divided by their individual time difference.
This adjustment recentres the AUC values by changing them to
the value they would be if each participant had the minimum time
difference in the sample. Hence, the adjustment statistically removes
the effects of differences in sample timing on AUC values.
The distributions of the raw TCPWP and TCPWD variables were
non-normal and so the same transformation used for the raw cortisol
values was applied to the raw TCPWP and TCPWD values.
Linear regression models were used to residualise cortisol measures
for the following covariates because they have been found to be
related to cortisol production (information was taken from the home
questionnaire): whether participants had diabetes (Hackett, Steptoe, &
Kumari, 2014); time of the first cortisol sample; how often participants
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drank alcohol in the previous 12 months; how often participants had
four or more alcoholic drinks in the last year; whether participants
had an alcoholic drink in the last week (Badrick et al., 2008); whether
participants currently smoked; and how many cigarettes per day
participants currently smoked (Badrick, Kirschbaum, & Kumari, 2007).
The residuals from these models were transformed to have a mean of
0 and a standard deviation of 1, to avoid any model fitting problems
due to the sizes of variances. The resulting variables were used in the
hypothesis testing models.
7.3.3.2 General cognitive ability measurement models
We modelled general cognitive ability and neuroticism as latent
variables, estimated from the covariances between test scores and item
responses respectively, using structural equation modelling (SEM). This
was done in order to evaluate how well the latent models fit our data,
and also to assess the measurement invariance of the models across
the two genotypic groups. Measurement invariance is an important
analytic step as it ensures that the same construct is being measured
in both groups. Measurement models were fitted using only data from
participants who had been genotyped and who had reported data on
the identified covariates (age at phone interview, sex, stroke).
A series of models were estimated to establish the plausibility of the
cognitive ability model. Each model contained a single latent factor
and the six cognitive test scores. The latent factor was identified by
constraining the loading of NART on the latent factor to 1.0. First, the
single factor model was fitted in the e4 allele carriers and non-carriers
separately. Then, a multiple group model was estimated with all
parameters free to vary across groups. This provided the baseline
model fit for subsequent tests of measurement invariance. The groups
for this model were defined by genotype status (e4 carriers and
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non-carriers). Models were evaluated based on three model fit criteria.
We aimed for the following cutoffs defined as indicating acceptable
fit (Schermelleh-Engel et al., 2003): CFI ≥ .95; RMSEA ≤ .08; SRMR ≤
.10. If there was model misfit, modification indices were consulted and
changes made as necessary until a satisfactory fit was obtained.
Measurement invariance was tested to check that our analyses
would be appropriate and that all participants could reasonably be
included in one-group models. We assessed measurement invariance
by sequentially including sets of equality constraints on the model
parameters, and testing for the difference in fit between these models.
Following standard procedures, we tested for measurement invariance
placing constraints on: (1) loadings; (2) intercepts; (3) residuals: and (4)
the correlated residual. To ascertain whether measurement invariance
assumptions held across groups, the sequentially constrained models
were compared based on a chi-square difference test with degrees of
freedom equal to the number of constrained parameters. Note that the
group sizes meant that our measurement invariance tests could detect
major deviations from measurement invariance, but they had limited
power to detect smaller deviations from measurement invariance.
The residual variances for each of the six cognitive tests in the
single-group measurement model of g in genotyped participants were
extracted for use in subsequent models.
7.3.3.3 Neuroticism measurement models
The procedure followed for the neuroticism measurement models was
the same as that for the g measurement models, except no residual
variances were extracted. The factor loading of the first item was fixed
to 1.0 for identification purposes.
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7.3.3.4 Hypothesis testing models
To statistically control for their effects, all models were fitted with the
following variables as covariates of the cognitive outcome: age; sex
(effects coded as -0.5 for females, 0.5 for males); and a dichotomous
indicator of having reported having had a stroke or a mini-stroke
coded as 0 for no and 1 for yes (Kase et al., 1998; Pendlebury &
Rothwell, 2009). Following recent recommendations (Stalder et
al., 2016), for models with the cortisol awakening response as the
predictor of interest, we also fitted models with waking cortisol and
the e4-by-waking cortisol interaction added as predictors.
Along with our main models, we fitted an additional set of childhood
intelligence controlled (CIC) models in which age 11 IQ was added as
a predictor. In the CIC models, the effect of a predictor on older age
cognitive ability can be interpreted as the best available approximation
of the effect of that predictor on cognitive change since age 11.
To properly statistically control for all of the covariates mentioned
here, including age 11 IQ in the CIC models, each model also included
all gene-by-covariate and environment-by-covariate interactions
as predictors of the cognitive outcome (Keller, 2014). So, for
example, in the main model for neuroticism, the following covariate
interactions were included: e4-by-age; e4-by-sex; e4-by-stroke;
neuroticism-by-age; neuroticism-by-sex; and neuroticism-by-stroke.
7.3.4 Bayes factor analyses
In the current analysis, we formulated specific hypotheses about the
direction and magnitude for each of the focal effects of interest in the
study. To ascertain how much evidence the data provided for each of
these hypotheses (alternative hypotheses) compared to the standard
null hypothesis of no effect, we calculated Bayes factors.
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Bayes factors compare two theories as explanations of the data and
indicate how strongly each theory is supported by the data compared
to the other. Bayes factors are a continuous measure of support for
one hypothesis relative to another hypothesis. They indicate how one’s
prior odds for the probabilities of the theories underpinning each of the
hypotheses should be adjusted in light of the data. A Bayes factor of
1 indicates the data do not provide evidence for one theory versus the
other. When comparing a null hypothesis and an alternative hypothesis,
as we do here, a Bayes factor below 1/3 indicates substantial relative
evidence for the null hypothesis, a Bayes factor above 3 indicates
substantial relative evidence for the alternative hypothesis, and a Bayes
factor between 1/3 and 3 indicates no substantial evidence for either
hypothesis (Jeffreys et al., 1961, cited in Dienes, 2014).
The theories compared by Bayes factors are represented by probability
distributions. Note that these distributions represent probability
densities for the effect size of interest and are not the expected
distributions of data under each hypothesis. Here, the null hypothesis
was represented by a distribution with all of the probability density at
an effect size of zero, i.e., a nil null. Each alternative hypothesis was
represented by a half-normal distribution where the standard deviation
was the expected effect size. The expected effect sizes were based
on the previous research cited later in this section. As the alternative
hypotheses were represented by half-normal distributions, all the
probability density in these representations was on the hypothesised
side of zero (i.e., all on the positive or negative side depending on
the hypothesised direction of the effect) and most of the density was
below the expected effect size, which made this a conservative choice
of distribution (Dienes, 2014). Thus, the chosen distribution for each
alternative hypothesis specified both the hypothesised direction and
the hypothesised magnitude of the effect.
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The primary focus of the current study is evaluating evidence for the
interaction with APOE e4 status. Previous research reporting some
of these interactions has found them to be larger in size than the
associated main effects (e.g., Corsentino et al., 2009; Dar-Nimrod,
Chapman, Franks, et al., 2012; Rajan et al., 2014). We took a
conservative approach and considered that this may be an overestimate
of the size of the effect (Ioannidis, 2008), so we limited the expected
interaction effect sizes at the associated expected main effect sizes.
For the AUC cortisol measures, our alternative hypotheses had an
expected main effect size of 0.12. This is the mean effect size of
diurnal variability on four cognitive measures for which coefficients
could be standardised in Gerritsen et al. (2011). The expected effect
size for the AUC cortisol measures interaction, -0.09, was the mean
standardised difference between e4 and non-e4 groups for models
predicting two cognitive measures with diurnal variability that were
reported in full by group in Gerritsen et al. (2011). For waking cortisol,
we limited the expected effect size to 0.08, the size of the association
between morning cortisol and reasoning in Singh-Manoux et al. (2014).
The main effect sizes for depressive symptoms and neuroticism were
taken from Crook et al. (2018), which used a sample closely related to
this study’s sample.
In summary, our expected effect sizes (as standardised betas) were as
follows:
• 0.08: waking cortisol
• -0.08: APOE e4-by-waking cortisol interaction
• 0.12: total cortisol production during the waking period, cortisol
awakening response, cortisol awakening response (waking cortisol
controlled)
• -0.12: total cortisol production during the waking day, diurnal
cortisol slope
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• -0.09: all APOE e4-by-cortisol interactions except for e4-by-waking
cortisol
• -0.18: depressive symptoms
• -0.18: APOE e4-by-depressive symptoms interaction
• -0.25: neuroticism
• -0.25: APOE e4-by-neuroticism interaction
7.4 Results
Table 7.1: Descriptive statistics for cortisol, depressive
symptoms, neuroticism and cognitive tests
n M SD Skew Kurtosis
age at phone interview (years) 330 78.19 0.89 -0.55 -1.26
raw cortisol sample 1 (ug/ml) 307 32.20 27.35 4.32 25.36
raw cortisol sample 2 (ug/ml) 306 32.41 20.58 3.10 18.10
raw cortisol sample 3 (ug/ml) 304 6.73 8.98 3.87 15.83
CAR 297 2.80 26.65 0.25 2.16
TCPWP 297 11.04 0.94 -0.52 2.79
DCS 293 -2.28 1.21 0.52 2.76
TCPWD 293 1.97 0.50 -0.24 4.04
HADS-D 329 2.36 1.85 1.27 1.90
Mini-IPIP item 4 329 2.05 1.12 0.69 -0.59
Mini-IPIP item 9 329 2.65 1.16 0.62 -0.60
Mini-IPIP item 14 328 3.15 1.33 -0.16 -1.20
Mini-IPIP item 19 329 2.93 1.24 0.16 -1.09
National Adult Reading Test 327 34.23 8.32 -0.73 0.18
Semantic fluency 329 18.38 5.25 0.46 0.08
RAVLT immediate recall 326 46.23 11.33 -0.07 -0.43
Symbol Digit Modalities Test 322 42.30 8.92 -0.28 -0.03
Raven’s SPM 326 32.82 7.83 -0.50 -0.13
RAVLT delayed recall 324 9.28 3.42 0.30 -0.41
Moray House Test 316 48.74 10.81 -0.84 0.94
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Note.
CAR = cortisol awakening response. TCPWP = total cortisol production
during the waking period. DCS = diurnal cortisol slope. TCPWD = total
cortisol production during the waking day. HADS-D = Hospital Anxiety
and Depression Scale-Depression. IPIP = International Personality Item
Pool. RAVLT = Rey Auditory Verbal Learning Test. Raven’s SPM = Raven’s
standard progressive matrices.
Table 7.1 contains descriptive statistics. The sample was 56%male (144
females, 186males). There were 250 e4 non-carriers and 80 e4 carriers.
For the non-cortisol variables, those who indicated having Parkinson’s
or dementia or who hadmissing data for the sex, age at phone interview,
APOE e4 status or the stroke variable were excluded. Note that for the
cortisol variables, those for whom residualised cortisol variables were
not created were also excluded, i.e. those who were taking glucocorticoid
medication or had missing data on the cortisol covariates. Atypically,
most included participants had higher cortisol values upon awakening
than they did 45 minutes later. As expected, though, for almost all
participants cortisol values were higher in the early samples than in the
late sample. The n range for the models fitted was 280-332, which
meant that our measurement invariance tests were likely powered to
detect major but not minor deviations from measurement invariance.
7.4.1 Measurement models
7.4.1.1 General cognitive ability measurement models
One correlated residual, between RAVLT immediate recall and RAVLT
delayed recall, was added to the general cognitive ability measurement
model to improve fit based on its modification index. This correlated
residual was retained in subsequent models. Chi-square tests indicated
that measurement invariance of test loadings, intercepts and residuals
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held across e4 carriers and non-carriers (all ps ≥ .05). The results
of these model indicated that there were no statistically identifiable
differences in the measurement of general cognitive ability across the
e4 status groups. As a result, it was reasonable to conduct subsequent
analyses on a single combined sample. The final measurement model
for general cognitive ability, fitted in a single group model, fit well: CFI
= .986; RMSEA = .056; SRMR = .031. The standardised loadings in this
model were .54 for NART, .39 for semantic fluency, .44 for immediate
recall, .32 for the Symbol Digit Modalities Test, .74 for Raven’s matrices
and .67 for delayed recall. The correlation between the recall residuals
was .75.
7.4.1.2 Neuroticism measurement models
One correlated residual, between Mini-IPIP items 4 and 14, was added
to the model. It made the best improvement to fit of two correlated
residuals we considered, each of which had near-identical modification
indices. Chi-square tests indicated that measurement invariance of
test loadings, intercepts and residuals held across e4 carriers and
non-carriers (all ps ≥ .05). The final neuroticism measurement model,
fitted in a single group, fit well: CFI = 0.999; RMSEA = .015; SRMR
= .014. The standardised item loadings were -.28, .52, .58 and .43
for Mini-IPIP items 4, 9,14 and 19 respectively, and the correlation
between the residuals of items 4 and 4 was .18. Again, as with
the general cognitive ability models, the results indicated that there
were no statistically identifiable differences in the measurement of
neuroticism across groups, and support the use of a combined single
sample for subsequent analyses.
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7.4.2 Hypothesis testing via Bayes factors
Tables 2-7 contain the results from models predicting general cognitive
ability, and the predicting of specific cognitive abilities over and above
g. Each table presents standardised betas, standard errors and Bayes
factors from 16 models, as two model types were fitted for each of the
eight predictors. For each predictor, a main model was fitted. Each
main model included the main effect of the predictor, the interaction of
the predictor with APOE e4 status, and all health and other covariates.
For each predictor, we also fitted a model which added statistical
control for age 11 IQ on the older age cognitive measures. For each
predictor, comparing the models with and without control for childhood
intelligence enabled us to consider whether controlling for prior ability
attenuates effects. The range of ns for the main models was 294
to 332. The range of ns for the models with childhood intelligence
controlled was 280 to 317.
In the sections that follow, we first present the results for general
cognitive ability, before discussing the models predicting the residuals
for each of the cognitive tests. The latter set of models essentially
investigated the effects of cortisol, depression and neuroticism on
specific cognitive domains after controlling for general ability (for
example, is there a specific effect of depressive symptoms on semantic
fluency?).
7.4.2.1 General cognitive ability
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Table 7.2: General cognitive ability predicted by cortisol





































WC 0.12 0.07 2.40 -0.08 0.08 1.35 0.06 0.11 1.06 -0.05 0.06 1.17
CAR 0.03 0.07 0.70 0.00 0.08 0.66 0.00 0.12 0.69 0.00 0.05 0.52
CAR (WCC) 0.15 0.09 2.49 -0.10 0.10 1.40 0.04 0.12 0.87 -0.06 0.07 1.15
TCPWP 0.14 0.07 5.23 -0.11 0.09 1.59 -0.01 0.11 0.66 -0.05 0.07 1.02
DCS -0.02 0.08 0.66 0.02 0.08 0.58 -0.05 0.10 0.91 -0.05 0.05 1.08
TCPWD 0.06 0.07 0.30 -0.01 0.10 0.79 -0.03 0.10 0.81 -0.04 0.06 0.86
DS -0.15 0.08 3.47 0.08 0.07 0.21 -0.04 0.08 0.61 0.02 0.05 0.21
N 0.11 0.10 0.19 -0.17 0.11 2.07 0.24 0.18 0.30 -0.06 0.10 0.60
Note.
MM = main model. CICM = childhood intelligence controlled model. SE = standard error. BF = Bayes factor.
WC = waking cortisol. CAR = cortisol awakening response. WCC = waking cortisol controlled. TCPWP = total
cortisol production during the waking period. DCS = diurnal cortisol slope. TCPWD = total cortisol production
during the waking day. DS = depressive symptoms. N = neuroticism.
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Table 7.2 contains the results from models with the general cognitive
ability factor as the outcome. We used Bayes factors to compare the
null hypothesis of no effect to pre-specified alternative hypotheses.
This means that for each effect tested, we can assess whether there
was relative evidence for the null compared to the alternative (BF ≤
1/3), relative evidence for the alternative compared to the null (BF ≥
3), or no strong relative evidence for either hypothesis (1/3 < BF <
3). The table shows that most Bayes factors produced were between
1/3 and 3, which means that for most tests, neither the alternative
nor the null hypothesis was strongly supported. Here, we will note
the hypothesised effects that were supported (BF ≥ 3, evidence for
the alternative hypothesis) and effects where results suggested no
relationship was more likely than the hypothesised relationship (BF ≤
1/3, evidence for the null hypothesis).
7.4.2.1.1 Depressive symptoms and general cognitive ability.
Depressive symptoms were related to lower contemporaneous general
cognitive ability (β [SE] = -0.15 [0.08], BF = 3.47). However, in
the model controlling for childhood intelligence, the results were
inconclusive regarding whether depressive symptoms were related to
worse general cognitive change since childhood (β [SE] = -0.04 [0.08],
BF = 0.61). Both before and after controlling for childhood intelligence,
the effect of depressive symptoms on general cognitive ability did not
vary depending on APOE e4 status (main model β [SE] = 0.08 [0.07],
BF = 0.21; childhood intelligence controlled model β [SE] = 0.02 [0.05],
BF = 0.21).
7.4.2.1.2 Total cortisol produced during the waking period and
general cognitive ability. The total cortisol produced during the
waking period was related to higher general cognitive ability (β [SE]
= 0.14 [0.07], BF = 5.23). Total cortisol produced during the waking
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period was not related to change in general cognitive ability (β [SE] =
-0.01 [0.11], BF = 0.66).
7.4.2.1.3 Total cortisol produced during the waking day and
general cognitive ability. The total cortisol produced during the
waking day was not related to general cognitive ability (β [SE] =
0.06 [0.07], BF = 0.30). However, there was no strong evidence
regarding this measure’s relationship with general cognitive change
since childhood (β [SE] = -0.03 [0.10], BF = 0.81).
7.4.2.1.4 Neuroticism and general cognitive ability. The null
hypotheses that neuroticism was not related to general cognitive
ability or general cognitive change were supported (main model β [SE]
= 0.11 [0.10], BF = 0.19; childhood intelligence controlled model β [SE]
= 0.24 [0.18], BF = 0.30).
7.4.2.2 Cognitive test residual models
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Table 7.3: National Adult Reading Test residuals predicted





































WC -0.17 0.08 0.47 0.09 0.07 0.36 -0.14 0.11 0.50 0.10 0.06 0.25
CAR 0.11 0.08 2.19 0.00 0.06 0.56 0.10 0.11 1.26 0.00 0.06 0.55
CAR (WCC) 0.11 0.10 1.55 0.09 0.09 0.43 0.04 0.12 0.85 0.13 0.08 0.33
TCPWP -0.03 0.08 0.44 0.11 0.08 0.33 -0.04 0.12 0.59 0.15 0.07 0.21
DCS -0.01 0.07 0.54 -0.03 0.07 0.80 -0.14 0.10 1.82 -0.07 0.06 1.44
TCPWD -0.08 0.08 1.21 0.06 0.08 0.47 -0.23 0.10 5.17 0.05 0.06 0.33
DS 0.05 0.07 0.22 0.04 0.05 0.18 0.04 0.06 0.22 0.00 0.05 0.26
N -0.17 0.10 2.11 -0.06 0.08 0.57 -0.28 0.14 4.45 -0.01 0.08 0.34
Note.
MM = main model. CICM = childhood intelligence controlled model. SE = standard error. BF = Bayes factor.
WC = waking cortisol. CAR = cortisol awakening response. WCC = waking cortisol controlled. TCPWP = total
cortisol production during the waking period. DCS = diurnal cortisol slope. TCPWD = total cortisol production
during the waking day. DS = depressive symptoms. N = neuroticism.
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Table 7.4: Semantic fluency residuals predicted by cortisol





































WC -0.13 0.07 0.29 0.09 0.07 0.35 -0.21 0.09 0.29 0.10 0.07 0.34
CAR 0.00 0.07 0.52 -0.03 0.07 0.80 -0.02 0.10 0.59 -0.02 0.07 0.76
CAR (WCC) -0.14 0.09 0.26 0.09 0.08 0.41 -0.16 0.11 0.34 0.11 0.09 0.38
TCPWP -0.13 0.07 0.20 0.07 0.08 0.39 -0.21 0.10 0.27 0.09 0.08 0.35
DCS 0.02 0.08 0.46 0.04 0.08 0.52 -0.06 0.11 0.96 0.04 0.08 0.52
TCPWD -0.13 0.06 4.77 0.15 0.06 0.17 -0.26 0.09 20.32 0.17 0.06 0.17
DS 0.02 0.07 0.27 0.00 0.06 0.34 0.06 0.07 0.21 0.01 0.07 0.30
N -0.05 0.08 0.55 -0.05 0.08 0.52 0.07 0.10 0.24 -0.07 0.08 0.70
Note.
MM = main model. CICM = childhood intelligence controlled model. SE = standard error. BF = Bayes factor.
WC = waking cortisol. CAR = cortisol awakening response. WCC = waking cortisol controlled. TCPWP = total
cortisol production during the waking period. DCS = diurnal cortisol slope. TCPWD = total cortisol production
during the waking day. DS = depressive symptoms. N = neuroticism.
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Table 7.5: RAVLT immediate recall residuals predicted by





































WC -0.04 0.07 0.49 0.15 0.08 0.30 0.11 0.12 1.30 0.15 0.07 0.28
CAR 0.04 0.08 0.75 -0.17 0.06 13.41 0.03 0.15 0.86 -0.17 0.06 14.66
CAR (WCC) 0.11 0.08 0.69 -0.16 0.09 3.04 0.03 0.13 0.84 -0.18 0.09 3.54
TCPWP 0.02 0.06 0.38 0.11 0.08 0.34 0.06 0.12 0.95 0.11 0.08 0.35
DCS -0.02 0.07 0.59 -0.14 0.07 5.17 0.00 0.10 0.64 -0.14 0.07 3.82
TCPWD -0.04 0.06 0.80 0.14 0.08 0.28 0.03 0.12 0.61 0.15 0.08 0.28
DS -0.20 0.06 79.60 0.02 0.06 0.25 -0.18 0.08 6.62 0.01 0.06 0.28
N -0.02 0.09 0.40 0.16 0.06 0.07 0.07 0.12 0.29 0.15 0.06 0.06
Note.
MM = main model. CICM = childhood intelligence controlled model. SE = standard error. BF = Bayes factor.
WC = waking cortisol. CAR = cortisol awakening response. WCC = waking cortisol controlled. TCPWP = total
cortisol production during the waking period. DCS = diurnal cortisol slope. TCPWD = total cortisol production
during the waking day. DS = depressive symptoms. N = neuroticism.
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Table 7.6: Symbol Digit Modalities Test residuals predicted





































WC 0.15 0.08 2.75 -0.13 0.07 3.48 0.18 0.12 1.94 -0.16 0.07 6.92
CAR -0.11 0.07 0.24 0.11 0.06 0.24 -0.12 0.12 0.44 0.11 0.06 0.22
CAR (WCC) -0.04 0.10 0.53 0.06 0.09 0.50 -0.05 0.14 0.66 0.04 0.09 0.57
TCPWP 0.12 0.08 1.96 -0.07 0.07 1.32 0.09 0.14 1.12 -0.11 0.08 1.95
DCS -0.04 0.09 0.81 0.04 0.08 0.49 0.13 0.14 0.51 0.05 0.09 0.54
TCPWD 0.13 0.07 0.22 -0.11 0.06 3.40 0.23 0.11 0.28 -0.15 0.06 7.11
DS -0.08 0.07 1.18 0.06 0.07 0.20 -0.01 0.07 0.43 0.05 0.06 0.21
N 0.09 0.35 0.73 -0.03 0.36 0.85 0.09 0.12 0.26 -0.01 0.07 0.28
Note.
MM = main model. CICM = childhood intelligence controlled model. SE = standard error. BF = Bayes factor.
WC = waking cortisol. CAR = cortisol awakening response. WCC = waking cortisol controlled. TCPWP = total
cortisol production during the waking period. DCS = diurnal cortisol slope. TCPWD = total cortisol production
during the waking day. DS = depressive symptoms. N = neuroticism.
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Table 7.7: Raven’s Standard Progressive Matrices residuals






































WC 0.09 0.07 1.72 -0.15 0.07 4.75 0.08 0.12 1.14 -0.16 0.07 5.63
CAR 0.04 0.06 0.72 0.01 0.05 0.47 0.00 0.11 0.69 0.01 0.05 0.43
CAR (WCC) 0.15 0.08 3.25 -0.18 0.08 4.41 0.11 0.11 1.30 -0.16 0.08 3.55
TCPWP 0.10 0.07 2.03 -0.22 0.08 12.14 0.02 0.11 0.74 -0.22 0.07 16.72
DCS 0.03 0.08 0.43 0.07 0.07 0.37 0.00 0.13 0.74 0.05 0.07 0.42
TCPWD 0.07 0.07 0.26 -0.13 0.07 3.05 0.10 0.15 0.57 -0.15 0.07 4.40
DS 0.04 0.06 0.19 -0.05 0.06 0.63 0.02 0.06 0.25 -0.06 0.06 0.77
N 0.15 0.09 0.14 -0.10 0.07 1.25 0.28 0.15 0.20 -0.11 0.09 1.16
Note.
MM = main model. CICM = childhood intelligence controlled model. SE = standard error. BF = Bayes factor.
WC = waking cortisol. CAR = cortisol awakening response. WCC = waking cortisol controlled. TCPWP = total
cortisol production during the waking period. DCS = diurnal cortisol slope. TCPWD = total cortisol production
during the waking day. DS = depressive symptoms. N = neuroticism.
19
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Table 7.8: RAVLT delayed recall residuals predicted by





































WC 0.04 0.08 0.99 0.04 0.09 0.59 0.14 0.13 1.39 0.01 0.08 0.69
CAR 0.01 0.07 0.54 -0.08 0.06 1.92 0.00 0.13 0.71 -0.08 0.06 2.02
CAR (WCC) 0.01 0.09 0.66 -0.10 0.11 1.33 0.03 0.13 0.83 -0.14 0.11 1.73
TCPWP 0.06 0.08 0.94 0.04 0.10 0.59 0.05 0.13 0.91 -0.01 0.09 0.76
DCS -0.01 0.08 0.60 -0.10 0.07 2.04 0.08 0.10 0.44 -0.07 0.07 1.27
TCPWD 0.06 0.07 0.31 0.01 0.09 0.67 0.10 0.12 0.46 -0.01 0.09 0.75
DS -0.12 0.06 2.90 0.00 0.06 0.33 -0.12 0.09 1.71 -0.02 0.07 0.44
N -0.05 0.09 0.53 0.17 0.07 0.08 -0.07 0.12 0.72 0.16 0.07 0.07
Note.
MM = main model. CICM = childhood intelligence controlled model. SE = standard error. BF = Bayes factor.
WC = waking cortisol. CAR = cortisol awakening response. WCC = waking cortisol controlled. TCPWP = total
cortisol production during the waking period. DCS = diurnal cortisol slope. TCPWD = total cortisol production
during the waking day. DS = depressive symptoms. N = neuroticism.
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Tables 7.3-7.8 contain 192 coefficients from 96 models. For most of
these coefficients (130), there was not strong evidence for either the null
or the alternative hypothesis. Nonetheless, 24 show evidence in favour
of the alternative and 38 show evidence in favour of the null. Here, we
will describe some of the most notable results in these tables, including
depressive symptoms and neuroticism results, as well as results from
tests of e4-by-cortisol interactions.
7.4.2.2.1 Depressive symptoms and cognitive test residuals.
Depressive symptoms were related to worse (residualised) immediate
recall, both before and after controlling for childhood intelligence
(main model β [SE] = -0.20 [0.06], BF = 79.60; childhood intelligence
controlled model β [SE] = -0.18 [0.08], BF = 6.62). The null hypothesis
was supported in models where depressive symptoms predicted
National Adult Reading Test, semantic fluency and Raven’s matrices
residuals. The null hypotheses that the relationships of depressive
symptoms with cognitive test residuals did not vary according to APOE
e4 status was supported in the models with and without childhood
intelligence controlled for the National Adult Reading test, immediate
recall and Symbol Digit Modalities Test residuals.
7.4.2.2.2 Neuroticism and cognitive test residuals. Of the 24
neuroticism effects tested, 13 provided no strong evidence for either
the null or the alternative hypothesis, 10 provided evidence for the
null, and only one provided evidence for the alternative hypothesis.
Notably, there was strong evidence for the null hypotheses about the
e4-by-neuroticism interaction predicting immediate and delayed recall
residuals (β range = 0.15-0.17, BF range = 0.06-0.08, all p-values <
.05 ). These results suggested that after general cognitive ability was
taken into account, possessing the e4 allele was related to higher recall
scores, the opposite to what was hypothesised.
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7.4.2.2.3 APOE e4-by-cortisol interactions and immediate recall
residuals. The relationship between the cortisol awakening response
and immediate recall residuals was more negative in e4 carriers
(main model β [SE] = -0.17 [0.06], BF = 13.41; childhood intelligence
controlled model β [SE] = -0.17 [0.06], BF = 14.66), including after
waking cortisol levels were controlled for (main model β [SE] = -0.16
[0.09], BF = 3.04; childhood intelligence controlled model β [SE] =
-0.18 [0.09], BF = 3.54). The diurnal cortisol slope, the other cortisol
dynamics measure studied, was also more strongly negatively related
to immediate recall residuals in e4 carriers than E4 non-carriers (main
model β [SE] = -0.14 [0.07], BF = 5.17; childhood intelligence controlled
model β [SE] = -0.14 [0.07], BF = 3.82). On the other hand, the total
cortisol produced during the waking day interaction coefficients were
positive, rather than negative, as was expected. There was evidence for
the null hypothesis about this interaction (main model β [SE] = 0.14
[0.08], BF = 0.28; childhood intelligence controlled model β [SE] = 0.15
[0.08], BF = 0.28).
7.4.2.2.4 APOE e4-by-cortisol interactions and Raven’s matrices
residuals. Measures of total cortisol production related more
negatively to Raven’s matrices residuals in E4 carriers. The evidence
for the e4 interaction was stronger for the total cortisol production
during the waking period (main model β [SE] = -0.22 [0.08], BF =
12.14; childhood intelligence controlled model β [SE] = -0.22 [0.07],
BF = 16.72) than the total cortisol production during the waking day
(main model β [SE] = -0.13 [0.07], BF = 3.05; childhood intelligence
controlled model β [SE] = -0.15 [0.07], BF = 4.40).
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7.4.2.3 Age 11 IQ effects in cognitive test residual models
Briefly, it is of interest to note the magnitude of the effects of age 11
IQ predicting the residuals for each cognitive test after controlling for g.
These coefficients give an indication of how strongly prior general ability
as measured by the Moray House Test No. 12 relates to specific abilities
over and above general ability in later life. The β ranges were: 0.44
to 0.51 for NART residuals; 0.07 to 0.11 for semantic fluency residuals;
-0.07 to -0.03 for immediate recall residuals; -0.03 to 0.00 for symbol
digit residuals; 0.14 to 0.19 for Raven’s residuals; and -0.14 to -0.13 for
delayed recall residuals.
7.5 Discussion
In this replication-and-extension study, we tested the older-age
associations of depressive symptoms, neuroticism and six cortisol
measures with general cognitive ability and the specific variance
associated with six cognitive tests. We also tested whether these
associations were moderated by possession of the APOE e4 allele.
Additionally, we repeated each model with age 11 cognitive ability as a
covariate of the cognitive outcome to test associations with cognitive
change since childhood.
We replicated previous findings that depressive symptoms are related to
worse general cognitive ability, with a small-to-moderate effect size.
However, unlike in some previous studies, this negative association was
not stronger in e4 carriers. We also found that producing more cortisol
during the waking period (the first ~45 minutes after waking) was
related to higher general cognitive ability, with a small-to-moderate
effect size. We failed to replicate an association between neuroticism
and worse general cognitive ability. Also against expectations, the
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total cortisol produced during the waking day was not related to worse
general cognitive ability.
We will now discuss the notable results from models relating depressive
symptoms, neuroticism and cortisol to the specific variance of cognitive
tests, categorised by predictor type.
7.5.1 Depressive symptoms
Depressive symptoms seem to be mostly related to cognitive test scores
through a factor of general cognitive ability.
After removing the variance in cognitive tests associated with the
general factor, we found depressive symptoms were not related to
results on the National Adult Reading Test, a semantic fluency test or
Raven’s matrices. For those three tests, there was relative support for
the null hypothesis (versus the alternative hypothesis that a negative
association does exist).
However, we did find that depressive symptoms were related to
lower residualised immediate recall test scores. Future research could
also investigate the relationship between depressive symptoms and
delayed recall residuals (BF = 2.90). This result is consistent with
previous research that compared depression cases and controls, as a
meta-analysis found memory was impaired in depression and there
was greater impairment on immediate recall than delayed recall (Burt,
Zembar, & Niederehe, 1995).
Overall, results suggested that depressive symptoms were not more
strongly related to cognitive ability or cognitive change since childhood
in e4 carriers. Interestingly, the lack of moderation matches most
previous studies that have measured cognition with multiple tests
along with an ordinal or continuous depressive symptoms variable
(Crook et al., 2018; Köhler et al., 2010; Luciano et al., 2015; but see
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Rajan et al., 2014) and contrasts with studies that have used cognitive
impairment screeners or cognitive impairment diagnoses as outcomes
(Corsentino et al., 2009; Geda et al., 2006; Irie et al., 2008; Karlsson
et al., 2015; Kim et al., 2011; Niti et al., 2009). It is possible, then,
that depressive symptoms are more strongly negatively related to
pathological cognitive ageing in e4 carriers, but are not more strongly
negatively related to ability in cognitively healthy individuals. This
would follow from studies of amyloid-associated depression, which is
characterised by a high amyloid-β (Aβ) 40 to Aβ 42 peptides (Sun et
al., 2008). Amyloid-associated depression has been related to broader
cognitive impairment than nonamyloid depression (Sun et al., 2008)
and it may indicate greater risk for Alzheimer’s disease in e4 carriers
(Qiu et al., 2015).
7.5.2 Neuroticism
Overall, the results suggested neuroticism did not have a moderate
strength relationship to poorer cognitive ability.
The expected effect size for the neuroticism effects was -0.25, which
was the estimate for the relationship between neuroticism and general
cognitive ability in the Lothian Birth Cohort 1936 (Crook et al., 2018).
This was stronger than the other expected effect sizes. Future studies
should adjust the expected effect for this main effect based on our
results, as our study suggests it is unlikely that the relationship is this
strong.
After removing general cognitive variance, neuroticism seemed to be
related to better immediate and delayed recall in e4 carriers, both before
and after controlling for childhood intelligence; these interactions were
statistically significant and positive, the opposite to the hypothesised
direction. Future studies into the e4-by-neuroticism interaction should
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consider the cognitive tests used.
7.5.3 Cortisol
The cortisol measure with the most notable results was the total
cortisol production during the waking day. Against expectations, it
was not related to worse general cognitive ability. It also displayed
interesting patterns of results in the models predicting cognitive test
residuals. For example, as hypothesised, it was related to poorer
semantic fluency ability, both before and after controlling for childhood
intelligence. Against expectations, though, this relationship was
stronger in e4 non-carriers rather than e4 carriers; the e4 interactions
in these models were statistically significant in the unexpected direction
(positive). Also against expectations, producing more cortisol over the
day was not related to poorer symbol digit modalities residuals. This
relationship was positive, so although the e4 interaction was supported
in these models, it made the association less positive rather than more
negative in e4 carriers. If the effects studied here exist and are related
primarily to the total amount of cortisol produced rather than cortisol
dynamics, it would follow that the total cortisol production during
the waking day, which incorporates all cortisol production throughout
the waking day, should be the cortisol measure most closely linked to
cognitive variables. Future studies on cortisol-cognition relationships
should consider using this cortisol measure and should aim to clarify
relationships involving it and cognitive abilities.
Notably, the relationship between a flat diurnal cortisol slope and poorer
immediate recall was stronger in e4 carriers, which replicated one of
Gerritsen et al. (2011)’s findings.
A steeper cortisol awakening response (both with and without control
for waking cortisol) and a flatter diurnal cortisol slope were related to
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poorer immediate recall residual scores. The latter finding replicates
Gerritsen et al. (2011), who used raw immediate recall scores rather
than residuals from a general factor model. On the other hand,
waking cortisol and the total cortisol produced during the waking
day were not related to worse performance on immediate recall in e4
carriers; parameter estimates for these interactions were positive and
small-to-moderate in effect size.
Finally, we did not replicate Evans et al. (2012). Their study found a
greater cortisol awakening response was related to better executive
functioning (Evans et al., 2012). However, in our main model without
control for waking cortisol levels, the association between the cortisol
awakening response and semantic fluency residuals was close to zero.
After controlling for waking cortisol, the association was negative and
the Bayes factor provided notable evidence for the null hypothesis.
Hence, our data suggested no relationship is more likely than a positive
relationship regarding cortisol awakening response and executive
functioning.
7.5.4 Strengths and weaknesses
One methodological strength of this study was the calculation of
Bayes factors for each hypothesis. This made it possible for us to find
evidence for the null hypothesis, and made it clear when this was the
case compared to when there was simply no clear evidence for either
the null or the alternative hypothesis. We encourage the interested
reader to consider their own alternative hypotheses for the main and
interaction effects being tested here and calculate their own Bayes
factors. One can do this by entering their prior expectations about
the relevant effect, along with the estimate and standard error from
this study, into an online calculator (Dienes, n.d.). Alternatively, or in
addition, the reader can decide on their prior odds for the alternative
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theories we present. These prior odds can then be multiplied by the
Bayes factors obtained to produce the reader’s posterior odds for the
probability of the theory.
A strength of this study is that a measure of age 11 intelligence was
available, which enabled us to test the relationships of older age
depressive symptoms, neuroticism and cortisol with long-term change
in cognitive ability. Another strength was the number and range of
measurements available in older age. Having three cortisol samples
enables different aspects of cortisol secretion to be investigated. Plus,
having several cognitive test results enabled a strong general factor
of cognitive ability to be fitted using structural equation modelling,
and relationships with general and specific cognitive variance to be
separately tested. In addition, having item-level neuroticism data
enabled a latent factor of neuroticism, rather than a sum score, to be
used in model testing. Unlike sum scores, latent variable scores weight
the contributions of indicators by how strongly they relate to the factor
(DiStefano, Zhu, & Mîndrilă, 2009). This means that the resulting
factor scores are more valid estimates of the factor than sum scores,
because they are not contaminated by measurement error or by the
variance specific to each indicator (DiStefano et al., 2009).
The main weakness of this study was the sample size, which was
insufficient to provide substantial evidence for either the null or the
alternative hypothesis in most cases. The study would also have
benefitted from longitudinal measurements of the predictors and the
outcome in older age, as this would have enabled the relationships
between changes in these variables over time to be analysed.
Another limitation of the study is that the cognitive test used in
childhood differed from those used in older age. This meant that our
tests of effects on cognitive change since childhood were only the best
available approximations of such effects. The approximation worked
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well for cognitive outcomes where age 11 IQ was strongly linked to
older age ability, such as general cognitive ability, but for the residuals
of some cognitive tests, not having childhood results on the same test
limited the study’s capability to test effects on change.
Finally, a limitation of this study is that it did not test whether the
relationships between the predictors and the outcomes were nonlinear.
Spurious interaction effects are sometimes found when one of the
predictors has a nonlinear relationship with the outcome and this
nonlinearity is omitted from the model (Belzak & Bauer, 2019). This
was less likely in our study because the sample size was relatively
large and the APOE-predictor correlations were not very strong (Belzak
& Bauer, 2019). Future studies should consider testing nonlinear
relationships between the interacting predictors and the outcome,
particularly in studies where the sample size is small.
7.5.5 Directions for future research
Future research could apply a similar design to a larger sample of
older adults, so that substantial evidence would be produced for more
hypotheses. Researchers could also recalibrate the effect sizes expected
by alternative hypotheses based on our results and/or their personal
beliefs.
Ideally, future studies should include continuous subclinical measures,
like the questionnaire and tests used in our study, as well as clinical
measures of depression and cognition. This would enable a nuanced
approach to be taken to studying these relationships.
7.5.5.1 Incorporating amyloid-beta measurement
Also worth exploring are possible pathways through which these
potential moderations could function. A prime candidate pathway
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would be Aβ load.
Studies have reported that the relationship between Aβ load and
cognition is moderated by e4 status such that in e4 carriers, Aβ load
has a medium-strength negative relationship with cognition, but in
non-e4 carriers there is only a weak negative relationship if there is one
at all (Kantarci et al., 2012; Lim et al., 2013). Depression has also been
consistently linked to Aβ load (Harrington, Lim, Gould, & Maruff, 2015),
and one study using a sample with various cognitive statuses found a
positive relationship between plasma cortisol and Aβ load (Toledo et
al., 2012). In addition, a recent study using a sample of cognitively
healthy older adults reported that plasma cortisol moderated the effect
of Aβ load on some cognitive declines such that in those with high Aβ
load, decline was greater in those with high plasma cortisol (Pietrzak
et al., 2016).
A study with longitudinal measures of all relevant variables could
help to clarify these relationships and understand which particular
relationships, if any, are moderated by e4 status. This could also help
to clarify the directions of the relationships between variables, for
example, whether Aβ plaques tend to precede or follow depressive
episodes. In a previous example of this approach, autoregressive latent
trajectory modelling was used to find that depressive symptoms are
related to later memory decline, but memory was not related to later
change in depressive symptoms (Zahodne, Stern, & Manly, 2014).
7.5.5.2 Glucocorticoids: Experimentation
With regard to the relationships involving cortisol, a range of related
options are available if the effects of glucocorticoids in general are
studied instead.
Researchers could also take an experimental approach to testing the
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effect and the moderation of the effect of glucocorticoids on cognition.
For example, previous studies have tested the effects of acute and
chronic hydrocortisone administration on cognitive ability (Porter,
Barnett, Idey, McGuckin, & O’Brien, 2002; Young, Sahakian, Robbins,
& Cowen, 1999). A similar design could be used with the addition of
genotyping participants.
7.5.5.3 Glucocorticoids: Observing exposure
Another option would be to study people who have already been exposed
to high levels of glucocorticoids. For example, one study looked at
the relationship between glucocorticoid medication and psychiatric
disorders (Fardet, Petersen, & Nazareth, 2012), while other researchers
have used a case-control design to look at the effects of previous
Cushing’s disease on psychopathology and cognition (Tiemensma,
Biermasz, et al., 2010; Tiemensma, Kokshoorn, et al., 2010). To study
the moderation of relations by e4 status, the genotyping of participants
would be added to the design.
7.5.6 Conclusion
In summary, we investigated the relationships of depressive symptoms,
neuroticism and cortisol with cognitive ability in older age, including
the moderation of these relationships by APOE e4 allele possession.
Depressive symptoms were related to poorer general cognitive ability,
and, beyond that, to poorer immediate recall ability. However,
depressive symptoms were not more strongly negatively related to
general cognitive ability or immediate recall ability in APOE e4 carriers,
in both models with and without control for childhood intelligence.
Against expectations, neuroticism and the total cortisol produced
during the waking day were not related to poorer general cognitive
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ability. A steeper cortisol awakening response and a flatter diurnal
cortisol slope were related to worse immediate recall ability in e4
carriers. However, there were also cortisol effects on specific cognitive




This chapter will begin by summarising the key findings of each study in
the thesis. The chapter will then consider the wider applicability of the
findings of this thesis. The limitations of our findings will be discussed.
Following this, we will identify potentially fruitful future directions for
allostatic load research. Finally, we will summarise the conclusions and
discussion points of this chapter.
8.1 Summary of findings
The studies in Chapters 4-6 applied latent growth curve modelling
to LBC1936 study data to test the contemporaneous (age ~70) and
associated change (ages ~70 to ~79) relationships of allostatic load
and other physiological and psychological variables.
In Chapter 4, we tested the contemporaneous and longitudinal
relationships of allostatic load and three other physiological weathering
measures: biological age, epigenetic age, and telomere length.
The two most closely related measures were allostatic load and
biological age, which are calculated using mostly the same biomarkers.
Contemporaneously measured allostatic load and biological age were
211
moderately correlated. Change in the two variables over time was
strongly correlated. However, aside from allostatic load and biological
age, the physiological weathering measures tended to be only weakly
correlated, so the measures seem to mostly index different aspects of
physiological weathering.
The next two chapters tested the associations of allostatic load with
psychological variables. The Chapter 5 study found that higher allostatic
load was correlated with lower general cognitive ability, although with
only a small effect size. After controlling for participant dropout, the
effect size was reduced by approximately a third, which suggested that
the correlation was partially driven by those who dropped out of the
study. The study also tested the correlation between change in allostatic
load and change in general cognitive ability, but the estimates for this
parameter were not large and standard errors were wide relative to
the estimates. Next, the Chapter 6 study found that higher allostatic
load was correlated with contemporaneously depressive symptoms and
the effect size was small-to-moderate. As with the previous chapters,
estimates of longitudinal relationships produced small effect sizes and
wide standard errors.
Finally, the study in Chapter 7 fitted structural equation models
to 36-Day Sample study data. This study tested the relationships
of cognitive ability measures with cortisol measures, depressive
symptoms, and neuroticism, and whether these relationships were
moderated by possession of the APOE e4 allele. The study used Bayes
factors to calculate the evidence the data provided for alternative and
null hypotheses about the relationships. The total cortisol production
during the waking period was related to higher general cognitive ability,
with a small effect size. The total cortisol produced during the entire
waking day was not related to general cognitive ability. Additionally,
depressive symptoms were related to lower general cognitive ability
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and this relationship was not moderated by APOE e4.
8.2 Is allostatic load clinically useful for
psychological conditions?
Allostatic load researchers have often suggested that allostatic load
summary scores may be clinically useful for psychological conditions.
For example, Seeman et al. (1997) studied cognitive ageing, as well
as physical functioning and cardiovascular disease, and concluded
that “the concept of allostatic load may provide the basis for a more
comprehensive assessment of major risks in the aging process” (Seeman
et al., 1997, p. 2259). Regarding depressive symptoms, Juster et al.
(2011) posited that allostatic load scores could be used to identify and
more effectively treat individuals at risk of depressive symptoms.
The studies in Chapters 5 and 6 used a non-clinical sample and
measures of allostatic load, cognitive ability and depressive symptoms
that provided substantial information about sub-clinical individual
differences. The results of these studies, then, cannot be generalised
to clinical populations. The results can, however, inform as to whether
allostatic load scores would greatly help clinicians hoping to identify
older adults at risk of cognitive ageing and depressive symptoms. We did
find that allostatic load was related to contemporaneously measured
general cognitive ability and depressive symptoms. Importantly,
though, effect sizes for these relationships were small. Estimates were
also small for the dual change relationships in these studies and the
confidence intervals for these parameters were wide. Due to the small
sizes of these effects, we must conclude that allostatic load scores offer
limited clinical utility for cognitive ageing and depressive illness.
Nevertheless, the allostatic load concept may still have some clinical
213
utility for these conditions. As the effect sizes are small, large datasets
will be required to leverage the allostatic load model. For example,
as referenced in Chapter 6, a machine learning algorithm helped
to identify the allostatic load biomarker serum glucose as a novel
marker for depressive symptoms in a large cohort study (Dipnall
et al., 2016). Analyses of even larger datasets, such as national
electronic health records (see Bates, Saria, Ohno-Machado, Shah,
& Escobar, 2014 for an overview of big data and health research),
could benefit from the allostatic load model. For example, a recent
study using electronic health records from the UK National Health
Service to predict first cardiovascular events found that machine
learning algorithms incorporating additional allostatic load biomarkers
from the metabolic system improved prediction of cardiovascular
events relative to established formulas (Weng, Reps, Kai, Garibaldi, &
Qureshi, 2017). This study may have benefitted from including primary
mediators of allostatic load, such as cortisol, as plasma cortisol was
found to be a cause of cardiovascular disease in a recent Mendelian
randomisation study (Crawford, Timpson, Smith, & Walker, 2015).
Similar approaches could potentially be applied to predicting cognitive
ageing and depressive symptoms.
In summary, allostatic load scores seem to offer little clinical utility
for cognitive ability and depressive symptoms. The allostatic load
model, though, points towards markers and pathways that can improve
prediction of non-psychological conditions and show promise for the
prediction of psychological conditions.
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8.3 Relationships with cognitive ability:
allostatic load vs. cortisol
If allostatic load summary scores are to be clinically useful, then
they should relate more strongly to outcomes of interest than single
biomarkers. In this thesis, we used data from two similar older age
samples to test how cognitive ability relates to allostatic load scores
and various cortisol measures. Comparing the effect sizes from these
studies enables us to roughly assess whether the effect sizes are similar
or suggest that cognitive ability relates substantially more strongly to
allostatic load or cortisol. For contemporaneously measured general
cognitive ability, the correlation with allostatic load in the LBC1936 was
-.13 (mean age at Wave 1 = 69.5 years), while the mean standardised
beta for cortisol measures in the 36-Day-Sample was .09 (mean age
= 78.2 years). After dropout was added to the model, the allostatic
load-general cognitive ability correlation was attenuated to -.08. In
this model, the correlation was the relationship for those who did not
drop out by Wave 4 (mean age = 79.3 years), when participants were
close in mean age to the 36-Day-Sample at the time of their cognitive
tests. In conclusion, the effect sizes for these relationships all tend to
be small and do not suggest that allostatic load summary scores have
substantially greater clinical utility than cortisol measures for older age
cognitive ability. This conclusion chimes with the previous research
described in the introduction of Chapter 5; studies relating cognitive
ability to allostatic load summary measures and individual allostatic
load biomarkers have both tended to report small-to-moderate effect
sizes.
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8.4 On our allostatic load operationalisation
Our LBC1936 allostatic load operationalisation used biomarkers from
the cardiovascular, inflammatory/immune and metabolic systems
(including BMI, an anthropometric marker; see Juster et al., 2010,
Figure 4 for a categorisation of allostatic load biomarkers). It did not
include any neuroendocrine biomarkers, nor any primary mediators
of the stress response (Juster et al., 2010; Seplaki et al., 2005). This
is a notable limitation, because neuroendocrine markers and other
primary mediators differentiate allostatic load measures from other
biomarker composites based on clinical markers (Seeman et al., 2001),
including metabolic syndrome summaries (Eisenmann, 2008) and the
Framingham Risk Score (D’Agostino et al., 2008). Primary mediators
have been found to improve prediction of mortality as well as physical
and cognitive declines (Goldman, Turra, et al., 2006; Karlamangla et
al., 2002; Seeman et al., 2001).
Our allostatic load operationalisation then, might also be thought of as
an expanded measure of metabolic syndrome, or more generally as a
measure of multisystem physiological dysregulation. Note that these
limitations were part of a necessary trade-off, as cohort studies that
do have allostatic load data on primary mediators lack the repeated
measures and/or the other variables required to answer most of our
research questions. It is extremely rare to have, as the LBC1936 has, four
waves of data on the same allostatic load biomarkers, DNA methylation,
telomere length, and an extensive battery of gold-standard intelligence
tests.
It is worth considering what different allostatic load operationalisations
imply about the importance of different biomarkers and physiological
systems. The calculation methods used in most allostatic load studies,
including ours, weight every biomarker equally. For example, in a
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study using sample quartile-based cutoffs, for all biomarkers used a
biomarker value in the quartile indicating highest risk would add 1 to
an individual’s allostatic load score. This means that the contribution
of each physiological system to the overall score will depend on the
biomarkers included in the score calculation.
However, many allostatic load studies, including ours, use secondary
data. In a secondary data study, the researchers must work with a
previously determined biomarker set. If the researcher uses all the
measured allostatic load biomarkers are when calculating allostatic
load scores, the contribution of each physiological system to allostatic
load scores will also be dictated by the data collection protocol. If
the researcher chooses to use only a subset of the measured allostatic
load biomarkers, the available weightings of each physiological system
can also be limited; for example, in our study, no neuroendocrine
biomarkers were collected, so the contribution of this system was fixed
at zero. Future allostatic load studies with neuroendocrine biomarkers
could test their hypotheses using allostatic load scores computed
using different biomarker sets, to assess the effects of including
neuroendocrine biomarkers and varying the weighting of different
physiological systems.
Perhaps the most commonly used allostatic load operationalisation
with differential weighting of biomarkers is factor analysis. This
approach, however, has various problems, as outlined in Chapter 2. In
Section 8.6, we will mention an upcoming test of a novel allostatic load
operationalisation with differential weighting of biomarkers.
8.5 Constraints on generality
Characteristics of our studies’ samples and designs place constraints
on how broadly our findings can be generalised. We were interested
217
in processes of change in older age, so we used samples that were
older aged and homogeneous in age. This means that our findings
may not generalise to other age groups. In particular, allostatic load
may relate differently over time to biological age and epigenetic age in
age-heterogeneous samples.
Results from our models that assumed missing data were not missing
at random hint at another constraint on generality. The most notable
difference in these models was that the baseline correlation between
allostatic load and general cognitive ability was attenuated by around a
third after dropout was included in the model, which suggests that the
correlation was weaker in participants who remained healthy enough to
participate in the study up to around age 79. There are twomain aspects
to this selection effect: a survivor effect and a participation effect.
Around 75% of Scottish Mental Survey 1947 participants survived to
age 70 (Čukić et al., 2017). By age 79, the proportion of survivors was
reduced to around 55% (Čukić et al., 2017). Regarding participation,
most potential participants contacted declined to participate (Deary et
al., 2007). Also, generally, those who do participate in epidemiological
studies tend to be more educated and have higher socioeconomic status
(Galea & Tracy, 2007). An example comes from the 6-Day-Sample,
which we used data from in Chapter 7. The mean difference in age 11
Terman-Merill IQ between the full sample and those who survived to
age 77 was 2.4 IQ points, while the mean difference between those
who survived and those who participated in the follow-up study was a
substantially larger 8.8 IQ points (Johnson, Deary, & Bouchard, 2017).
Both survivor and participation effects, then, made our follow-up
sample less-than-representative of the nearly whole population
studied in the Scottish Mental Survey 1947. Future studies of allostatic
load and general cognitive ability in older age should keep in mind
that this relationship may be weaker in participants willing and able to
participate at older ages.
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Also, the samples we used were ethnically homogeneous as all
participants were white. Previous research has observed differences in
allostatic load between ethnic groups (e.g., Geronimus, Hicken, Keene,
& Bound, 2006), so if these differences were not mirrored on the other
variables studied here, then the correlations observed may differ in a
sample with a different ethnic makeup.
Our findings may also not generalise to studies using other allostatic
load and cortisol calculation methods. One example is that the
contemporaneous and longitudinal correlations between allostatic
load and biological age would likely be smaller if a non-continuous
operationalisation of allostatic load was used.
8.6 Future directions
Many interesting and worthwhile studies could follow from those
presented here. Here, we will focus on three broader issues for future
research: the choice of operationalisations, data size, and the length of
time between measurements.
Debate remains around which allostatic load operationalisation is the
most appropriate. We have preregistered a study (Crook & Booth,
2017a) that aims to clarify how closely correlated allostatic load scores
from different operationalisations are, as well as how strongly different
allostatic operationalisations relate to three key criterion variables:
depressive symptoms, self-rated health, and mortality. The study
will calculate allostatic load scores using nine calculation methods,
including a novel method based on weighting biomarkers’ score
contribution by their association with perceived psychological stress.
This new operationalisation has some parallels with Klemera-Doubal
biological age, which weights biomarkers’ contribution to biological
age estimates based on how closely they relate to chronological age.
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We will apply the nine calculation to four biomarker sets: primary
mediators of allostatic load; secondary outcomes of allostatic load; a
full set of available allostatic load biomarkers; and a smaller set of more
commonly measured biomarkers. The correlations between scores and
comparisons of criterion variable associations should help to elucidate
whether a secondary outcome-based operationalisation like the one in
this thesis should be expected to produce similar scores and results to
another operationalisation.
It is also worth noting that results will be affected by how the
other study variables are operationalised. For example, in Chapter
7, we tested associations between cortisol measures and a factor
of neuroticism. However, neuroticism has various facets, including
anxiety, depression, angry hostility, and impulsiveness (Costa Jr. &
McCrae, 1995). These facets likely have different relationships with
cortisol levels and dynamics. For example, a study of adolescents found
that vulnerability and impulsiveness, but not angry hostility, were
related to higher basal cortisol, while no relationships were found with
other cortisol measures (Laceulle, Nederhof, van Aken, & Ormel, 2015).
Hence, if we had chosen to operationalise neuroticism using its facets,
our results would have differed. The thesis’s results would also have
differed if we operationalised other variables, such as biological age or
depressive symptoms, using different indicator variables or calculation
methods.
Another important issue is data size. Allostatic load is associated
with psychological variables, such as cognitive ability and depressive
symptoms, but with only small-to-moderate effect sizes. Also,
allostatic load, cognitive ability and depressive symptoms are
multifaceted, so there are complex relationships underlying the
associations observed between summary variables. This means that
where hypotheses are being tested, larger datasets will be required
220
to provide strong evidence for the null or alternative hypotheses. For
example, the study in Chapter 7 did not produce strong evidence for
the null or the alternative hypothesis for most parameters tested
because of the modest sample size. When planning data collection or
acquisition, researchers tend to focus on obtaining an adequate sample
size. Often, less focus is placed on the various other study design
variables that can affect statistical power. In longitudinal studies,
the dataset’s size and shape, not just the sample size, are important:
statistical power can be improved by increasing the number of repeated
measures. For instance, the dual change associations tested in this
thesis often had large standard errors, which would have been reduced
if the same participants had been observed on more occasions (Hertzog
et al., 2006).
The statistical power to detect correlated change is also affected
by the growth rate reliability, which depends on the proportion of
between-individual variance as well as the duration of the study,
the number of measurements, and the timing of measurements
(Willett, 1989). Hence, researchers can increase the power of a
study to detect a slope-slope correlation by carefully planning the
timing of measurements (Rast & Hofer, 2014). For example, intensive
measurement burst designs early in a study can improve power in the
earlier phases of a longitudinal study (Rast & Hofer, 2014). Future
research using secondary data should take care to note where models
have not precisely estimated a parameter of interest or hypothesis
tests have not provided strong evidence for or against the focal
hypothesis. Future research collecting new data should use power
calculations and/or data simulation, combined with estimates from
previous studies, to ensure that their studies will provide adequate
answers to their research questions.
Finally, to better understand the relationships investigated in this
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thesis, future research should collect data with different lengths of
time between measurements. In our longitudinal studies, we focused
on long-term changes in older age. The LBC1936 has a typical cohort
study design, where many variables are measured at each wave and the
waves are a few years apart, so it was ideal for this purpose. Also, both
the LBC1936 and the 36-Day-Sample enabled us to test associations
with age 11 IQ, an example of the advantages of uncommon gaps
between measurements. Going forward, researchers planning cohort
studies should consider having some measurements weeks, days or
hours apart rather than years apart. This would help to elucidate how
allostatic load and its biomarkers relate to other variables at shorter
timespans. For example, one study measuring blood pressure, heart
rate and affect measured each variable four times each working day
for two weeks (Ilies, Dimotakis, & Watson, 2010). Another measured
burnout symptoms every day for two weeks and measured the cortisol
awakening response and dehydroepiandrosterone-sulphate on two
days, as well as the dexamethasone-suppressed cortisol awakening
response on a third day (Sonnenschein et al., 2007). Importantly,
these short-term bursts of repeated measures can be included within a
cohort study that has longer gaps between its main measurement waves
(Sliwinski, 2008). The Effects of Stress on Cognitive Aging, Physiology
and Emotion project, for instance, has four 14-day measurement burst
periods across a three-year period (Scott et al., 2015). Each wave
includes smartphone surveys and cognitive tests throughout each day,
five days where four saliva samples are delivered, and a lab visit for
further tests (Scott et al., 2015). Particularly if researchers wish to use
burst sampling on a subset of a larger cohort, representative sampling
can be used alongside planned missingness designs to maximise
statistical power for a given budget (Rhemtulla, Savalei, & Little,
2016). In summary, cohort studies with years between measurements
provide only a snapshot of allostatic load levels. Designs incorporating
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measurement of allostatic load biomarker measurements with shorter
intervals will help to elucidate how allostatic load develops and how it
relates to cognitive ability and depressive symptoms within the day or
the week rather than only over periods of years.
8.7 Summary
Although this thesis found allostatic load was associated with
contemporaneously measured general cognitive ability and depressive
symptoms, the effect sizes were small. The contemporaneous
association between allostatic load and general cognitive ability in
the LBC1936 was of a similar size to the average association between
cortisol and general cognitive ability in the 36-Day-Sample. Hence,
our results suggest that for cognitive ability and depressive symptoms,
allostatic load summary scores have limited clinical utility. The
generalisability of our findings is constrained by aspects of our sample
and design. This includes our allostatic load operationalisation,
as scores were calculated from allostatic load secondary outcome
biomarkers, and no primary mediators of allostatic load were included.
To better understand correlations between allostatic load scores from
different operationalisations, as well as how the use of different
operationalisations affects relationships with criterion variables, we
preregistered and will conduct an allostatic load operationalisation
comparison study. Future substantive studies should carefully consider
their allostatic load operationalisation(s) and our preregistered study
will assist with that. To ensure that they can answer their research
questions, studies that collect new data should also ensure that they
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Considering the Appropriateness
of the Factor Analytic
Operationalization of
Allostatic Load
In a recent issue of Psychosomatic Medicine, Wiley et al.
(1) made a valuable contribution to the discussion of the
optimal measurement of allostatic load (AL). In the most
comprehensive factor analytic investigation of AL to date,
they found that a bifactor model with a general AL factor
and seven physiological system factors fits better than a
higher-order model in which the seven system factors
loaded on the general AL factor. Similar models have been
applied by the author (T.B.) and others to operationalize AL
(2–4). Here, we consider the primary theoretical assump-
tions underlying latent variable modeling, argue that the
construct of AL is inconsistent with these assumptions,
and propose alternate operationalizations of AL.
UNDERLYINGCONSTRUCT (COMMONCAUSE)
A latent variable model is estimated based on the patterns of
covariance in a set of variables. By including an AL general
factor in a latent variable model, researchers are positing that
an underlying construct is the common cause of the observed
covariation in all of the modeled biological measures. Al-
though the theoretical relation of the common cause or con-
struct to the original variables differs in bifactor versus
higher-order models, in either case, wemust ask:What could
this common factor be? Wiley et al. stated that the AL factor
“[captures] the notion that there is an underlying process
influencingmultiple physiological systems” ((1): p. 4). How-
ever, the observation of a general factor estimated from inter-
individual summary statistics (i.e., covariances) says little
about what this process may actually be.
INDEPENDENCE CONDITIONAL ON THE
LATENT TRAIT
A primary assumption of latent variable models is that once
the effect of the latent factors has been accounted for, the mea-
sured variables—in this case, the biological measures—are in-
dependent. This is unlikely to be the case with AL measures.
Levels of different biomarkers are linked causally to each
other, rather than only through the common cause latent vari-
able(s). For example, body mass index (BMI) has previously
been used as a metabolic system AL biological measure
(e.g., (2,5)). However, Mendelian randomization studies have
found that increased BMI has a causal effect on levels of
other metabolic biological measures as well as levels of AL
biomarkers used to represent other physiological systems,
such as blood pressure and inflammation (e.g., (6)). Thus,
it is most likely that the biomarkers are not conditionally in-
dependent but are instead dynamically related in complex
networks. Such networks can produce observed correla-
tions between variables that have no common cause (7).
INTERCHANGEABILITY OF INDICATORS
A further assumption of the latent variable model is that the
definition of the latent variable does not change when dif-
ferent sets of indicators are used (8). This holds because
the indicators are affected by, but do not affect, the latent
variable. Another key finding ofWiley et al. was that fitting
models in which the biological measures from each of the
7 physiological systems were excluded caused no large
changes in AL factor loadings (1). This method provides
only a weak test of interchangeability. The stability of gen-
eral intelligence factor loadings has long been a research
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focus for intelligence researchers, so AL researchers may
benefit from applying their approaches to this issue (e.g.,
(9,10)). For example, researchers could compute and corre-
late AL scores from different nonoverlapping multisystem
sets of biological measures (8). The existence of diverse
causal links between AL biological measures from different
physiological systems suggests to us that the nature of what
relates the biomarkers may change depending on which
measures are included in the model. We predict that more
thorough, more powerful tests of the stability of AL factor
loadings will find that it does not hold.
FORMATIVE VERSUS REFLECTIVE INDICATORS
In the common factor model, the biological measures are re-
flective indicators, that is, they are manifested by a common
cause latent variable. However, to the extent that the model
assumptions are violated (previously discussed), the factor
model is not appropriate. Thus, it may instead be profitable
to consider the biological measures as formative indicators,
that is, as variables that define the construct (8). This way
of thinking about how the biological measures relate to AL
is consistent with any number of weighted or sum scores.
It is also consistent with AL theory, in that more severe, more
widespread physiological dysregulation will relate to higher
AL scores.
Alternatively, the associations between AL biological
measures could be modeled using each measure individu-
ally, without the need for any single latent or observed sum-
mary. This could be done with network analysis, which has
been used beneficially by researchers studying symptom
networks in mental disorders (11). Allostatic load indicators
can also be modeled separately without consideration of
their associations. Consistent with this approach, Psycho-
somatic Medicine typically provides data of separate bio-
logical measures when articles report about complex
phenomena such as AL and metabolic syndrome.
Aside from any issues regarding model assumptions,
two further points warrant comment about the models pre-
sented by Wiley et al.
IMPROVED MODEL FIT FOR BIFACTOR
APPROACH
The complex causal links between biological measures
from different physiological systems also help to explain
why the bifactor AL model fits better than the hierarchical
AL model. The hierarchical model imposes “proportional-
ity constraints” ((12): p. 115): the ratio of the AL general
factor loadings to the system factor loadings is constrained
to equality within the biological measures of each physio-
logical system. Considering the diverse causal links be-
tween different AL biomarkers, both within and across
systems, these proportionality constraints are likely to be vi-
olated. Furthermore, it has been shown that when the true
model contains “unmodelled complexity” ((13): p. 407) in
the form of small correlated residuals and cross-loadings,
or even modeled complexity in the form of correlated resid-
uals across factors, fit indices and criteria may be biased in
favor of the bifactor model. Consequently, the better fit of
the bifactor model follows from AL theory and research,
as well as from methodological findings, for reasons other
than those Wiley et al. (1) focused on.
VARIANCE EXPLAINED BY PHYSIOLOGICAL
DYSREGULATION FACTORS
Statistically, a desirable property of a general factor is that it
accounts for most variance in the constituent indicator var-
iables. In the study by Wiley et al., the AL factor explained
only approximately 11% of the variance in the AL biologi-
cal measures. Some of the physiological system-specific
factors were also weak. For example, the hypothalamic-
pituitary-adrenal axis and inflammation factors explained
only approximately 9% and 16% of the variance in their re-
spective biological measures. Note that weak factor satura-
tion of physiological dysregulation factors has also been an
issue in other samples (2,3).
PROPERTIES OF OPTIMAL SCORES FOR AL
Ideally, AL scores should be: 1) calculated using biological
measures from various physiological systems; 2) consis-
tently calculated across samples; and (3) closely related to
criterion variables. Those who desire scores that are rooted
in AL theory would prefer the AL scoring method that pro-
duces the scores most closely related to chronic/repeated
perceived stress. For a pragmatist, the focus may not be
on investigating how different physiological dysregulation
scores relate to prior perceived stress but rather on find-
ing the scores that most strongly predict important health
outcomes such as cardiovascular disease and death. It
may also be advantageous to have scores that explicitly rep-
resent the accumulation of the effects of repeated environ-
mental challenges.
Our theoretical and methodological concerns with the
factor analytic operationalization of AL suggest to us that
factor scores will not prove to be the optimal AL scoring
method. We therefore believe that further research is re-
quired to determine the optimal operationalization(s) of AL.
ZANDER CROOK, MSc
Department of Psychology
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The Authors Reply: Pursuing
the Optimal Operationalization
of Allostatic Load
In their commentary on our paper (1), Crook and Booth (2)
raise important questions regarding the theoretical and
methodological appropriateness of applying factor analysis
to model allostatic load (AL). They argue that factor scores
are not the “optimal” measure of AL and conclude that
more research is needed.
From a methodological perspective, Crook and Booth ar-
gue that the poor fit of the hierarchical model may be due to
the proportionality constraint inherent in its structure.Whether
the proportionality constraint or other features of the model
are the sources, it does not change the result that the hierar-
chical model provided an inferior fit to the data than did the
bifactor model. Considering the bifactor model, Crook and
Booth suggested a stronger test of exchangeability by com-
puting and correlating AL scores from nonoverlapping bio-
markers (2). However, unlike intelligence research, studies
on biomarkers tend to have relatively few indicators as a
consequence of feasibility factors (e.g., available blood sam-
ple volume, participant burden, and cost). Separating already
limited biomarker panels into two nonoverlapping sets will
be too few to estimate the bifactor model in many studies.
As advances in multiplexing reduce barriers to assaying nu-
merous biomarkers (3), we look forward to studies that ad-
dress this question.
Crook and Booth also note that, on average, the general
factor explains approximately 11% of the variance in the
biomarkers (2). In psychometric studies of carefully designed
scales, 11%may be considered a small amount of variance,
but this is expected for biomarkers for several reasons.
First, except for the heart rate variability measures, each
biomarker is distinct (e.g., interleukin 6 and tumor necrosis
factor α are separate analytes with unique roles in the im-
mune system and inflammatory processes). Second, bio-
markers have circadian rhythms, which introduce variability
due to the timing of assessment. Third, the timeframe reflected
in each biomarker varies. For example, glycosylated hemo-
globin approximately indexes the previous three months,
overnight urinary epinephrine and norepinephrine index
approximately 12 hours, and blood pressure is compara-
tively momentary. Fourth, the general factor accounted for
variance over and above the covariates age and sex. There-
fore, we expected the general factor to account for a modest
amount of the variance in biomarkers. Furthermore, consid-
ered over and above the effects of age, 11% of the variance
is not necessarily trivial. Finally, the overall model (i.e.,
general + system factors and covariates) accounted for an
average of 55% of the variance in biomarkers, rising to
60% when excluding soluble intracellular adhesion mole-
cule 1 and low-density lipoprotein. If researchers believe
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